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SUMMARY 
Parkinson's disease (PD) is a neurodegenerative disease characterized by 
a set of motor and non-motor symptoms. Gait disorders are among the most 
disabling motor impairments in PD patients, as they severely affect their 
quality of life. 
In recent decades, the treadmill has been explored as a tool for improving 
gait in PD. Understanding the mechanisms underlying these improvements 
will ameliorate the efficacy and prescription of physical therapy in PD. 
However, in spite of the growing body of evidence that links gait to cognitive 
function, the role played by attention in the gait improvements associated to 
treadmill walking in PD is still unknown. In the same way, the possible 
associated neurophysiological mechanisms have never been explored.  
However, transcranial direct current stimulation (tDCS), a form of non-
invasive brain stimulation, has been explored recently in order to improve 
gait in PD, and offers a promising tool in increasing the efficacy of 
rehabilitative interventions. It could also enhance our understanding of PD-
pathophysiology. Nevertheless, the combined use of tDCS and the treadmill 
in PD has not yet been investigated. 
The work presented here consists of three studies. The first explores the 
attentional demands involved in gait improvements associated with the 
treadmill in PD. The second investigates the immediate kinematics and 
neurophysiological effects of a single treadmill walking session on PD. The 
third study investigates the kinematic and neurophysiological effects of the 
combined use of tDCS and treadmill walking in patients with PD. 
The results of this thesis do not support attentional resources as a possible 
mechanism for treadmill-associated gait improvements in PD. Likewise, a 
specific therapeutic effect of a single treadmill walking session on gait in PD 
was observed, with no associated neurophysiological changes in the 
outcomes measured. However, the combination of tDCS and treadmill 
resulted in a specific spinal excitability modulation. Further studies would be 
recommended to explore the role of belt displacement and constant speed as 
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main underlying mechanisms. Additional studies are also needed to 
investigate the functional significance of the interaction of tDCS and treadmill 
walking in PD. 
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RESUMEN 
La enfermedad de Parkinson (EP) es una enfermedad neurodegenerativa, 
caracterizada por un conjunto de síntomas motores y no motores. Los 
trastornos de la marcha se consideran entre los síntomas motores más 
incapacitantes que afectan severamente a la calidad de vida de los pacientes 
con EP. 
En las últimas décadas, el tapiz rodante ha sido explorado como una 
herramienta que mejora la marcha de los pacientes con EP. Conocer los 
mecanismos subyacentes a estas mejoras, ayudará a aumentar la eficacia y 
la prescripción de la fisioterapia en la EP. Sin embargo, a pesar de la creciente 
evidencia que vincula la marcha a la función cognitiva, todavía no sabemos 
el papel de la atención como mecanismo subyacente a las mejoras de la 
marcha asociadas al tapiz rodante en la EP. De la misma manera, no se han 
explorado los posibles mecanismos neurofisiológicos asociados. 
Por otro lado, se ha explorado recientemente la estimulación transcraneal 
de corriente continua directa (tDCS), una modalidad de estimulación cerebral 
no invasiva, para mejorar la marcha en la EP, ofreciendo una herramienta 
prometedora para potenciar la eficacia de las estrategias de rehabilitación, 
además de mejorar nuestra comprensión de la fisiopatología en la EP. Sin 
embargo, todavía no ha investigado la combinación de tDCS con el tapiz 
rodante en la EP. 
El trabajo presentado aquí consta de tres estudios. El primero explora si 
las demandas atencionales están involucradas en las mejoras de la marcha 
asociadas con el tapiz rodante en la EP. El segundo investiga los efectos 
cinemáticos y neurofisiológicos inmediatos de una sesión de tapiz rodante en 
la EP. El tercer estudio explora los efectos cinemáticos y neurofisiológicos de 
la combinación de tDCS y tapiz rodante en la EP. 
Los resultados de esta tesis indican que los recursos atencionales no 
explican las mejoras de la marcha asociadas sobre el tapiz rodante en la EP. 
Del mismo modo, se observó un efecto terapéutico específico de sola sesión 
de tapiz rodante sobre la marcha en la EP, sin cambios neurofisiológicos 
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asociados. Sin embargo, la combinación de tDCS y tapiz resultó en una 
modulación específica a nivel espinal. Recomendamos más estudios que 
exploren el papel del desplazamiento de la banda rodante y la velocidad 
constante como principales mecanismos subyacentes, así como, se necesitan 
más estudios para investigar la importancia funcional de la combinación de 
la tDCS y el tapiz rodante en la EP. 
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RESUMO 
A enfermidade de Parkinson (EP) é unha enfermidade neurodexenerativa, 
caracterizada por un conxunto de síntomas motores e non motores. Os 
trastornos da marcha considéranse entre os síntomas motores máis 
incapacitantes que afectan severamente á calidade de vida dos pacientes con 
EP. 
Nas últimas décadas, o tapiz rodante foi explorado como unha ferramenta 
que mellora a marcha na EP. Coñecer os mecanismos subxacentes a estas 
melloras, incrementará a eficacia e a prescrición da fisioterapia na EP. Con 
todo, a pesar do crecente corpo de evidencia que vincula a marcha á función 
cognitiva, aínda non se sabe se a atención xoga aquí un papel primordial. Da 
mesma maneira, os posibles mecanismos neurofisiolóxicos asociados nunca 
foron explorados. 
Doutra banda, explorouse recentemente a estimulación cerebral 
transcraneal de corrente contínua directa (tDCS), unha modalidade de 
estimulación cerebral non invasiva, para mellorar a marcha na EP, ofrecendo 
unha ferramenta prometedora para potenciar a eficacia das intervencións de 
rehabilitación, ademais de mellorar a nosa comprensión da fisiopatoloxía na 
EP. Con todo, aínda non investigou a combinación de tDCS co tapiz rodante 
na EP. 
O traballo presentado aquí consta de tres estudos. O primeiro explora se 
as demandas atencionais están involucradas nas melloras da marcha 
asociadas co tapiz rodante na EP. O segundo investiga os efectos cinemáticos 
e neurofisiolóxicos inmediatos dunha sesión de tapiz rodante na EP. O terceiro 
estudo explora os efectos cinemáticos e neurofisiolóxicos da combinación de 
tDCS e tapiz rodante na EP. 
Os resultados desta tese indican que os recursos atencionais non explican 
as melloras da marcha asociadas sobre o tapiz rodante na EP. Do mesmo 
xeito, observouse un efecto terapéutico específico de soa sesión de tapiz 
rodante sobre a marcha na EP, sen cambios neurofisiolóxicos asociados. Con 
todo, a combinación de tDCS e tapiz rodante resultou nunha modulación 
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específica a nivel espinal. Recomendamos máis estudos que exploren o papel 
do desprazamento da banda rodante e a velocidade constante como 
principais mecanismos subxacentes, así como, necesítanse máis estudos para 
investigar a importancia funcional da combinación da tDCS e o tapiz rodante 
na EP. 
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PREFACE 
The present work, the thesis titled Treadmill walking in the gait 
rehabilitation in Parkinson's disease: neurophysiological mechanisms and 
their combination with the non invasive brain stimulation contains 
experimental work performed between 2013 and 2017 at Faculty of Sports 
Science and Physical Education of University of A Coruña, Department of 
Sports Science. Also, some work was performed during an stance in the 
laboratoy at the Department of Nutrition, Exercise and Sport Sciences at 
University of Copenhagen under the supervision of Dr. Jens Bo Nielsen from 
September to December 2014. 
Three original experimental studies are included. The first and third 
studies have already been published in the international peer review journal 
American Journal of Physical and Rehablitation Medicine. The second study is 
under review in the peer review journal Human Movement Science. 
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1.1 GENERAL OVERVIEW OF PARKINSON´S DISEASE 
Parkinson’s disease (PD) is a common progressive neurodegenerative 
disorder described in 1817 by James Parkinson in the classic “Essay on the 
Shaking Palsy” (Parkinson, 2002). The cardinal signs of PD are related to 
motor dysfunction, including resting tremor, bradykinesia, rigidity, gait 
disturbances and postural instability (Jankovic, 2008; Berardelli et al., 2013). 
Nevertheless, PD is characterized clinically by a combination of motor and 
non-motor symptoms that severely threaten the quality of life (QoL) (Schrag 
et al., 2000; Barone et al., 2009; Soh et al., 2011) and poses a significant 
economic burden on patients and society (Noyes et al., 2006; Findley, 2007). 
The main pathological finding associated with the motor deficits of PD is 
the degeneration of the dopaminergic neurons of the substantia nigra pars 
compacta (SNc) (Halliday et al., 2011). The motor symptoms appear when 
at least 60% of dopaminergic neurons are lost and 80–85% of dopamine 
content in the striatum is depleted (Jankovic, 2008). Catecholaminergic and 
serotoninergic brainstem neurons may also degenerate. Lewy bodies 
(eosinophilic inclusion bodies containing many different proteins) are present 
mainly in the surviving neurons (Braak et al., 2003). The pathogenesis 
mechanisms that cause dopaminergic cell death may include defective 
handling of proteins, mitochondrial dysfunction, oxidative stress, and 
inflammation (Schapira & Jenner, 2011). 
1.1.1 Epidemiology 
PD is considered to be the second most common neurodegenerative 
disorder after Alzheimer’s disease, and affects 0.3% of the entire population 
in industrialized countries. Standardized incidence rates of reported PD are 
10-20 per 100,000 people per year (Twelves et al., 2003). Incidence varies 
depending on age, gender and ethnicity (Van Den Eeden, 2003). Incidence 
and prevalence are consistently higher in men than in women, and the 
average age of onset in PD is established at about 60 years old, so it is 
principally considered to be a disease of the elderly (Wirdefeld et al., 2011). 
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The number of patients is expected to rise considerably in the coming 
decades, due to the ageing of the population. 
1.1.2 Etiology 
The purely sporadic etiologic basis in PD has changed now to a view where 
both environmental and genetic factors contribute to the onset of the illness 
(Schapira & Jenner, 2011). 
In 1980s was discovered the 1-methyl-4-phenyl-1, 2, 3, 6,-
tetrahydropyridine (MPTP), a substance structurally similar to the herbicide 
paraquat, that could destroy dopaminergic neurons causing chronic 
parkinsonism (Langston & Irwin, 1984). MPTP finding was stimulated studies 
focus on environmental factors, and most important, generated novel 
experimental models of PD. 
Environmental factors on the occurrence of PD range from the general, in 
terms of a potential role for industrialization, rural environment, well water, 
plant-derived toxins, and bacterial and viral infection, to the specific, as 
occurs with exposure to organic solvents, carbon monoxide, and carbon 
disulfide (Schapira & Jenner, 2011). Despite of the wide literature, the degree 
of evidence of some environmental factors, for instance, pesticides, metals 
or magnetic fields are few (Richardson et al., 2009; Kieburtz & Wunderle, 
2013). The evidence for cigarette smoking and caffeine intake as protective 
factors appears clear, but there is still uncertainty over the role of others, for 
example, exercise, anti-inflammatories, antihypertensive (most notably 
calcium antagonists), and antilipidaemics (Warner & Schapira, 2003; Chin-
Chan et al., 2015; Kalinderi et al., 2016). 
On the other hand, the last decade has been characterized by a 
remarkable acceleration in the identification of genes that appear to cause an 
illness very similar to PD or PD itself (Wirdefeldt et al., 2011). So far 18 
mutations in genes / loci have been identified, that include autosomal 
dominant forms (PARK1-4, PARK5, and PARK8), recessive autosomal forms 
(PARK2, PARK6, PARK7, and PARK9) locus and mutations of genes associated 
with PARK10-16. Despite of these, only 10 to 15% of patients with the disease 
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show a familiar form, indicating that more PD genes and loci remain to be 
identified. The increasing knowledge about genetics of PD has provided clues 
about the molecular mechanisms involved in its pathogenesis. For instance, 
Park1 and Park4 are α-synuclein genes located on chromosome 1 and 4 
respectively, that carries the genetic code for the production of α-synuclein 
protein present in Lewy bodies (Fujioka &Wszolek, 2014). 
1.1.3 Basal ganglia circuitry in PD 
The term Basal Ganglia (BG) refers to a group of nuclei in the forebrain 
and midbrain that are extensively connected to different parts of the cerebral 
cortex, thalamic nuclei and specific mesencephalic structures. These sets of 
nuclei include the striatum (caudate and putamen), the globus pallidus pars 
externa (GPe) and pars interna (GPi), the subthalamic nucleus (STN) and the 
substantia nigra pars compacta (SNc), and pars reticulata (SNr). The 
organization of the connectional relationships of the BG has had a great 
impact on the insight into the pathophysiology of PD and other movement 
disorders.  
The main BG inputs come from the cerebral cortex and from the thalamus, 
while the projections of the BG have an ascending component and a 
descending component. The ascending component, the so-called basal 
ganglia-thalamo-cortical loops, projects to the cortical areas. The BG loops 
are functionally subdivided as motor, oculo-motor, associative, limbic, and 
orbitofrontal, according to the main cortical projection areas (DeLong, 1990). 
This arrangement explains the influence of BG on sensorimotor, 
cognitive/executive and emotional-motivational functions. The descending 
component consists of the BG projections directed to mesencephalic 
structures and, in turn, to motor output structures in the lower brainstem and 
spinal cord. These projections form the neuronal basis for the influence of the 
BG on posture and balance, as well as on muscle tone.  
The classical model of BG organization was also developed in the late 
1980s and was focused on motor control (Albin et al., 1989; DeLong, 1990). 
This model was based on the following findings: 
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1) Cortical motor areas and the primary somatosensory cortex project to 
the striatum in a somatotopical manner. 
2) Striatal efferent neurons are GABAergic medium spiny neurons (MSNs) 
that project to BG output, i.e., GPi and SNr, through two different pathways: 
‘‘direct’’ and ‘‘indirect’’. MSNs of the “direct” monosynaptic pathway contain 
dopamine (DA) D-1 receptors, co-express the peptides substance-P and 
dynorphin, and project directly from putamen to GPi/SNr. MSNs of the 
“indirect” polysynaptic pathway contain DA D-2 receptors and co-express 
enkephalin, and pass to the GPe and from there to both output nuclei (GPi 
and SNr), either directly or via the intercalated STN.  
3) DA modulates glutamatergic effects of corticostriatal inputs by exerting 
a dual effect on striatal neurons, exciting D1 neurons in the direct pathway 
and inhibiting D2 neurons in the indirect circuit (Gerfen & Surmeier, 2011), 
which in turn exert a tonic inhibition of the thalamus. 
4) Reduced BG output leads to movement facilitation and increased BG 
activity to movement inhibition. 
According to this model, DA deficiency in the parkinsonian state causes a 
hyperactivity of the indirect pathway and hypoactivity of the direct pathway 
(DeLong, 2001), promoting increased activity in the STN and GPi/ SNr, which 
in turn causes increased thalamic inhibition and finally a decrease in the 
excitation of the cortical motor systems and the brainstem (Obeso et al., 
2000). Thus, the balance of BG activity shifts toward the “indirect” circuit, 
where the GPe-STN-GPi microcircuit plays a paramount role (Figure 1). 
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Figure 1 Parkinsonism-related changes in overall activity (“rate model”) in 
the basal ganglia-thalamocortical motor circuit.  
Black arrows indicate inhibitory connections; gray arrows indicate excitatory 
connections. Abbreviations: CM, centromedian nucleus of thalamus; CMA, cingulate 
motor area; Dir., direct pathway; D1, D2, dopamine receptor subtypes; Indir., 
indirect pathway; M1, primary motor cortex; Pf, parafascicular nucleus of the 
thalamus; PMC, premotor cortex; PPN, pedunculopontine nucleus; SMA, 
supplementary motor area; VA, ventral anterior nucleus of thalamus; VL, 
ventrolateral nucleus of thalamus (Wichmann, Delong, Guridi, & Obeso, 2011). 
 
The classical model provides a reasonable explanation for the origin of 
akinetic features in PD, such as movement initiation, and the response to 
drugs and surgery. Other typical features in PD such as reduced blinking rate, 
a positive Meyerson’s sign, and decreased arm swing are probably mediated 
by brainstem mechanisms, which are also functionally impaired by excessive 
basal ganglia inhibitory outputs. 
However, despite the existence of more complex BG models, they do not 
provide a definitive explanation for the two other cardinal features of PD, that 
is, rigidity and tremor, as well as gait dysfunction, attention and learning 
deficits, emotional disturbances, and cognitive disorders, all of which have 
now been acknowledged to form part of the global clinical picture of PD 
(Marsden & Obeso, 1994; Obeso, Marin, et al., 2008; Obeso, Rodríguez-Oroz, 
et al., 2008). 
8 | G e n e r a l  O v e r v i e w  o f  P D  
 
1.1.4 Clinical manifestations 
The clinical PD hallmarks include motor parkinsonism. Despite the 
diagnosis of PD being mainly dependent on motor symptoms, a period called 
the premotor phase has been described in which non-motor symptoms can 
precede PD motor impairments. 
PD is diagnosed on clinical criteria and there is no definitive test for its 
diagnosis. However, there are some established criteria to make the diagnosis 
as objective as possible. According to the Parkinson's UK Brain Bank, the 
diagnosis of PD is based on the presence of at least two cardinal symptoms 
(bradykinesia combined with one of the three other cardinal signs, i.e., 
rigidity, resting tremor or postural instability) of progressive, unilateral onset 
and response to levodopa. In addition, none of a number of exclusion criteria 
must be present, and other typical PD signs might support the diagnosis.  
1.1.4.1 Motor features 
Motor features comprise mainly the four cardinal signs of PD (resting 
tremor, bradykinesia, rigidity, and gait disturbances/postural instability), plus 
a widespread number of other motor abnormalities, called secondary motor 
symptoms, such as dysarthria, hypophonia, dysphagia and sialorrhoea, 
among others (Table 1). In addition, flexed posture, gait disorders and 
freezing (motor blocks) have been included among the classic features of PD 
(Shahed & Jankovic, 2007). 
Table 1 PD motor symptoms. 
 
Tremor, bradykinesia, rigidity, postural instability  
Hypomimia, dysarthria, dysphagia, sialorrhoea 
Decreased arm swing, shuffling gait, festination difficulty arising from 
chair, turning in bed  
Micrographia, cutting food, feeding, hygiene, slow activities of daily 
living 
Glabellar reflex, blepharospasm, dystonia, striatal deformity, scoliosis, 
camptocormia 
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a) Bradykinesia 
From a purist perspective, bradykinesia refers to slowness of movement, 
akinesia refers to poverty of spontaneous movement and the term 
hypokinesia means smaller amplitude of movement. However, in the 
literature the term bradykinesia tends to group these motor features within 
the same construct. Bradykinesia encompasses difficulties with planning, 
initiating and executing movement with performing sequential and 
simultaneous tasks (Berardelli et al., 2001). Bradykinesia is the motor sign 
that appears to correlate best with a degree of dopamine loss, due to the 
potentially correlations with disease severity and response to treatment 
(Rodríguez-Oroz et al., 2009). 
b) Classic tremor  
Classic tremor is the most common and easily recognized symptom of PD. 
It is characterized by a low frequency rhythmic oscillation within a bandwidth 
of 4 or 6 Hz that occurs at rest (Shahed & Jankovic, 2007). Hand-tremor is 
described as a supination-pronation tremor (“pill-rolling”), but rest tremor in 
PD can also involve the lips, chin, jaw and legs. This type of tremor is 
pathophysiologically separated from bradykinesia and rigidity, and the 
response of tremor to dopaminergic agents is less than bradykinesia 
(Jellinger, 2012). It is now realized that classical tremor in PD is mediated by 
an abnormal oscillatory activity in an extensive motor network that involves 
the BG, cerebellum, thalamus, and motor cortex (Hallett, 2014). 
c) Rigidity 
Rigidity is essentially an increase in resistance to passive movement. It 
has been thought for decades that rigidity should be related to an 
enhancement of stretch reflex excitability (Cantello et al., 1991; Delwaide et 
al., 1993; Moreau et al., 2002). It is known that rigid patients present an 
enhanced cortical excitability, coupled with DA depletion and increased BG 
output (Rodríguez-Oroz et al., 2009). However, it has not yet been clarified 
how BG changes associated with dopamine depletion modify the excitability 
of stretch reflex mechanisms. 
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d) Postural stability and gait disorders 
Parkinson's patients have difficulties with balance, both sitting and 
standing, and also with walking. When PD patients are standing, they adopt 
a flexed posture, with the body inclined slightly forward, with flexed knees 
and arms in front of the body (Kim et al., 2013). The typical gait of these 
patients is slow with short, shuffling steps, swinging arms and a flexed 
posture. The pathophysiology of postural instability and gait problems is 
complex and is not caused by a single factor, but is the result of a combination 
that includes changes in postural reflexes (anticipatory postural reflexes and 
automatic postural reactions), rigidity and akinesia (Hanakawa et al., 1999b).  
1.1.4.2 Non-motor features 
PD not only involves the degeneration of mesencephalic dopaminergic 
structures, but also of the peripheral autonomic nervous system, dorsal 
motor vagal nucleus, olfactory bulb, brainstem centers and the neocortex 
(Wolters et al., 2014).  
Pending the exact localizations and severity of the pathological condition, 
autonomic nervous system dysfunctions, sleep-wake disorders, sensory 
disorders, and neuropsychiatric disorders are part of the non-motor 
symptomatology of PD (Table 2) (Chaudhuri et al., 2006). 
Table 2 The non-motor symptom complex of PD. 
Neuropsychiatric symptoms  Depression, apathy, anxiety 
 Anhedonia 
 Cognitive impairment (executive dysfunction) 
 Hallucinations, illusion, delusions 
 Dementia 
 Obsessional behaviour (usually drug induced), 
repetitive behaviour 
 Confusion 
 Delirium (could be drug induced) 
 Panic attacks 
Sleep disorders  Restless legs and periodic limb movements 
 Rapid eye movement (REM) sleep behaviour 
disorder and REM loss of atonia 
 Non-REM-sleep related movement disorders 
 Excessive daytime somnolence 
 Vivid dreaming 
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 Insomnia 
 Sleep disordered breathing 
Autonomic symptoms  Bladder disturbances 
 Urgency 
 Nocturia 
 Frequency 
 Sweating 
 Orthostatic hypotension 
 Falls related to orthostatic hypotension 
 Coat-hanger pain 
 Sexual dysfunction 
 Hypersexuality (likely to be drug induced) 
 Erectile impotence 
 Dry eyes (xerostomia) 
Gastrointestinal symptoms 
(overlaps with autonomic 
symptoms) 
 Dribbling of saliva 
 Ageusia 
 Dysphagia and choking 
 Reflux, vomiting 
 Nausea 
 Constipation 
 Unsatisfactory voiding of bowel 
 Faecal incontinence 
Sensory symptoms  Pain 
 Paraesthesia 
 Olfactory disturbance 
Other symptoms  Fatigue 
 Diplopia 
 Blurred vision 
 Seborrhoea 
 Weight loss 
 Weight gain (possibly drug induced) 
 
Some non-motor symptoms, such as olfactory problems, constipation, 
depression, mid cognitive impairment (executive domain) and rapid eye 
movement disorder may precede the first motor manifestations (Marras & 
Chaudhuri, 2016). This primary clinical phase is called premotor stage (Table 
3). For instance, cognitive dysfunction may be present from the early stages 
of PD and might involve a more extensive cognitive dysfunction in the future 
stages. Impairment may be mild or severe enough to justify the diagnosis of 
dementia (Tolosa & Pont-Sunyer, 2011). Mild cognitive impairment can 
include executive dysfunction and impairment of attention and working 
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memory, as well as deficits confined to language, memory, or visuospatial 
domains. 
Table 3 Survey of primary (premotor) non-motor symptoms in PD. 
Autonomic 
dysfunction 
Parasympatheic cholinergic: Dry mouth, gastrioaresis, 
constipation, pollakisuria, incontinence, erectile dysfuncion, 
pupillomotor abnormalities 
Sympathetic cholinergic: thermoregulatory dysfunction, 
hypo/hyperhidrosos (drenching sweats) 
Sympathetic noradrenergic: cardiovascular dysfunction, 
baroreflex failure, orthostatic hypotension 
Sleep-wake 
disorders 
Insomnia and sleep fragmentation, fatigue, excessive 
daytime sleepiness and sleep attacks, REM sleep behavioral 
disporder 
Sensory disorders Pain, hyposmia, impaired color vision 
Neuropsychiatric 
disorders 
Apathy, anxiety and panic attacks, depression, mid cognitive 
impairment (executive domain) and psychosis 
 
1.1.5 Treatment 
Nowadays, treatment approaches in PD are focused on alleviating 
symptoms and maximizing functions. The mainstay of intervention for people 
with PD is medical management, including pharmacology and, to a lesser 
extent, surgical options (Kakkar & Dahiya, 2015). Nevertheless, patients 
require an holistic and multispecialty approach to maximize their QoL, and 
the QoL of their carers (Johnson, 2015).  
In recent years, there have been remarkable advances in the knowledge 
of the etiology and pathophysiology of the disease, helping the development 
of new treatments. Although cellular and genetic research is advancing in the 
clinical domain, the current treatments for PD continue to show important 
limitations, such as medication-related complications and surgical risks. 
These facts highlight the need to improve the current treatments, and to 
investigate adjunctive therapies. 
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a) Pharmacological therapy 
Levodopa is the precursor to DA, norepinephrine and epinephrine, and 
crosses the blood-brain barrier and is converted into DA in the nigrostriatal 
nerve terminals. Levodopa is usually administrated with carbidopa, a 
peripheral dopa decarboxylase inhibitor, which enhances the therapeutic 
benefits of levodopa. It remains the most potent drug for controlling 
symptoms in PD, principally bradykinesia.  
Despite  the advances in levodopa therapy, such as  rapid-onset 
formulations and duodenal infusion therapy, the response to levodopa 
becomes less reliable and less predictable over time, and after 5 years of 
therapy, medication-related complications develop in the majority of patients 
(Jankovic, 2008). Motor complications, such as dyskinesia, wearing-off, and 
“on–off” fluctuations, are well-recognized (Nutt, 2001; Stacy, 2009). 
DA agonists and non-dopaminergic therapy, such as catechol-o-methyl-
transferase (COMT) inhibitors, Monoamine oxidase B (MAO-B) inhibitors, 
amantadine, etc. are other modalities in the pharmacological management of 
PD and may be used concomitantly or sequentially with levodopa. For 
instance, DA agonists activate DA receptors and only provide a modest 
improvement in parkinsonian symptoms, but this improvement may be 
sufficient in the early stages in order to delay the introduction of levodopa. 
COMT inhibitors prolong DA response, improving the percentage of levodopa 
that enters the brain. MAO-B inhibitors degrade dopamine and can be used 
to prolong the effect of dopaminergic agents or as a monotherapy 
(Katzenschlager et al., 2011).  
Future pharmacological therapies involve the use of neurotrophic factors 
to enhance the survival of midbrain dopaminergic neurons in vitro and to save 
degenerating neurons in vivo (Zhang et al., 2012; De Munter et al., 2014). 
b) Surgical treatment 
Deep brain stimulation (DBS) is the gold standard for surgical treatment 
in PD, such as levodopa is for pharmacotherapy. DBS was introduced as a 
validated therapy in the 1990s. It uses a device called a neurostimulator to 
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deliver electrical signals to the different areas of the brain. The two main 
targets for DBS are STN and GPi. DBS of the STN leads to improvements in 
rigidity, tremor and bradykinesia, while dyskinesias are dramatically 
improved with GPi-DBS (Bronstein et al., 2011). A new target of DBS is the 
pedunculopontine  nucleus (PPN), with promising results in gait function 
(Pierantozzi et al., 2008; Ferraye et al., 2010; Hariz et al., 2013). 
Nevertheless, DBS has some disadvantages, such as the need for careful 
patient selection to achieve favorable outcomes, and adverse effects, which 
include perioperative, hardware-associated complications and stimulation-
induced complications (Huys et al., 2014). 
Lesional procedures have been largely replaced by DBS, but under certain 
conditions, unilateral pallidotomy, unilateral thalamotomy, and even 
subthalamotomy remain useful alternatives. Other innovative surgical 
treatments include magnetic resonance–guided focused ultrasound (MRgFU), 
a new lesioning modality that may have some advantages over current 
lesioning procedures; and gene and cellular therapies, including stem cells, 
which remain avenues to be investigated (Fox et al., 2011). 
Based on DBS studies, new treatment techniques for PD patients have 
been developed, such as repetitive transcranial magnetic stimulation (rTMS) 
(Benninger & Hallett, 2015) and transcranial direct current stimulation (tDCS) 
(Fregni et al., 2005a). The rationale behind these techniques, which are 
known as non-invasive brain stimulation (NIBS) techniques, is that they are 
based on attempting to reverse the clinical deficits of abnormal brain 
functioning and physiology. RTMS modulates cortical excitability. High-
frequency (≥5 Hz) rTMS has proved to be facilitatory (Pascual- Leone et al., 
1994), and low-frequency rTMS (≤1 Hz) has proved to be inhibitory (Chen et 
al., 1997). tDCS delivers a continuous current to the scalp that modulates 
membrane excitability and induces shifts in cortical excitability, with  polarity 
defining the effects (Nitsche & Paulus, 2000; Lang et al., 2005; Nitsche et al., 
2008). Recent studies have suggested that these techniques may have 
additional therapeutic potential that goes beyond that of conventional 
therapies (Fregni et al., 2005b; Elahi et al., 2009; Zhu et al., 2015). However, 
more studies are necessary in order to demonstrate substantial clinical 
effects. 
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c) Multispecialty care 
Despite medical management, most patients with PD continue to 
experience a wide range of motor and non-motor symptoms. A multispecialty 
approach seems to be preferable over a single-clinician approach in order to 
improve QoL, motor functioning, day-to-day activities and the psychosocial 
burden involved. A wide range of disciplines might have potential value for 
PD care (Van der Marck & Bloem, 2014), including medical specialists, 
specialized nurses, and allied healthcare professionals (such as physical 
therapists, occupational therapists, speech–language therapists, dieticians, 
social workers, sexologists and neuropsychologists). In recent years, several 
allied health disciplines have become more evidence-based. The evidence 
grade is highest for physical therapy (Keus et al., 2009) and speech–language 
therapy (Ramig et al., 2001), followed by occupational therapy (Dixon et al., 
2007). 
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1.2 GAIT DISORDERS OF PARKINSON´S DISEASE 
1.2.1 Features of PD gait 
Gait disturbances are one of the classic features of PD, which manifest 
themselves in almost all patients and often lead to a decline in their QoL 
(Ebersbach et al., 2013). Gait difficulties become progressively more 
levodopa-resistant, and thus are considered the hallmarks of the advanced 
stages of PD. 
PD gait is mainly characterized by the inability to generate an appropriate 
stride length (Morris et al., 1996). Associated disturbances include a reduced 
gait speed, reduced arm swing (Wood et al., 2002), increased stride-to-stride 
variability, increased double limb support time, gait instability, stooping, 
difficulty turning, and forward-flexed posture (Nieuwboer et al., 2009; Huang 
et al., 2012; Ebersbach et al., 2013). In advanced stages, more complex gait 
disturbances may appear, including FOG, motor blocks, festination and 
disequilibrium. All these gait features cause significant disabilities resulting 
from falls, immobility, and loss of independence (Bloem et al., 2016). Falls 
are considered to be one of the most serious complications of motion in PD, 
with an incidence of 70% during a 1-year follow-up, when recurrent falls have 
been shown to occur in approximately 50% of cases (Bloem et al., 2004; 
Okuma, 2014).  
a) Stride length, gait speed and cadence 
PD patients typically show a reduced walking velocity, which is associated 
with reduced stride length and a compensatory increase in cadence. An 
abnormal slowness of gait speed has already been reported in early and 
middle stages of PD, compared with healthy subjects (Ebersbach et al., 
2013). The reduced stride length of PD subjects is present even though the 
cadence (steps per minute) remains intact (Morris et al., 1996). Thus, the 
main problem of gait hypokinesia is PD subjects’ particular difficulty in the 
internal regulation of stride length.  PD subjects have higher cadence rate 
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than control subjects for any given velocity, but this is a compensation for 
reduced step size (Morris et al., 1994).  
b) Gait variability 
The ability to maintain a steady gait pattern is also impaired in PD 
subjects, which is thought to reflect reduced motor automaticity. Gait 
variability typically means walking fluctuations from one stride to the next. 
PD patients show a higher variability of stride duration, and even an increased 
variability of leg muscle activation during walking (Schaafsma, 2003; Baker 
et al., 2008; Lord et al., 2011). Increased gait variability is associated with 
an increased fall risk in older adults, as well as in patients with PD (Hausdorff, 
2003).  
c) Complex gait disturbances 
As the disease progress, more complex gait disturbances can appear, such 
as FOG and festination. FOG is defined as a “brief, episodic absence or marked 
reduction of forward progression of the feet despite the intention to walk” 
(Bloem et al., 2004; Nutt et al., 2011). This definition includes episodes in 
which the patient cannot initiate gait (“start hesitation”) and arrests forward 
progression during walking (“turn” and “destination” hesitation). Festination 
is the tendency to move the center of gravity forward, walking increasingly 
rapidly with smaller steps (Nutt et al., 2011). Festination is mostly shown in 
patients suffering from FOG; however, it may occur independently. 
1.2.2 Associations between cognition and gait in PD 
Gait impairments in PD include a reduced gait speed, increased stride-to-
stride variability, and a specific difficulty in regulating stride length. In 
addition, people with PD suffer from a deficit in executive functions and 
attention abilities. A growing body of evidence links gait to cognitive function 
in healthy young subjects (Marquis et al., 2002; Verghese et al., 2002b; 
Hausdorff et al., 2005) and also in PD subjects (Amboni et al., 2010), 
suggesting that gait is not quite automatic, but consumes some attention 
resources (Camicioli et al., 1997; Brauer et al., 2002; Woollacott & 
Shumway-Cook, 2002). A 2-year follow-up study of 26 PD patients 
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established that “on” state FOG correlated with a faster progression of 
executive dysfunction. Thus, in early PD, better attention and executive 
function can compensate for a loss of gait automaticity, but this is no longer 
an efficient strategy when the disease progresses and both attention and 
executive function deteriorate too. These results emphasize the interrelation 
that exists between gait and cognitive symptoms in PD. 
The dual-task (DT) paradigm has been used to study this dependence 
(Canning, 2005). Dual tasking is a component of the executive function (Della 
et al., 1995) and refers to the ability to divide attention between tasks that 
are performed at the same time (Yogev-Seligmann et al., 2008). Several 
theories have been proposed to explain DT interference, such as the “capacity 
sharing model” and the “bottleneck model”. All of them agree that when two 
tasks are performed concurrently, performance decrements in one or both 
tasks (Marois et al., 2005; Yogev-Seligmann et al., 2008). For instance, 
according to the capacity sharing model, when two attentionally demanding 
tasks are performed simultaneously, competition of attentional resources 
results in the deterioration of performance in one or both of the tasks (Tombu 
& Jolicœur, 2003). 
It has been shown that gait impairments are exacerbated under DT 
conditions in PD. When PD patients perform an additional motor or cognitive 
task when walking, they manifest a slower gait speed, shorter strides, 
increased double support time, and increased stride-to-stride variability, 
exacerbating their risk of falling in DT situations (Morris et al., 1996; Bloem, 
2000; Bond, 2000; O’Shea et al., 2002; Hausdorff, 2003; Galletly & Brauer, 
2005; Yogev et al., 2005). 
DT causes competition for attention, but also poses a challenge in 
prioritizing one of the two tasks. It has been shown that, while healthy 
controls give attentional priority to posture and gait, PD patients are at higher 
risk of falling because they use a “posture second” strategy (Bloem et al., 
2006). Fallers had poorer scores on executive function tests than non-fallers, 
while the gait speed and coordination of fallers were worse than those of non-
fallers, particularly under DT conditions (Plotnik et al., 2011). 
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When considering the effects of various interventions on PD gait, single-
task walking in PD has been well described, but there is less research that 
examines the efficacy of different pharmacological, surgical, or rehabilitative 
therapies on DT walking in this population (Kelly et al., 2012). It is important 
to point out the functional significance of DT, since it is a common activity in 
daily life. Further studies are therefore required to evaluate the efficacy of 
the treatment on gait under DT conditions, and consequently, on the 
interaction of gait and executive functions.  
1.2.3  The physiopathology of gait disorders in PD 
Firstly, it is interesting to consider the pathogenesis of hypokinesia within 
the physiopathology of PD gait, since the reduced stride length is the main 
hallmark of PD gait disturbances (Morris et al., 1996). Studies on primates 
and in people with PD reported that the interaction between BG and the 
supplementary motor area (SMA) is disrupted during movement performance 
in hypokinesia. The reduced amplitude of a movement in hypokinesia could 
result from a disorder in a motor set-related activity within the BG, which is 
needed for the running of the entire sequences of a movement (Brotchie et 
al., 1991). The set-related activity in the BG contributes to set-related activity 
in the SMA, so as to maintain the entire sequence in preparedness for running 
(Cunnington et al., 1995; Iansek et al., 1995). Thus, an abnormal motor set-
related activity from BG to the cortex, for a whole gait sequence, could affect 
the ability to elicit a normal step in PD subjects (Morris et al., 1994). 
Several studies indicate that the cortico-frontal regions are likely to be 
involved in the physiopathology of gait disorders in PD patients. The 
hypoperfusion of the SMA and other parts of the frontal lobe were found to 
be associated with severe gait disturbances and bradykinesia in PD (Matsui 
et al., 2005; Mito et al., 2006; Nutt et al., 2011). SPECT has been used to 
investigate the mechanisms underlying the improvement of gait in PD 
patients when exposed to visual stimuli. In these conditions, it seems that PD 
patients can compensate for the impaired SMA function by the activation in 
the lateral premotor cortex (Hanakawa et al., 1999). Even, a dysfunctional 
striato-frontal (in the “executive-attention” networks) and downstream 
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cortico-pontine pathways  may both play a critical role in the physiopathology 
of FOG (Herman et al., 2013). 
Secondly, a subject’s walking pattern is adjusted according to individual 
EMG bursts and relative timings. Orlovsky et al. (1999) stated (Orlovskiĭ et 
al., 1999). 
“…the locomotor activity in humans has been much more thoroughly 
studied than its neural control and in this matter we have to rely mainly on 
extrapolations from simpler animal models”.  
The neural networks that generate locomotor bursts have been 
extensively investigated in animals. These networks are hierarchically 
structured, including: 1) Lower effector levels; 2) Center pattern generators 
(CPGs) for locomotion; 3) Several locomotor areas located in the brainstem, 
which controls CPGs; 4) Higher level control systems, such as basal ganglia 
and neocortex (Grabli et al., 2012). Thus, we should regard research in 
animals in order to understand the neural control of PD gait. 
On the one hand, forward propulsion of the body is mainly powered by 
contraction of the calf muscles, with a contribution from the knee extensors 
(Neptune et al., 2001). Thus, it is important to highlight the reflex control of 
the ankle extensors on gait. The stretch reflex has been suggested as making 
a substantial contribution to motor output during animal and human walking 
(Andersen et al., 1994; Nielsen & Sinkjaer, 2002). The electrical stimulation 
of Ia fibers in peripheral nerves elicits the monosynaptic component of the 
stretch reflex, which can be recorded from the muscles as an action potential 
(H-reflex) (Capaday, 2002). For the interpretation of the H-reflex, it is 
important to note that its circuit is embedded in a complex neural system, 
and its behavior reflects the integral activity of the whole (Figure 2). 
 
C h a p t e r  1  I n t r o d u c t i o n  | 21 
 
 
 
 
Figure 2 Basic spinal circutry and its corticospinal control.  
At the peripheral end, the sensitivity of the receptor organ, the muscle spindle, to 
muscle stretch is controlled by the independent γ-motoneuron system (not shown). 
Centrally, collaterals of group Ia afferents from muscle spindles inhibit the 
antagonistic α-motoneuron pool, via Ia-inhibitory interneurons (Ia-Int.). These form 
part of the neural circuits that mediate reciprocal inhibition between antagonistic 
muscles. Additionally, a presynaptic inhibitory network (Pre-Inh.) controls the 
efficacy of synaptic transmission from the Ia-afferent terminals to α-motoneurons. 
The presynaptic inhibition circuit can be activated from the periphery by stimulation 
of muscle flexor nerves. The last order of interneurons inhibits Ia-neurons, and 
consequently reduce the reflex response. At the same time, stimulation of the motor 
cortex reduces presynaptic inhibition (i.e. inhibits presynaptic inhibition). 
Corticospinal neurons that project to a given motoneuron pool also inhibit the 
antagonistic motoneuron pool via Ia-inhibitory interneurons, adding an extra layer of 
complexity to the reciprocal inhibitory pathway. Several other circuits could be added 
to the figure, but what is important is that descending pathways act simultaneously 
on α-motoneurons and interneurons (Adapted from Capaday et al., 2002) 
 
The amplitude of the H-reflex and its relationship  with the background 
level of motor activity is strongly dependent on the motor task (Sinkjaer et 
al., 2000; Nielsen & Sinkjær, 2002). In human gait, neural mechanisms that 
modulate the SOL H-reflex during the normal step cycle include increased 
activity of α-motoneurons during the stance phase (Capaday & Stein, 1986), 
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increased postsynaptic inhibition of α-motoneurons during the swing phase 
(Lavoie et al., 2013), and a tonic increase in presynaptic inhibition of group 
Ia afferent terminals projecting to the α-motoneurons. 
In PD, only a few studies have evaluated some spinal reflex related to 
gait. Pierantozzi et al. (2008) showed that DBS of the PPN provides a 
distinctive influence on H-reflex, suggesting that it has a role in gait 
impairments in PD (Pierantozzi et al., 2008). Hiraoka et al. (2005) found a 
reduction of the SOL H-reflex during gait initiation in PD (Hiraoka et al., 2006) 
and, finally, Meunier and colleagues (2000) reported a correlation between 
the decreased reciprocal Ia-inhibition, at the onset of voluntary ankle 
dorsiflexion, with axial signs of PD patients (Meunier, et al., 2000a).  
On the other hand, in non-mammalian vertebrates and quadrupedal 
mammals, such as rats and cats, the isolated spinal cord can generate 
spontaneous locomotor bursts in the complete absence of peripheral 
feedback. CPGs are the neural networks of the spinal cord that generate these 
bursts. At the same time, CPGs are regulated by descendent supraspinal 
signals and afferent input of the limbs (Golgi tendon organs, Ia-muscle 
spindles, mechanoreceptors in the foot), which regulate the stance phase and 
the swing phase of the step cycle (Crommertet al., 1998). In humans, there 
is indirect evidence of the existence of spinal CPGs, and if they exist, they are 
much less robust than in mammals. 
Given the mechanical complexity of human bipedal locomotion, and that 
complete spinal cord lesion in humans leads to paralyses with no recovery of 
gait, it is often suggested that the corticospinal tract has a more predominant 
role in the control of walking in humans than in other animals. The 
involvement of cortical structures in the control of human gait can be 
assessed using several non-invasive methods, such as neuroimaging, 
transcranial magnetic and electrical stimulation (TMS and TES, respectively). 
As has been noted, neuroimaging studies showed the involvement of the SMA 
(among other regions) on hypokinetic PD gait. Moreover, recent TMS studies 
revealed abnormalities in intracortical facilitation (ICF) of the primary motor 
cortex that may be related to decreased stride length and slower gait speed 
in PD subjects (Vacherot et al., 2010a). 
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Finally, experiments in decerebrate cats demonstrated that electrical 
stimulation of an area of the brainstem region triggered walking and even 
galloping. This area is called the mesencephalic locomotor region (MLR), 
which is gaining importance in the physiology of gait. MLR is composed by 
the PPN and the cuneiform nucleus (CN). Both nuclei have reciprocal 
connections with BG (SNc, STN, pallidum) and have major outputs to the 
descending reticulo-spinal pathway and the ascending thalamo-cortical 
pathway. The neurons of the MLR are mainly cholinergic and GABAergic.  
Recently the dysfunction of the MLR of the brainstem has been 
emphasized in the physiopathology of gait and balance disorders in PD 
(Pahapill & Lozano, 2000; Grabli et al., 2012). In normal monkeys, lesions in 
the PPN induce akinesia and gait and balance disorders. In people with PD, 
DBS of the PPT region can improve gait function (Alam, Schwabe, & Krauss, 
2010). Furthermore, post-mortem studies have shown that the degree of 
cholinergic neuronal loss within the PPN in PD patients has a correlation with 
the level of dopamine cell loss (Zweig et al., 1989) and, importantly, with the 
occurrence of falls (Karachi et al., 2010).  
In summary, the physiopathology of PD gait is certainly complex, and the 
neurophysiology of gait has not been extensively studied in people with PD, 
which hinders the targeting of successful treatment strategies. The inclusion 
of neurophysiological measures in studies related to PD gait can help to 
increase knowledge about it and, ultimately, to improve the effectiveness of 
medical and rehabilitation treatments. 
1.2.4 Gait rehabilitation in PD 
Although pharmacological therapies ameliorate many parkinsonian 
symptoms, especially in the early stages of the disease, as the disease 
progresses the effectiveness of pharmacological therapy is diminished, 
leading to the worsening of gait disorders and the appearance of more 
complex gait symptoms. Even certain temporal aspects of parkinsonian gait 
disorder remain therapeutically resistant, both in the short-and  long- term 
(Pötter-Nerger & Volkmann, 2013) with other gait difficulties persisting or 
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worsening after surgical treatment, such as FOG and postural instability. 
Therefore, the treatment of gait disorders is crucial in PD patients’ 
rehabilitation programs in order to maximize exercise tolerance, improve the 
gait pattern, maintain or increase independence regarding mobility, and 
reduce the risk of falls (Gage & Storey, 2004; Keus et al., 2009; Van der Eijk 
et al., 2011). 
The most widely used form of non-pharmacological therapy for improved 
gait in PD is physical therapy. In 2000, Morris was the first to describe a 
theoretical framework supporting the use of physical therapy in PD (Morris, 
2000). Morris described specific approaches to improve the performance of 
functional motor tasks, with emphasis on gait, postural instability and 
prevention of falls. These strategies incorporate the use of external cues 
(visual, auditory, or proprioceptive cues) and cognitive strategies, such as 
attentional strategies, in order to activate alternative pathways in the brain 
bypassing the defective BG circuitries of PD patients (Morris et al., 1996). 
A Cochrane meta-analysis that included 33 randomized controlled trials 
with a total of 1,518 participants, showed that physical therapy provides 
short-term benefits in the treatment of PD gait (Tomlinson et al., 2012). The 
trials included were categorized as follows: general physical therapist, 
exercise, treadmill, cueing, dance, and martial arts. Significant benefits on 
gait with clinical relevance after physical therapy intervention compared with 
a placebo or no intervention were considered in this review for the two- or 
six-minute walk test, speed, Berg Balance Scale, and Unified Parkinson´s 
Disease Rating Scale (UPDRS) total. Improvements were also demonstrated 
for other walking outcomes, such as stride length (Fisher et al., 2008a; Sage 
& Almeida, 2009; Boehm et al., 2011; Almeida & Bhatt, 2012). Later, Gisbert 
et al. (2015) published a patient- intervention-comparison-outcome analysis, 
showing that the results of the Cochrane review could be applied to patients 
(Gisbert, 2015).
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1.3 TREADMILL WALKING IN GAIT REHABILITATION IN 
PD 
The treadmill is a device used for walking or running while staying in the 
same place. The motorized treadmill began to be employed in the medical 
field for ergometry studies in the middle of the 20th century (Yu et al., 1951). 
Nowadays, the treadmill is a familiar device employed in gyms, hospitals and 
research centers. 
In the physiological field the treadmill has been used to explore the 
neurophysiology of locomotion in mammals. Pioneering studies in spinalized 
cats showed that these animals could step on the treadmill with their hind-
limbs, if their body weight was externally supported (Edgerton et al., 1992). 
On the basis of these experiments, the same approach was applied to humans 
with spinal cord injury (Wernig & Müller, 1992). A harness that supported a 
part of the patient’s body weight was used in order for them to maintain an 
erect posture when they walked on the treadmill. More recently, the use of 
the treadmill has been introduced for gait rehabilitation in other neurological 
pathologies such as PD. 
1.3.1 Treadmill walking studies in gait rehabilitation in 
PD 
Over the last few decades, the treadmill has become a therapeutic tool for 
gait rehabilitation in PD. Miyai et al. (2000) conducted the two initial studies 
to study treadmill training with supported body weight in people with PD, and 
found improvements in UPDRS, ambulation speed and number of steps (Miyai 
et al., 2000, 2002). Later, their findings were replicated and extended. 
Several weeks of treadmill training without body weight support led to 
improvements in some lower limb tasks, such as walking along a corridor 
(Kurtais et al., 2008), and also in specific gait parameters of PD patients, 
such as enlarged stride length, increased speed, decreased double support 
time, and reduced swing time variability. In 2010, Mehrholz et al. (2010) 
conducted a meta-analysis that included 8 trials with a total of 203 
participants. The review provided evidence of the use of treadmill training in 
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patients with PD in order to improve gait parameters that included speed and 
stride length (Mehrholz et al., 2010). 
One important feature of treadmill training programs is the reported long-
lasting effects (Miyai et al., 2002; Toole et al., 2005; Herman et al., 2007; 
Bello, 2013; Nadeau, 2014). After 4 weeks of treadmill training, 
improvements in balance, gait, range of motion and motor UPDRS were 
maintained for one month (Toole et al., 2005). Recently, improvements in 
speed, cadence and stride length have been reported that persisted until 6 
months after the treadmill training (Nadeau et al., 2014).  
In addition to the long-term effects, the immediate effects of one treadmill 
session have also been investigated. Gait speed, stride length and double 
stance improved immediately after one session of treadmill walking (Miyai et 
al., 2000; Pohl et al., 2003). Improvements in gait speed were also found 10 
minutes after a treadmill gait session, where advanced PD patients increased 
their gait speed as a result of an improvement in stride length (Bello et al., 
2008). 
In order to discover the effect of the treadmill in gait rehabilitation in PD 
patients, it is necessary to determine the differences between treadmill 
walking and overground walking. When walking on the treadmill, a group of 
advanced PD patients (H&Y 3) improved their step length while walking in 
comparison with overground walking (Bello et al., 2008). Moreover, PD 
patients increased their step length, but no other gait parameters, after 
treadmill training in comparison with overground training (Bello, 2013). The 
immediate effects of one treadmill session in comparison with one session of 
overground walking have not yet been investigated. This is of importance in 
order to determine whether the treadmill has a specific therapeutic effect in 
PD. 
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1.3.2 Mechanisms implicated in treadmill gait benefits 
in PD 
An understanding of the mechanisms underlying the gait improvements 
associated with the treadmill will improve the prescription and efficacy of 
physical therapy in PD. Several mechanisms have been proposed (Bello & 
Fernández-Del-Olmo, 2012). Some of them are related to the different 
contexts in which the walking took place, such as the external cues provided 
by the treadmill and the attentional strategies used by PD patients; and 
others are related to the features of the treadmill itself, such as constant 
speed or the use of handrails (see Table 4). 
Table 4 Summary of the main mechanisms implicated in treadmill gait 
benefits in PD (Adapted from Bello et al., 2012).  
Mechanism Arguments to Support 
this Theory 
Arguments to Question this 
Theory 
Central 
Pattern 
Generator 
Treadmill training could 
provide adequate sensory 
inputs, which may 
stimulate the spinal 
locomotor circuitry 
It is undetermined whether CPG is 
relevant in the gait improvement 
of PD patients 
External 
sensory cues 
Treadmill walking provides 
propioceptive signals that 
may be used by PD 
patients, triggering intact 
circuits and by- passing 
the defective 
pallidocortical circuit, in 
order to control movement 
Changes in regional flow evaluated 
with SPECT during treadmill 
walking, showed absence of the 
lateral premotor cortex-parietal 
overactivation that seems to 
accompany externally triggered 
movements in PD patients, 
indicating that treadmill-walking 
has an internally driven 
mechanism 
Visual 
feedback 
Modifications in the optical 
flow lead to modification in 
the gait pattern. 
Absence of visual flow may 
force the subject to look for 
another source of visual 
information, as an anchor 
for maintaining a stable 
position 
Only the absence of visual flow do 
not increase the step length in PD 
patients 
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Attentional 
strategies 
PD patients can use 
attentional strategies and 
compensate for the 
damaged automaticity 
 
Imposed 
and constant 
gait speed 
The constant speed of the 
treadmill could reduce the 
de- grees of freedom and 
help to minimize stride-to-
stride variations in gait 
timing 
 
Hand 
support 
Walking aids that have 
hand support, can improve 
balance and mobility in 
older adults and people 
with other clinical 
conditions 
PD patients reduce their speed and 
stride length when they walk with 
a wheeled walker in comparison 
with normal gait. 
Motor 
learning 
Improvement in gait is 
sustained several months 
after the treadmill training 
is completed. 
 
 
The visual cues and the handrail support are two of the possible 
explanations that have already been rejected. A recent study that used a 
treadmill simulator built by extracting the belt showed that visual feedback 
was not the main mechanism involved in the step length increase in PD 
patients during treadmill walking (Bello et al., 2010). Moreover, the fact that 
the patients held their arms on the handrail of the treadmill could improve 
their balance and may account for the adaptation of the step length observed 
over the treadmill (Bateni & Maki, 2005). However, two studies have shown 
that PD patients reduce their speed and stride length when they walk with a 
wheeled walker in comparison to normal gait (Frenkel-Toledo et al., 2005; 
Bello et al., 2010). 
One of the most plausible explanations so far is related to belt movement 
and proprioceptive signals. It is well known that PD patients can generate a 
normal gait pattern in the presence of adequate regulatory sensory 
stimulation. Lines placed on the floor at the desired step length, or rhythmic 
auditory cues, can assist the initiation and execution of gait in PD. These cues 
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would bypass the defective internal pallidocortical projections in PD, 
activating compensatory cortical pathways, possibly via the lateral premotor 
cortex, which controls externally guided movements (Hanakawa et al., 
1999a; Fukuyama et al., 2004). Frenkel-Toledo et al. (2005) suggested that 
the treadmill provides external cues to reduce gait variability (Frenkel-Toledo 
et al., 2005). Moreover, a recent study confirmed that improvements in stride 
length in PD are due to the belt movement itself, probably due to 
proprioceptive afferents generated by belt displacement (Bello et al., 2010). 
Thus, treadmill walking can provide proprioceptive signals that could bypass 
the defective pallidocortical circuit in PD.  
In this way, the proprioceptive afferents generated by the belt movement 
could provide suitable sensory inputs for the stimulation of the CPGs, i.e., the 
spinal locomotor circuitry (see 1.2.3) (Protas et al., 2005; Herman et al., 
2007; Fisher, 2008).The positive effect of the treadmill in humans with a 
spinal lesion has been attributed to the activation of the CPGs (Dietz, 2003; 
Shepherd, 1999). Thus, treadmill walking would stimulate the spinal 
locomotor circuitry in PD. Another explanation for the treadmill improvements 
is related to the assumption that treadmill gait can induce motor learning in 
PD (Protas et al., 2005; Herman et al., 2007; Fisher, 2008). This could explain 
why the improvement in gait is sustained several months after the treadmill 
training is completed (Herman et al., 2007). The motor learning induced by 
treadmill training can also be mediated by CPGs, since learning occurs at the 
spinal level in PD. Another possibility is that the neural changes may occur at 
cortical level. A recent study reported normalization of corticomotor 
excitability after treadmill walking exercise at high-intensity, as well gait 
improvements in early PD (Fisher et al., 2008).  
Besides belt movement and proprioceptive signals, attentional resources 
have also been proposed as a mechanism involved in the gait improvements 
associated with treadmill use in PD (Bello & Fernández-Del-Olmo, 2012). 
Although regulation of gait pattern is an automatic process that does not 
require attention in healthy adults, people with PD are able to improve their 
gait when they direct their attention to their walking movement, suggesting 
an impairment in the automatic control of their gait (Morris et al., 1996). 
Thus, it is plausible that the stable environment and absence of distracters 
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associated with walking over the treadmill could allow PD patients to allocate 
attention to their gait in comparison with an overground walking condition, 
and consequentially, bypass the defective pallidocortical circuit in PD. 
Having reported the several hypotheses underlying the improvements 
associated with the use of a treadmill in PD, it must be emphasized that there 
are no studies that have explored the role of attention as an underlying 
mechanism, notwithstanding the current association between attention and 
gait in PD. In the same way, there are no studies that investigate the possible 
neural mechanisms involved in treadmill gait benefits in PD. 
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1.4 TRANSCRANIAL DIRECT CURRENT STIMULATION 
(TDCS) IN GAIT REHABILITATION IN PD 
 
1.4.1 Basis of application of tDCS in PD 
TDCS is a model of NIBS that could enhance or reduce cerebral excitability 
by the use of low direct current delivered via two surface electrodes on the 
head, anode and cathode. Although the scalp possesses high impedance, 
sufficient intracranial current flows to produce changes in membrane resting 
thresholds within the cortex beneath each electrode. This results in an 
increase in activity under the anode and a decrease in activity beneath the 
cathode (Nitsche et al., 2005).  
TDCS has the capability to promote motor learning and consolidation, and 
may enhance long-term retention in healthy subjects (Nitsche et al., 2003). 
This provides the rationale for combining tDCS with a rehabilitative 
intervention, and has been shown to promote motor recovery in chronic 
stroke (Hummel et al., 2005). In recent years, there has been increased 
interest in tDCS as an intervention in PD. 
In PD, cortical excitability is increased during rest and decreased during 
voluntary activity which corresponds to reduced facilitation (Cantello et al., 
1991; Valls-Solé et al., 1994; Cantello et al., 2002). Impaired facilitation 
likely results from a deficient thalamo-cortical drive, while the increased 
activity during rest may be compensatory (Berardelli et al., 1996). The first 
placebo-controlled study that investigated the effects of a single tDCS session 
in PD reported that anodal tDCS of the primary motor cortex (M1) results in 
a motor function enhancement, along with a restoration of the reduced 
activity in motor and prefrontal cortices (Fregni et al., 2006). 
The physiological effects of anodal tDCS in PD have not been extensively 
investigated. RTMS release dopamine in the caudate and putamen 
corresponding to their cortico-striatal projections and could contribute to the 
acute effects of transcranial stimulation. Anodal tDCS causes widespread 
activation (Lang et al., 2005) that may trigger similar effects.  
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In view of the above, the use of tDCS in PD offers a promising rationale 
for improving the efficiency of rehabilitative interventions, as well as possibly 
enhancing our understanding of PD pathophysiology. 
1.4.2 tDCS studies in gait function in PD 
he rationale behind the application of tDCS on gait in PD comes from the 
DBS of the PPN (Plaha & Gill, 2005; Stefani et al., 2007), which has been 
reported to improve gait disturbances refractory to conventional therapy. In 
addition, tDCS has the capability to modulate spinal reflexes such as 
reciprocal Ia-inhibition in healthy people, demonstrating that the effects of 
the low direct current at the cortex reach spinal levels. 
Several studies have evaluated the effect of anodal tDCS on gait function 
in PD. TDCS has been suggested by some to improve gait, while others have 
found no benefit in PD. Several sessions of anodal tDCS delivered over the 
M1 and the premotor area improved upper-extremity bradykinesia and, to a 
lesser extent, walking time (Benninger et al., 2010). In a cross-over RCT, 5 
sessions of anodal tDCS of M1 in 10 patients had a beneficial effect on gait, 
FOG and motor performance, and these effects lasted throughout the 
observation period of 1 month (Valentino et al., 2014). However, a single 
session of anodal tDCS over M1 did not induce improvements on gait function 
measured with the 10-m walking test (Verheyden et al., 2013). 
It has also recently been shown that anodal tDCS, combined with physical 
training, increased gait velocity and improved balance in PD more than 
isolated physical training or tDCS alone, which did not produce motor 
improvements (Kaski, et al., 2014).  
Another possibility that has not been studied is the combination of 
treadmill walking and tDCS. This combined therapy could increase the effects 
of treadmill walking or tDCS alone on gait function in PD. 
  
 
 
CHAPTER 2.  
QUESTIONS OF RELEVANCE 
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After a brief review of the current data related to the topic of this thesis, 
some questions of interest remain unresolved: 
1) Are attentional demands a reliable underlying mechanism related to 
the gait improvements associated to treadmill walking in PD? 
2) What is the cognitive cost of treadmill walking and overground walking 
under dual-task conditions in PD? 
3) Could one session of treadmill walking lead to gait improvements in PD 
patients in comparison with one session of overground walking? 
4) What are the neural mechanisms that underlie gait improvements 
related to treadmill walking in individuals with PD? 
5) What are the effects of combining tDCS and treadmill walking in gait 
function in PD subjects? 
6) What are the effects of combining tDCS and treadmill walking in the 
neurophysiological function of PD subjects? 
This piece of research is an attempt to address these questions. Questions 
1 and 2 will be addressed in the first study. Question 3 and 4 will be addressed 
in the second study. Questions 5 and 6 will be addressed in the third study. 
 
  
 
 
  
 
CHAPTER 3.  
HYPOTHESIS AND MAIN 
AIMS OF THE STUDIES 
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3.1 Study I: Gait Pattern and Cognitive Performance 
During Treadmill Walking in Parkinson’s Disease 
3.1.1 Hypothesis 
Performance of a cognitive task during treadmill walking will lead to an 
impairment in one or both of the tasks in PD subjects. 
3.1.2 Aims 
 To explore whether attentional demands are involved in gait 
improvements in PD patients when they walk on a treadmill. 
 To investigate the gait pattern in PD subjects and controls when walking 
over the treadmill and when walking overground during the performance 
of a concurrent cognitive task. 
 To explore the cognitive performance in PD subjects and controls when 
walking over the treadmill and when walking overground during the 
performance of a concurrent cognitive task. 
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3.2 Study II: Acute kinematic and neurophysiological 
effects of treadmill and overground walking in 
Parkinson´s disease 
3.2.1 Hypothesis 
A single treadmill walking session, unlike a single overground walking 
session, would lead to gait improvements in PD, accompanied by walking-
related neurophysiological modulations. 
3.2.2 Aims 
 To explore the short-term effects of a single session of either treadmill or 
overground walking on kinematics in PD patients. 
 To address the immediate effects of a single session of either treadmill or 
overground walking on the excitatory and inhibitory cortical networks in 
PD patients. 
 To address the immediate effects of a single session of either treadmill or 
overground walking on spinal excitability in PD patients. 
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3.3 Study III: Treadmill walking combined with anodal 
tDCS in Parkinson's Disease: kinematic and 
neurophysiological effects 
3.3.1 Hypothesis 
The combination of treadmill walking with tDCS enhances the gait 
improvements associated with treadmill walking in PD subjects. 
3.3.2 Aims 
 To explore the acute effect of treadmill walking combined with anodal 
tDCS on gait function both on overground and treadmill walking in 
individuals with PD.  
 To investigate the possible spinal and cortical neural mechanisms involved 
in the effects of this combined therapy in PD individuals. 
 
  
 
 
 
  
 
CHAPTER 4.       
STUDIES 
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4.1 STUDY I: Gait Pattern and Cognitive Performance 
During Treadmill Walking in Parkinson’s Disease 
4.1.1 Abstract 
The aim of this study was to explore whether attentional demands are 
involved in gait improvements in PD patients when they walk on a treadmill. 
Nineteen individuals with idiopathic PD and 19 age-matched healthy controls 
participated in this study. Participants walked on a treadmill and on 
overground under single task (walk only) and DT (walk performing a 
simultaneous cognitive task) conditions. The DT paradigm was used to reveal 
the attention allocation behaviour. Gait pattern and cognitive performance 
was measured. The PD group showed reduced gait variability when walking 
on a treadmill in comparison with overground. However, this reduction did 
not deteriorate during the DT. Moreover, there were no differences in the 
cognitive performance between treadmill and overground walking. This study 
does not support the proposition attentional resource allocation as a possible 
mechanism for the treadmill-associated gait improvements observed in PD. 
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4.1.2 Introduction 
Gait disorders are among the most significant impairments in PD that 
severely affect the individual’s QoL (Keus et al., 2009). PD gait is 
characterized by a reduced gait speed, increased stride-to-stride variability 
and a specific difficulty to regulate stride length (Keus et al., 2009). In 
addition, people with PD suffer a deficit in executive functions and attention 
abilities, (see Dirbenger and Jahanshahi (2013), for an extensive review of 
executive deficits in PD; and Yogev-Seligmann et al. (2008), for a review of 
the role of executive function and attention in gait) (Yogev-Seligmann et al., 
2008; Dirnberger & Jahanshahi, 2013). These cognitive dysfunctions could 
explain the exacerbated gait impairments in PD subjects (i.e. reduced walking 
speed and stride length, and increased stride-to-stride variability) when they 
perform a concurrent task (O’Shea et al., 2002; Rochester et al., 2004; Yogev 
et al., 2005). Previous studies have examined the relationship between 
cognition and gait performance in people with PD using a secondary task 
during walking (DT paradigm) (Yogev et al., 2005; Yogev-Seligmann et al., 
2012; Kelly et al., 2012; Brauer & Morris, 2010; Chawla et al., 2015). DT is 
a component of executive function, which refers to the ability to allocate 
attention to tasks that are performed at the same time (Ivanoff, 2005). 
Although, several theories have been proposed to explain DT interference, all 
of them agree that when two tasks are performed concurrently, performance 
decrements are observed in one or both tasks (Marois et al., 2005; Kelly et 
al., 2012). For instance, and according to the capacity sharing model (O’Shea 
et al., 2002; Herman et al., 2007), when two attentionally demanding tasks 
are performed simultaneously, competition of attentional resources results in 
the deterioration of performance in one or both of the tasks. Therefore, it is 
important to explore the role of attention associated with therapeutic 
strategies to improve the gait in subjects with PD. 
In the last decade, several studies have shown the therapeutic use of 
treadmill training for gait rehabilitation in PD (Mehrholz et al., 2010). Several 
weeks of treadmill training lead to an improvements in several gait 
parameters such as enlarged stride length, increased speed, decreased 
double support, reduced swing time variability and reduced stride length 
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variability between others (Herman et al., 2007; Bello, 2013; Nadeau et al. 
2014; Tseng et al. 2015). Notably, subjects with PD increased their stride 
length after 5 weeks of treadmill training but not when the training consisted 
of walking overground (Bello, 2013). A recent study showed improvements 
in walking speed and walking endurance even 6 month after the treadmill 
training (Nadeau et al., 2014). In addition to these long term effects of 
treadmill training, immediate improvements on overground gait, such as 
faster speed and longer step length, have been reported after a single 
treadmill session in PD (Bello et al., 2008). 
The therapeutic effect of treadmill could be explained as a specific gait 
modulation in PD subjects when walking over this device. PD subjects walk 
on a treadmill with lower stride-to-stride variability (Frenkel-Toledo et al., 
2005) and higher length step in comparison with walking overground (Bello 
et al., 2008). However, the mechanisms underlying these positive treadmill 
effects in PD remain unknown, even though several theories have been 
postulated (Bello et al., 2010; Bello & Fernández-Del-Olmo, 2012). One of 
these theories refers to attentional resources. Although, regulation of gait 
pattern is an automatic process that does not require attention in healthy 
adults (Yogev et al., 2005), people with PD are able to improve their gait 
when they direct their attention to their walking movement (Morris et al., 
1996; Canning, 2005) suggesting an impairment in the automatic control of 
the gait. Thus, it is plausible that the stable environment and absence of 
distracters associated with walking over the treadmill allow PD patients to 
allocate attention to their gait in comparison with an overground walking 
condition. However, to the best of our knowledge there are no studies that 
have explored the role of attention during treadmill walking in subjects with 
PD. 
Therefore, the main goal of this study was to investigate whether attention 
could be an underlying mechanism for the gait improvements observed 
during treadmill walking in PD. To this end, and using a DT paradigm, the 
present work compared the gait pattern in PD and controls, when walking 
over the treadmill and when walking overground during the performance of 
a concurrent cognitive task. The proposed hypothesis was that if the gait 
improvements observed while walking over a treadmill depend on attentional 
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resources, performance of a cognitive task will lead to impairment in one or 
both of the tasks. 
4.1.3 Material and methods 
Subjects 
Nineteen individuals diagnosed with idiopathic PD by a neurologist, 
according to the United Kingdom Bank Criteria (Hughes et al., 1992) (11 
males and 8 females, mean age = 59.79 ± 12.63), and nineteen age-matched 
healthy controls (11 males and 8 females, mean age = 59.53 ± 12.1) were 
recruited for the study from a local community. Inclusion criteria for 
participants with PD was: diagnosis of idiopathic PD, the ability to walk for 10 
min without stopping or walking assistance, absence of neurologic disorders 
other than PD and absence of orthopedic, cardiovascular or visual 
disturbances that could affect gait. Healthy controls were included if they did 
not have history of neurological pathology or other disease that could affect 
the ability to walk. All participants did not use a treadmill for at least 12 
months prior to the experiment. No participant showed dementia as assessed 
by a mini-mental state examination (MMSE). The level of severity of motor 
signs associated with PD was measured in ON state (45 minutes – 1.5 hours 
after medication intake) using the Unified Parkinson´s Disease Rating Scale 
Part-III (Fahn et al.; 1987) (UPDRS-III) and Hoehn and Yahr scale (Hoehn 
MM, 1967) (H&Y). A neurologist confirmed the ON state. All participants gave 
their written informed consent according to the Declaration of Helsinki (1964), 
before entering the study. The experimental procedures were approved by 
the local ethics committee.  
Apparatus 
A treadmill with handrails (SportsArt 6300, Sports Arts Fitness) was used. 
Gait performance overground and on the treadmill was recorded using an 
optical detection system (Optogait, Microgait, USA). This optical and modular 
system included transmitting and receiving bars of infrared LEDs. The 
apparatus detected the interruptions of the communication between the bars 
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during walking. Wireless headphones (Philips Hi-Fi, SHD8600UG) were used 
for the cognitive task. 
Testing procedure 
All participants were tested in four conditions: overground single task (ST: 
walk only), overground dual task (DT: walk and perform a cognitive task), 
treadmill ST and treadmill DT. Single and dual task conditions were arranged 
in a random order. However, overground and treadmill conditions were not 
counterbalanced since it has been reported that treadmill walking has 
significant and long lasting effects on the speed and frequency of consequent 
overground walking(Bello et al., 2008). The experimental sessions were 
carried out while patients were ON medication, confirmed by a neurologist 
evaluating the motor items of the UPRDS scale (Figure 3). 
 
 
Figure 3 Flow chart of Study I. 
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The cognitive task consisted of a phoneme monitoring paradigm (Connine, 
1996). The phoneme monitoring task has been previously used in several 
studies of PD and gait (Springer et al., 2006; Bello, 2013; Wild et al., 2013). 
Participants were asked to listen to a 1-minute-long narration through 
wireless headphones and they had to count the number of times that two 
pre-specified words were repeated in the narration. At the end of the task, 
participants reported the number of times the words were repeated in the 
text. They were not allowed to use their voice or fingers to help in the count. 
The subjects were not given any instructions or information regarding 
prioritization of the tasks. Baseline measurement of the cognitive task 
(without walking) was performed in a sitting position at the beginning of the 
session. A total number of fourteen texts were used, that were arranged in a 
randomized order for the different cognitive tests (baseline measurement, 
overground DT and treadmill DT). The two pre-specified words differed for 
each text. For the DT condition, the subjects were not given any instructions 
or information regarding prioritization of the tasks. 
The overground walking tests started with a practical trial of 3 minutes to 
familiarize the subjects with the walkway and with them self-select 
comfortable speed. Participants were tested at their self-selected comfortable 
speed, up and down an 8 meters walkway, for a total time of 1 minute. The 
gait parameters were recorded during the straight walk but not during the 
turns. Thus, each overground condition (ST or DT) was repeated twice to 
obtain the same number of steps to that in the treadmill conditions. The only 
instruction that participants received was to walk at their preferred speed. 
The treadmill walking tests started with a period of familiarization of 3 
minutes to reach, on the treadmill, the gait speed previously established 
during the overground condition (ST). During the familiarization period, all 
participants were instructed to keep their steps close to the front of the 
treadmill to keep their body erected. The treadmill tests consisted of two new 
blocks of 3-minutes for ST and DT conditions. During the first minute, belt 
speed was increased to reach the overground speed. The measurements were 
taken in the second minute of each block (ST and DT). All participants walked 
on the treadmill holding the handrails (Bello, 2013; Bello et al., 2010) since 
some subjects, specifically individuals with PD, did not feel safe to walk 
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without the handrail support. Participants walked on the treadmill under the 
close supervision of a physical therapist. To minimize fatigue effects, rest 
periods of 3 minutes between treadmill blocks and over-ground measures 
were included.  
Data analysis 
The following variables of gait were evaluated: overground speed (m/s), 
stride length (m), stride frequency (Hz), coefficient of variation (CV) of stride 
length (%) and CV of stride frequency (%). Coefficients of variation were 
calculated using the following formulas: (standard deviation/ stride length) 
x100; (standard deviation/stride frequency) x100. The outcomes of gait 
measurements were recorded during the tests with Software OptoGait 
v.1.9.9.0, (Microgait, USA) and were exported to excel format for offline 
analysis.  
The variable of the cognitive task was called “cognitive performance”. The 
cognitive performance was evaluated by calculating the percentage of 
mistakes made when counting the two pre-specified words.  
Statistical analysis 
To determine group and gait differences, a t-test was performed using the 
demographic and anthropometric measures. A repeated-measures analysis 
of variance (ANOVA) was carried out to compare the changes in gait in 
different conditions. Two-way ANOVA was used for gait speed (analysed only 
overground), with “task” as the within subject factor and “group” as the 
between subject factor. For the remaining variables of gait, three-way ANOVA 
was used with “surface” (overground and treadmill) and “task” (single task 
and dual task) as within-subject´s factors, and “group” (PD and control) as 
between subject´s factor. Post Hoc t-tests were computed. Wilcoxon rank 
test was applied for each group to compare cognitive performance between 
baseline, over-ground and treadmill conditions. Mann-Whitney test was used 
to compare cognitive performance between PD patients and controls for 
baseline, overground and treadmill conditions. All statistical analysis was 
performed using PASW Statistics 18. With the exception of percentage of 
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mistakes, none of the data violated the normality assumption according to 
Shapiro-Wilk test. A P value ≤ 0, 05 was considered statistically significant. 
4.1.4 Results 
T-tests showed no significant differences for age, leg length, weight and 
height between PD and control groups (Table 5). 
Table 5. Characteristics of PD and control groups. 
 
Two-way ANOVA for gait speed showed a significant main effect for group 
and task factors (Table 6B), with higher overground speed in control 
participants compared with PD patients and also during ST compared with DT. 
No significant task*group interaction was found. 
Three-way ANOVA for stride frequency showed a significant main effect 
for group factor (Table 6B). The control group walked with a higher stride 
frequency than the PD group.  
 PD CONTROL Group Differences 
Age (years) 59.68 ± 12.81 59.53 ± 12.10 NS 
Weight (Kg) 79.91 ± 14.66 73.63 ± 8.6 NS 
Leg lengtha (m) 87.37 ± 7.22 85.64 ± 6.97 NS 
Height (m) 1.65 ± 0.072 1.65 ± 0.08 NS 
MMSE 29.38 ± 1.02 29.52 ± 0.89 NS 
Disease duration 
(years) 
5.08 ± 3.83 __ __ 
UPDRS-III 21.06 ± 10.69 __ __ 
H&Y stage 
(subjects in each 
stage) 
1 (n= 4); 1.5 
(n=3); 2  (n=6); 
2.5 (n= 6) 
__ __ 
Values are mean ± SD. t -test analysis for group differences. aDistance from 
the great trocanter to the floor. PD, Parkinson´s Disease; MMSE, Mini-Mental 
State Examination; H&Y, Hoen and Yahr; UPDRS-III, Unified Parkinson´s 
Disease Rating Scale motor section; NS, Not Significant; n; sample. 
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Three-way ANOVA for stride length revealed a significant surface*task 
interaction (Table 6B). The Post Hoc analysis showed that for the ST condition, 
there were no significant differences in stride length between surfaces. 
However, the stride length was shorter for DT than for ST, while walking 
overground (F = 44.30; P < 0.001), but there were no differences between 
DT and ST conditions during treadmill walking. On the treadmill, stride length 
for the DT condition was larger than for overground walking (F = 24.26; P < 
0.001). 
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Table 6 Means, standard deviations and ANOVA results of gait variables. 
A. Gait variables in PD and control groups 
 PD CONTROL 
 Overground Treadmill Overground Treadmill 
 ST DT ST DT ST DT ST DT 
Gait speed 
(m/s) 
1.07 ± 
0.23 
1.01 ± 
0.24 
1.07 ± 
0.23 
1.07 ± 
0.23 
1.33 ± 
0.20 
1.25 ± 
0.22 
1.33 ± 
0.20 
1.33 ± 
0.20 
Stride 
length (m) 
1.18 ± 
0.20 
1.13 ± 
0.20 
1.20 ± 
0.23 
1.19 ± 
0.24 
1.35 ± 
0.17 
1.31 ± 
0.17 
1.34 ± 
0.18 
1.36 ± 
0.16 
Stride 
frequency 
(Hz) 
0.90 ± 
0.07 
0.93 ± 
0.15 
0.90 ± 
0.07 
0.93 ± 
0.09 
0.98 ± 
0.07 
0.95 ± 
0.09 
1.00 ± 
0.09 
0.98 ± 
0.08 
CV of stride 
length (%) 
4.27 ± 
2.52 
4.63 ± 
2.44 
1.73 ± 
0.93 
1.54 ± 
0.76 
2.65 ± 
1.00 
3.35 ± 
1.41 
1.56 ± 
0.84 
1.56 ± 
0.83 
CV of stride 
frequency 
(%) 
2.60 ± 
0.80 
2.96 ± 
0.94 
1.90 ± 
1.12 
1.88 ± 
1.07 
1.84 ± 
0.53 
2.37 ± 
0.91 
2.91 ± 
1.97 
2.80 ± 
2.01 
Values are mean ± SD.  PD, Parkinson´s disease; ST, single task; DT, dual task; CV, 
coefficient of variation. 
B. ANOVA results of gait variables 
 Surface Task Group Surface× Task 
Surface× 
Group 
Task× 
Group 
Surface× 
Task× 
Group 
Gait speed 
(m/s) __ 
F=46.76 
P<0.001 
F=12.03 
P=0.001 __ __ NS NS 
Stride length 
(m) 
F=8.00 
P=0.008 
F=21.32 
P<0.001 
F=6.73 
P=0.01 
F= 29.77 
P<0.001 NS NS NS 
Stride 
frequency 
(Hz) 
NS NS F=7.37 P=0.01 NS NS NS NS 
CV of stride 
length (%) 
F=73.35 
P<0.001 NS 
F=4.11 
P=0.05 
F=5.72 
P=0.02 
F=7.67 
P=0.009 NS NS 
CV of stride 
frequency 
(%) 
NS NS NS F=4.65 P=0.04 
F=11.71 
P=0.002 NS NS 
CV, coefficient of variation; NS, Not significant. 
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The analysis of the CV of stride frequency showed significant 
surface*group and surface*task interactions (Table 6B) (Figure 4). Therefore, 
there were no specific group effects of the task in this parameter. The Post 
Hoc analysis of the surface*group interaction showed that overground PD 
patients walked with a higher CV of stride frequency than control subjects (F 
= 8.67; P = 0.006). However, PD patients showed a lower CV than control 
subjects while walking on the treadmill (F = 4.10; P = 0.050) due to a 
decrease of the CV values in the PD group (F = 6.93; P = 0.01) and an 
increase of CV in control subjects when walking on the treadmill in 
comparison with walking overground (F = 4.87; P = 0.03). The Post-Hoc 
analysis of the surface*task interaction indicated that the CV of stride 
frequency was higher during DT than during ST in the overground condition 
(F = 11.39; P = 0.002) but not in the treadmill condition. 
 
 
Figure 4 Comparison of the coefficient of variation of stride frequency 
between single and dual task, in PD and control groups.  
PD indicates Parkinson disease; CV, coefficient of variation; ST, single task; DT, 
dual task. 
 
ANOVA showed significant surface*group and surface*task interactions 
(Table 6B) for CV of stride length (Figure 5). These results indicated there 
were no specific group effects of the task on the CV of stride length. The Post 
Hoc analysis of the surface*group interaction showed that in overground 
condition PD subjects walked with a higher CV of stride length compared with 
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control participants (F = 6.21; P = 0.017). However, these differences were 
not significant on the treadmill. This was due to a significant reduction of the 
CV, in both PD and control subjects, for treadmill versus overground walking 
(F = 64.23; P < 0.001 and F = 16.79; P < 0.001). The Post Hoc analysis of 
the surface*task interaction showed that the CV of stride length was higher 
for DT compared with ST while walking overground (F = 4.39; P = 0.04), but 
there were no significant differences between the tasks on the treadmill. For 
treadmill walking the CV was significantly lower than for overground walking 
for both the ST and DT condition (F = 48.20; P < 0.001 and F = 66.45; P < 
0.001, respectively). 
 
 
Figure 5 Comparison of the coefficient of variation of stride length between 
single and dual task, in PD and control groups.  
PD indicates Parkinson disease; CV, coefficient of variation; ST, single task; DT, 
dual task. 
 
The Wilcoxon test in the control group did not show differences on 
cognitive performance between baseline, overground and treadmill conditions. 
However, the PD group showed significant differences between baseline and 
treadmill (Z = 2.550; P = 0.011). PD patients had a greater percentage of 
mistakes during treadmill walking compared with baseline. No differences 
were found between baseline and overground (Z = 1.221; P = 0.222) or 
between overground and treadmill walking (Z = 0.101; P = 0.92) in the PD 
group. Mann-Whitney tests did not show cognitive differences between 
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groups in the three task conditions. However, there was a tendency for a 
higher percentage of mistakes in PD participants in comparison with controls 
during overground (Z = 1.929; P=0.054) and treadmill (Z =1.875; P = 0.061) 
walking (Figure 6). 
 
 
Figure 6 Comparison of cognitive performance between control and PD 
subjects for baseline, overground, and treadmill conditions. 
 
4.1.5 Discussion 
The main goal of this study was to explore whether attentional resources 
may explain the gait improvements observed during treadmill walking in PD. 
The results show that during treadmill walking with and without the cognitive 
tasks, individuals with PD reduced their gait variability. These gait 
improvements did not deteriorate during the performance of a concurrent 
cognitive task. Moreover, cognitive performance did not show statistical 
differences between treadmill and overground walking. Therefore, these 
findings suggest that improvements of gait in PD patients during treadmill 
walking are independent of attentional demands to the task of walking. 
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Differences in gait parameters between surfaces 
The results showed that the PD group demonstrated a shorter stride 
length, lower velocity and higher gait variability compared with the control 
group while walking overground. However, the PD group reduced the CV of 
stride frequency and the CV of stride length when walking on the treadmill. 
The reduction of the stride frequency variability during treadmill walking has 
been previously reported in PD (Frenkel-Toledo et al., 2005). However, to our 
knowledge, the current study is the first to report a reduction in the variability 
of stride length. This is of relevance since a high stride to stride variability 
was associated with an increased risk of falls in PD (Schaafsma, 2003; 
Hausdorff et al., 2007). Therefore, the present investigation extends the 
benefits of this device, suggesting that walking on the treadmill could 
normalize the temporal variability as well as spatial gait variability in PD. 
Differences in gait between tasks  
The present data clearly demonstrate that during the performance of a 
secondary cognitive task all the participants displayed a decrease in the 
length of the step and speed together with an increase in the spatial and 
temporal variability of overground gait. This is in line with previous studies 
that showed a deterioration of gait disturbances in people with PD when they 
walk and perform a secondary task at the same time (Canning, 2005; 
Springer et al., 2006; Yogev-Seligmann et al., 2008; Bello et al., 2010). 
Other studies have also shown alterations of the gait pattern in healthy older 
adults while simultaneously performing a cognitive task, suggesting an age-
related reduction in dual task capacity (Morris et al., 1996; Rochester et al., 
2014). Moreover, there was a non-significant tendency, in PD participants, to 
perform the cognitive task during walking worse than control subjects. This 
tendency is in agreement with previous studies showing that PD individuals 
require more attention to regulate the gait pattern in order to compensate 
their damaged automaticity (Morris et al., 1996). Therefore, this report 
reinforces the hypothesis that walking during the performance of a cognitive 
task requires greater levels of cognitive function in PD patients (Plotniket al., 
2011). 
C h a p t e r  4  S t u d i e s  | 59 
 
 
The cognitive task did not affect any gait parameters during treadmill 
walking, in PD and control subjects. Overall, the gait variability reduction in 
PD participants, as a result of walking on the treadmill, did not deteriorate 
during the performance of the cognitive task. Therefore, the present study 
suggests that the adaptive changes of the gait pattern while walking on a 
treadmill are not related to increased attentional demands in comparison with 
walking overground. 
In the present work PD patients showed deterioration in their cognitive 
performance during treadmill walking in comparison with performing a 
cognitive task in a static position (baseline cognitive measurement). Previous 
studies showed that when the environment becomes more demanding, 
focusing on the cognitive task becomes too risky and the attention is allocated 
toward postural stability in order to reduce the likelihood of falling and secure 
safety (Yogev-Seligmann et al., 2012). Although, the handrail support during 
treadmill walking could improve the postural stability, it is likely that this 
effect was counteracted by the balance instability induced by the belt 
movement. This study suggests that, despite the handrail support, DT on a 
treadmill could be more demanding for PD participants compared with 
performing a cognitive task in a rest position without a simultaneous motor 
task. 
Mechanisms of treadmill walking in PD 
This article provides additional data in order to elucidate the role of 
attentional resource allocation in the treadmill associated gait improvements 
observed in patients with PD.  
One of the hypotheses to explain the gait improvements in PD subjects is 
that they are able to allocate more attention to walking on a treadmill than 
walking overground (Bello & Fernández-Del-Olmo, 2012). Previous studies 
showed that people with PD can normalize gait pattern when focusing 
attention on gait (Morris et al., 1996). However, during the performance of 
daily activities, distracters impede attention allocation with the consequent 
gait deterioration (Rochester et al., 2004). During treadmill walking, the 
environment is more stable and the absence of distracters could help PD 
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subjects to maintain their focus on the gait. The present study does not 
support this hypothesis. The results reported that CV of stride frequency was 
reduced during treadmill walking in both ST and DT conditions (Fig. 4). 
Moreover, an absence of differences in cognitive performance between 
treadmill and overground walking in PD was observed. Therefore, these 
findings suggest that attentional demands do not contribute to the gait 
improvements in PD.  
Alternative explanations for the gait improvements are the belt 
displacement and the constant speed provided by the treadmill (Frenkel-
Toledo et al., 2005; Bello et al., 2010; Bello & Fernández-Del-Olmo, 2012). 
The belt displacement enhances the hip extension movements during 
treadmill walking. These proprioceptive inputs (repeated contraction and 
relaxation of muscles groups) may act as an external rhythmical cue 
bypassing the defective pallidocortical projections, resulting in a normalized 
gait pattern (Bello et al., 2010). In addition, the propioceptive inputs during 
treadmill walking could stimulate the CPG. CPG refers to neural spinal circuits 
that can produce rhythmic movements. However, the role of CPG in human 
control remains unknown (Dietz, 2003). The constant speed provided by the 
treadmill could also contribute to minimizing the stride-to-stride variation in 
gait timing (Frenkel-Toledo et al., 2005), in contrast to overground walking 
where there are ongoing fluctuations in gait speed. The study results showed 
a reduction in both stride length and frequency variability on the treadmill in 
PD patients, in comparison with overground. Thus, PD patients could benefit 
from a constant speed, which improves gait timing. A recent study has 
suggested that the improvement in the step length may be due to the belt 
movement but that changes in variability may be influenced further by the 
imposed treadmill speed (Bello et al., 2010). 
Although, all subjects walked on the treadmill with the handrail support, 
it is unlikely that this could account for the gait improvement in subjects with 
PD. A previous study from our group clearly showed that, when PD subjects 
walked with a treadmill simulator without the belt but with hand support, 
stable environment and imposed speed, their step length did not improve in 
comparison with normal overground walking (Bello et al., 2010). Thus, hand 
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support may not be responsible for the gait improvements during treadmill 
walking that were observed in the present study.  
In summary, this is the first study that explores the role of attention in 
the gait improvements observed in PD subjects during treadmill walking. The 
present results show that PD subjects walking on a treadmill, while 
simultaneously performing a cognitive task, are able to maintain the 
reduction of their gait variability. Moreover, their cognitive execution was 
similar during treadmill and overground walking. These findings suggest that 
attentional resources are not involved in the gait treadmill improvements in 
PD subjects and point to belt displacement and constant speed as alternative 
explanations. 
Clinical implications 
The present study provides additional information that may be useful 
when considering the treadmill as a therapeutic tool to improve the gait in 
subjects with PD. The reduction of gait variability walking on a treadmill did 
not deteriorate during the performance of a concurrent cognitive task. 
Therefore, therapists may include performance of cognitive tasks during the 
treadmill walking in order to simulate real life conditions (i.e. walking while 
keeping a conversation). In addition, we recommend further studies that 
investigate the role of belt displacement and constant speed in gait 
improvements using treadmill walking in PD and to determine how these 
improvements translate to real life conditions. 
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4.2 STUDY II: Acute kinematic and neurophysiological 
effects of treadmill and overground walking in 
Parkinson’s disease 
4.2.1 Abstract 
The use of the treadmill as a gait rehabilitation tool has provided novel 
options for treatment of gait impairments in PD. However, the neural 
mechanisms underlying these therapeutic effects in PD remain unknown. Our 
goal was to examine the immediate short-term effects of a single session of 
treadmill and overground walking on gait, spinal and corticospinal parameters 
in PD. Fifteen PD participants were evaluated in two separate sessions and 
walking conditions: walking over a treadmill and walking overground. The 
following measurements were evaluated before and after each condition: 
overground walking performance, the Soleus (SOL) H-reflex, Reciprocal Ia-
Inhibition from the TA to the SOL muscle, ICF and Short Intracortical 
Inhibition (SICI) of the TA muscle. We found that treadmill walking, but not 
overground walking, lead to an improvement in the stride length and gait 
speed in the PD patients. Both walking conditions modulated spinal and 
corticospinal parameters in a similar way. This study provides evidence of a 
specific therapeutic effect of a single session of treadmill walking on gait in 
PD. Further studies are needed to explore other possible neural mechanisms. 
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4.2.2 Introduction 
Gait disturbances are one of the principal and most incapacitating 
symptoms of PD (Keus et al., 2009). PD gait is characterized by the inability 
to regulate an appropriate stride length, a reduced gait speed and an 
increased stride-to-stride variability (Ebersbach et al., 2013). Gait disorders 
in PD may also include festination, start hesitation during gait initiation, 
freezing of gait and falls (Ebersbach et al., 2013). The physiopathology of 
these gait disorders has not been studied extensively and only a few studies 
have investigated the neurophysiological aspects of parkinsonian gait. A 
recent study showed a reduction of the SOL H-reflex during gait initiation in 
PD (Hiraoka et al., 2006). Others have reported a correlation between the 
decreased reciprocal Ia-inhibition at the onset of a voluntary ankle 
dorsiflexion during axial swings in PD patients (Meunier et al., 2000a). In 
addition, TMS studies revealed abnormalities in ICF, that may be related with 
the decreased stride length and the slower gait speed in PD (Vacherot et al., 
2010a). 
In recent years, there has been an increased interest in the treadmill 
as a potential gait rehabilitation tool in PD. Several studies have shown that 
treadmill training enlarge stride length, increase gait speed, decrease double 
support and reduce gait in PD subjects (Miyai et al., 2000, 2002; Bello et al., 
2010; Bello, 2013). Gait benefits have been observed immediately after a 
single session of treadmill walking. For example, after walking on a treadmill 
for 20 minutes, PD patients were able to walk overground with lower stride-
to-stride variability (Frenkel-Toledo et al., 2005) and higher stride length 
(Fernández-Lago et al., 2015). Although, these short-term gait 
improvements were attributed to the treadmill walking, the studies did not 
examine whether these effects could also be achieved by a single session of 
overground walking. This is of relevance in order to determine whether the 
treadmill has a specific therapeutic effect in PD. 
In addition, although several hypotheses have been suggested in order 
to explain the beneficial effects associated with the use of a treadmill in PD 
(see review of Bello et al. 2012) (Bello & Fernández-Del-Olmo, 2012), the 
C h a p t e r  4  S t u d i e s  | 65 
 
 
neural mechanisms underlying these improvements still remain largely 
unknown.  
The aim of the current study was to explore the immediate effects of a 
single session of either treadmill or overground walking on gait, spinal and 
corticospinal measurements in PD. We hypothesized that only the treadmill 
walking session would lead to an improvement in the gait kinematics in PD 
subjects, as well as walking-related neurophysiological modulations. 
4.2.3 Material and methods 
Participants 
Fifteen individuals, diagnosed with idiopathic PD by a neurologist 
according to the United Kingdom Bank Criteria (Hugheset al., 1992), were 
recruited for the study from a local community. Inclusion criteria for 
participants was diagnosis of idiopathic PD, the ability to walk for 10 minutes 
without stopping or walking assistance, absence of neurologic disorders other 
than PD, not being treated with deep brain stimulation, and absence of 
orthopaedic, cardiovascular or visual disturbances that could affect gait. The 
participants did not use a treadmill for at least 12 months before the 
experiment. No participant showed dementia as assessed by the MMSE. The 
level of severity of the motor signs associated with PD was measured using 
the UPDRS-III (Fahn et al.,1987) and H&Y scale (Hoehn, 1967). Tests were 
conducted with the patients in the “ON” state (45 minutes – 1.5 hours after 
medication intake) when they were moving freely and easily without dystonia, 
excessive rigidity or tremor. All participants gave their informed consent 
according to the Declaration of Helsinki (1964), before entering the study. 
The experimental procedures were approved by the local ethics committee. 
Details of participants are shown in Table 7. 
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Table 7 Details of PD participants. 
 
 Sex Age 
(Yr) 
Weig
ht 
(Kg) 
Heig
ht 
(cm) 
Leg 
lengt
h 
(cm) 
Dise
ase  
Dura
tion 
 (yr) 
H&Y UPD
RS 
III 
MMS
E 
More 
sym
ptom
atic 
or 
onse
t side 
Medication 
1 M 45 84 170 87.5 7 2 30 30 L 
Levodopa/Carbidopa 
750/187.5, Entacapone 
1000, Pramipexole 2.1, 
Rasagiline 1 
2 M 85 69 180 90.1 16 3 58 27 R Levodopa/Carbidopa 600/150, Entacapone 800 
3 M 42 87 175 92 2 1.5 18 28 L Levodopa/Carbidopa 200/50, Entacapone 200 
4 F 67 51 151 80.5 4 1.5 21 29 L Levodopa/Benserazide 250/50, Rasagiline 1 
5 F 51 62 160 88 10 2 21 29 I 
Levodopa/Carbidopa 
800/400, Pramipexole 3.15, 
Amantadine 300 
6 M 67 81 174 91 8 1.5 9 30 L 
Levodopa/Carbidopa 
450/112.5, Entacapone 600, 
Pramipexole 3.6 
7 F 45 64 171 93 7 1.5 21 30 L Levodopa/Carbidopa 150/25, Trihexyphenidyl 2 
8 M 60 85 165 82 5 1.5 23 30 R Levodopa/Benserazide 175/43.75, Pramipexole 2.1 
9 M 36 86 168 90 4 1 9 29 R 
Levodopa/Carbidopa 
150/37.5 Entacapone 600, 
Rotigotine 4, Rasagiline 1 
10 M 59 75 170 83.5 2 1.5 32 30 R Rasagiline 1, Pramipexole 1 
11 M 56 75 173 90 3 2.5 26 30 L Levodopa/Carbidopa 350/75 Rasagiline 1, Rotigotine 8 
12 F 67 67 147 74 3 1.5 18 29 R Rasagiline 1 
13 F 49 73 150 77.5 8 1.5 12 26 R Levodopa/Carbidopa 500/125 Pramipexole 1 
14 F 62 76 160 85 10 1.5 12 30 L 
Levodopa/Benserazide 
900/225, Ropinirole 16, 
Rasigiline 1 
15 M 59 75 165 91.1 9 2 16 27 R 
Levodopa/Carbidopa 
300/75, Rasagiline 1, 
Ropinirole 6 
Mean  56.67 74.00 154.18 86.35 6.53 1.68 21.23 28.93   
DS  12.48 10.13 43.32 5.73 3.86 0.46 12.20 1.33   
Yr, years; M, male; F, female; R, right; L, left. 
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Study protocol 
All participants performed three sessions, one familiarization session 
with the treadmill and two experimental sessions corresponding to the two 
walking conditions: overground walking and treadmill walking. The 
experimental sessions were arranged in random order and separated by a 
period of one week. A summary of the protocol is shown in Figure 7. 
 
 
Figure 7 Scheme of an experimental session of Study II.  
Walking protocol consisted of 4 blocks (5 minutes per block) of either treadmill or 
overground walking, with 3 minutes of rest between blocks. 
 
Spinal measurements, gait overground test performance and 
corticospinal measurements were recorded, in that order, before (pre) and 
after (post) each walking condition. Spinal measurements were tested first, 
to exclude the possibility that the post-measurements of the gait overground 
test may mask possible spinal modulations. Corticospinal parameters were 
measured at the end, to ensure that the post-measurements of the gait 
overground test took place at least 10 minutes after each of the walking 
conditions (Bello et al., 2008). The self-selected gait speed obtained during 
the first gait overground test, was used for the subsequent walking 
conditions.  
The treadmill walking condition consisted of four 5-minutes blocks of 
treadmill walking with a 3-minutes rest period between blocks. During the 
first minute of each block, the belt speed was increased to the overground 
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self-selected, preferred speed. All the participants walked on the treadmill 
holding the handrails since some participants did not feel safe to walk without 
the handrail support. The subjects walked on a motorized treadmill (SporsArt 
6300, Sports Arts Fitness) under the close supervision of a physical therapist.  
The overground condition consisted of four 5-minutes blocks of 
overground walking with a 3-minutes rest period between blocks. The 
overground walking session was conducted in an indoor facility. PD 
participants had to walk forming a square marked with cones (20x20m). The 
walking direction was alternated in each block, either clockwise or counter-
clockwise. The walking speed was monitored during the session, in order to 
confirm that each patient maintained the overground walking speed obtained 
at the beginning of the experimental session. 
Outcome measures 
The gait overground test 
Gait performance was recorded overground using an optical detection 
system (Optogait, Microgait, USA), after a familiarization trial. Participants 
were recorded walking up and down an 8 meters walkway at their self-
selected comfortable speed, for a total time of 2 minutes. The gait parameters 
were recorded during the straight walking portion, but not during the turns.  
The following gait variables were evaluated: speed (m/s), stride length 
(m), stride frequency (Hz), CV of the stride length (%) and of the stride 
frequency (%). CV is an indicator of variability, where CV = (standard 
deviation/ mean) x100. 
Neurophysiologic measurements  
Spinal and corticospinal recordings were performed at rest before and 
after each walking condition. Subjects were seated comfortably in a reclining 
armchair; with the feet resting on a foot support so that the hips were flexed 
at a 120 degrees, the knees semi-flexed at 160 degrees, and the ankles were 
positioned at 110 degrees of a plantar flexion. 
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Electromyographic (EMG) was recorded by a pair of adhesive surface 
electrodes 2-cm apart (bipolar), placed over the SOL and Tibial Anterior 
muscles bellies, according to SENIAM recommendations (Hermens et al., 
2000). Muscles from the more symptomatic side of the PD patients were 
recorded. The reference electrode was placed over the medial malleolus bone 
surface. The recording sites were shaved, abraded and cleaned with isopropyl 
alcohol to obtain low impedance (Z, 5kΩ). The EMG signals were 
simultaneously digitized using an acquisition car at a sampling rate of 5kHz 
per channel (Digitimer D360, Welwyn Garden City, UK), and then recorded 
using a Signal script software (Cambridge Electronic Devices, Cambridge, UK).  
Hmax/Mmax ratio 
Transcutaneous electrical stimulation of the posterior tibial nerve was 
used to elicit the H-reflex in the SOL muscle using a Digitimer stimulator 
(model DS7, Welwyn Garden City, UK). The optimum site of nerve stimulation 
was first located using a hand-held electrode. The cathode (2 cm diameter 
brass hemisphere) was placed on the popliteal fossa and the anode (5 cm2) 
above the patella. The adhesive electrodes were fixed with an elastic strap. 
The stimulus that was used was a rectangular pulse with a duration of 1 ms. 
The maximum H-reflex response (Hmax) and the maximum M amplitude 
(Mmax) were recorded. 
Reciprocal Ia-inhibition 
To evaluate the reciprocal Ia-inhibition from the TA to the SOL muscles, 
the size of the SOL control H-reflex was adjusted to Hmax/2 (Crone, 1990) 
and to 20- 25% of the Mmax, and kept constant throughout the experiment. 
The conditioning stimulus was applied to the common peroneal nerve through 
bipolar electrodes placed at the neck of the fibula. Rectangular pulses of 1 
ms duration were used. The conditioning stimulus was adjusted to the Tibialis 
Anterior (TA) motor threshold intensity. Special care was taken to ensure a 
pure TA contraction (Meunier et al., 2000b). The conditioning–test 
interstimulus interval was determined using 0.5 ms steps until the maximum 
reciprocal Ia-inhibition of SOL H-reflex response was reached, and this value 
was then kept constant throughout the experiment. Ten unconditioned and 
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ten conditioned reflexes were recorded. Mean as well as standard error of the 
mean (SEM) values are reported. The amount of inhibition was defined as: 
[(mean control H value – mean conditioned H value)/mean control H value)] 
×100. 
Corticospinal measurements 
The following measures, elicited by TMS, were recorded: the motor 
evoked potential (MEP), SICI and ICF of the TA muscle. TMS was delivered 
using a double cone coil connected to a Magstim 200 magnetic stimulator 
(Magstim, Dyfed, United Kingdom). The optimal scalp location was 
determined by placing the coil over the inter hemispheric scissura and by 
moving it around until the hotspot that was contralateral to the most affected 
side, was located. We determined the resting motor threshold (RMT) in 
accordance with the International Guidelines (Rossini et al., 1994): the 
nearest 1% of the maximum stimulator output was defined as the minimum 
stimulus intensity required to produce MEPs of >50 µV in at least 5 of 10 
consecutive trials. In the paired-pulse TMS recordings, a subthreshold 
conditioning stimulus was delivered at 80% of the RMT, following a 
suprathreshold test stimulus intensity set at 130% of the RMT. Based on 
results observed by Vacherot et al. (2010), SICI was elicited at an 
interstimulus interval of 3 ms, whereas ICF was elicited at an interstimulus 
interval of 15 ms (Vacherot et al., 2010a). A total of 10 tests, 10 SICIs and 
10 ICFs stimuli were randomly delivered and recorded in a single block 
(Kujirai et al., 1993). SICI and ICF amplitudes were expressed as the 
percentage of the mean amplitude of the unconditioned MEP.  
Statistical analysis 
To explore the changes in walking performance and of the 
neurophysiological parameters before and after each walking condition, a 
two-way ANOVA, with “condition” (treadmill and overground) and “time” (pre 
and post) as the main factors, was performed for each of the following 
variables: gait speed, stride length, stride frequency, CV of stride length and 
CV of stride frequency, Hmax/Mmax ratio, Reciprocal Ia-inhibition, MEP, ICF 
and SICI. 
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Post Hoc t-tests were computed. Variables did not violate assumption 
of normality, except for the SICI and ICF variables. The analyses of these 
variables were conducted using logarithmic transformation values. All 
statistical analyses were performed using PASW Statistics 18. A P value ≤ 0, 
05 was considered statistically significant. 
4.2.4 Results 
The gait overground test 
The results of the gait parameters are shown in Table 8. 
Table 8 Mean and standard deviations of gait variables before, and after a 
single session intervention. 
 
 TREADMILL OVERGROUND 
 PRE POST PRE POST 
Gait speed 
(m/s) 1.17±0.26 1.25±0.24 1.21±0.19 1.20±0.22 
Stride length 
(m) 1.23±0.19 1.29±0.18 1.26±0.17 1.23±0.16 
Stride 
frequency 
(Hz) 
0.94±0.09 0.95±0.09 0.95±0.07 0.97±0.09 
CV of stride 
length (%) 4.52±2.01 3.94±1.78 4.30±1.78 4.22±2.29 
CV of stride 
frequency 
(%) 
3.08±1.41 2.84±1.06 2.90±1.32 2.85±1.47 
PRE, pretest; POST, postest; CV, coefficient of variation. 
 
The analysis of the overground gait speed showed a significant 
condition×time interaction (F=6.981, p=0.019) without significant main 
effects for condition and time. Post hoc analysis showed that gait speed was 
faster for post-treadmill compared with pre-treadmill (p=0.001). No 
significant gait speed changes were found for the pre vs. post-overground 
condition (Figure 8). 
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The analysis of the stride length also showed a significant 
condition×time interaction (F=4.94, p=0.043) without significant main 
effects for condition and time. Post hoc analysis showed that the stride length 
was larger post-treadmill compared with pre-treadmill (p=0.007). No 
significant changes were found for the overground condition (Figure 8). The 
analysis for the remaining gait parameters did not show significant main 
effects or interactions (Figure 8). 
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Figure 8 Results of walking performance. 
PRE, pretest; POST, postest; #, (p<0.005). 
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Neurophysiological measurements 
The analysis of the Hmax/Mmax ratio revealed a significant main effect 
for time (F=23.308, p<0.001), without a significant main effect for condition 
nor a significant condition×time interaction. The Hmax/Mmax ratio was lower 
after than before the two walking conditions (Figure 9). No significant main 
effects or interactions were found for the reciprocal Ia-inhibition. 
The analysis of the absolute MEP amplitudes for single TMS pulses did 
not show significant main effects nor a significant interaction. The analysis of 
ICF values showed a significant main effect for time (F=7.053, p=0.019), 
without a significant effect of condition or a condition×time interaction. ICF 
values decreased after, compared with before, the two walking conditions 
(Figure 9). No significant main effects or interactions were found for 
measurements of SICI (Figure 9). 
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Figure 9 Results of spinal and cortical excitability.  
PRE, pretest; POST, postest; ICF, intracortical facilitation; *, significant main effect 
(p<0.005). 
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4.2.5 Discussion 
The current study demonstrated that a single session of treadmill 
walking, but not of overground walking, lead to immediate gait improvements 
in PD patients. However, the spinal and corticospinal modulations that were 
observed in our study were not specific to the therapeutic effect of treadmill 
walking.  
Our study showed that PD participants increased their overground gaits 
peed and stride length after, compared to before, a 20 minutes session of 
treadmill walking. Previous findings have reported similar improvements in 
PD gait after a single session of treadmill walking (Miyai et al., 2000; Bello et 
al., 2008; Kurtais et al., 2008). For instance, overground gait speed, stride 
length and double stance duration have been shown to improve after a single 
session of treadmill walking with weight support. However, none of these 
studies have compared a single session of treadmill walking with a single 
session of overground walking. To our knowledge the current study is the 
first to show that 20 minutes of overground walking does not improve gait in 
PD. Therefore, our results suggest a specific therapeutic effect of treadmill 
walking in PD subjects.  
The current investigation showed that the changes in the 
neurophysiological parameters were comparable across the two walking 
conditions, i.e. treadmill and overground walking. We found that ICF values 
decreased after both walking interventions in PD patients. Thus, the observed 
ICF reduction was not specific to the treadmill, but instead as a result of the 
walking movement itself. The ICF of the lower limb areas has not been 
investigated extensively in PD, and to date only one study has reported ICF 
impairments in the TA muscle (Vacherot et al., 2010). In this study PD 
patients manifested an abnormal reduced ICF that correlated with the 
observed shortened stride length and reduced gait velocity. However, it is 
difficult to compare the results of this study with our current findings since, 
unlike our study, ICF values were measured before any walking activity was 
performed and half of the patients manifested freezing of gait (Vacherot et 
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al., 2010b). Our findings suggest that ICF is not a mechanism underlying the 
gait improvement associated with treadmill walking in PD. 
The current study showed that the SICI values did not change after a 
single session of treadmill and overground walking. SICI has been shown to 
be mediated by cortical GABAa activity (Werhahn et al., 1999; Ziemann et al., 
1996) and can be modulated by a short period of motor skill training involving 
ankle muscles (Perez et al., 2004). Several studies have suggested that gait 
improvements associated with treadmill walking may be related to motor 
learning mechanisms, since the improvements are sustained for several 
months after the treadmill training has been completed (Protas et al., 2005; 
Herman et al., 2007; Fisher et al., 2008b). However, our SICI findings 
suggest that it is unlikely that the gait improvements, observed after a single 
session of treadmill walking, are related to the acquisition of a motor skill. 
In addition, we observed spinal modulations after both the treadmill 
and walking sessions as indicated by a reduction of the Hmax/Mmax ratio 
values. However, we did not observe any significant changes in the reciprocal 
Ia-inhibition. A previous study showed that the SOL Hmax/Mmax ratio and 
the recruitment curve of H-reflex at rest are similar in PD and control subjects 
(Dietrichson, 1971). However, several other studies have suggested that this 
reflex has a role in the gait impairments that are observed in PD (Hiraoka et 
al., 2005; Hiraoka et al., 2006; Pierantozzi et al., 2008). There is some 
evidence to suggest that the depression of the SOL H-reflexes can occur after 
different training tasks such as a single training session of cycling (Meunier 
et al., 2007), balance (Freyler et al., 2014), and co-contraction (Perez et al., 
2007) in healthy adults. Thus, it is likely that the depression of the 
Hmax/Mmax ratio observed in the present study may be due to the actual 
walking activity. Our findings suggest that both the H-reflex and the 
reciprocal Ia-inhibition are not involved in the gait improvements associated 
with a single session of treadmill walking in PD. Further studies are needed 
to elucidate the neural mechanisms involved in treadmill walking 
improvements in PD, perhaps using other neurophysiologic parameters. 
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4.3 STUDY III: Treadmill walking combined with anodal 
tDCS in Parkinson's Disease: kinematic and 
neurophysiological effects. 
4.3.1 Abstract 
The use of treadmill as a gait rehabilitation tool and advances in NIBS has 
provided novel and low-risk options for treatment of gait impairments in PD. 
We tested the hypothesis that combining treadmill walking with tDCS 
enhances the gait improvements associated with treadmill walking in PD 
subjects. We explored the effects of these combined methodologies on spinal 
and corticospinal parameters. Eighteen PD participants were evaluated in 
separate sessions under three treadmill walking conditions: treadmill walking 
alone (treadmill), treadmill walking combined with anodal tDCS 
(AtDCS+treadmill), and treadmill walking combined with sham tDCS 
(StDCS+treadmill). Overground walking performance, the SOL H-reflex, 
Reciprocal Ia-Inhibition from the TA to the SOL muscle, ICF and SICI of the 
TA muscle, were measured before and after each treadmill condition. The SOL 
H-reflex and walking performance on the treadmill were also evaluated. All 
treadmill conditions improved walking performance and modulated spinal and 
corticospinal parameters in a similar way. However, AtDCS+treadmill lead to 
a different modulation of Reciprocal Ia-Inhibition from the TA muscle to the 
SOL in comparison with the other treadmill conditions. Although, a single 
session combining treadmill walking and anodal tDCS did not enhance the 
improvements of gait parameters associated with treadmill walking in PD, the 
specific modulation of the Reciprocal Ia-Inhibition point out to an interaction 
of the effects of these tools. Further studies are needed to explore the 
functional significance of this interaction. 
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4.3.2 Introduction 
Gait disturbances are among the most significant impairments in PD that 
severely affect the individual's QoL (Keus et al., 2009). PD gait is 
characterized by a particular difficulty with the internal regulation of stride 
length. This is often accompanied by a reduced gait speed, and an increase 
of the double support phase and stride variability (Ebersbach et al., 2013).  
Gait disturbances in PD may be linked with the degeneration of the PPN 
of the MLR (Grabli et al., 2013), coupled with bidirectional disruptions of 
signals to the BG (Mena-Segovia et al., 2004). However, neurophysiological 
features associated with parkinsonian gait have been not been investigated 
extensively. Findings suggest that PD subjects show an inhibited SOL H-reflex 
during gait initiation (Hiraoka et al., 2006). This H-reflex inhibition is removed 
after deep brain stimulation of the PPN (Pierantozzi et al., 2008), suggesting 
a role of this reflex in the gait impairments in PD. In addition, abnormalities 
in ICF detected by TMS may also be involved in the shortened stride length 
and reduced gait speed that are observed in PD patients (Vacherot et al., 
2010a). 
Although, dopaminergic therapies ameliorate many of the parkinsonian 
symptoms especially in the early stages of the disease, as the disease 
progresses, effectivity of pharmacological therapy is diminished 
(Katzenschlager & Lees, 2002). Therefore, treatment of gait symptoms 
continues to be a challenge. As a result, a significant number of rehabilitation 
strategies have been explored in order to improve the gait in this population 
(Tomlinson, 2012). The use of treadmill as a gait rehabilitation tool and 
advances in NIBS has provided novel and low-risk options for treatment of 
gait impairments in PD. 
Several studies have shown that treadmill training leads to improvements 
of gait parameters in people with PD, such as enlarged stride length, 
increased gait speed, decreased double support and reduced gait variability 
(Miyai et al., 2000; Kurtais et al., 2008; Fisher, 2008; Bello, 2013). These 
improvements could even occur after one single treadmill walking session in 
PD (Bello et al., 2008) and may be related with the gait modulation that takes 
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place when the patients walk on the treadmill. Treadmill walking has been 
shown to be associated with longer stride length and a more stable gait 
pattern in PD patients,  compared with overground walking at an identical 
speed (Frenkel-Toledo et al., 2005; Fernández-Lago et al., 2015). 
TDCS is a NIBS technique that consists of delivering weak currents 
through a pair of electrodes placed on the scalp, with the capability to 
modulate corticomotor excitability (Nitsche et al., 2008) and spinal reflexes 
such as reciprocal Ia-inhibition in healthy people (Roche et al., 2012). In PD, 
tDCS application over motor cortex produced a polarity-dependent effect on 
corticospinal motor excitability that seemed to correlate with motor function 
enhancements (Fregni et al., 2006). Anodal tDCS over motor cortex resulted 
in modest improvements of gait function in PD subjects (Benninger et al., 
2010). In addition, the combination of anodal tDCS and physical training 
seems to be more efficient than the application of tDCS alone (Kaski et al., 
2014). Therefore, combining treadmill walking with tDCS may be an effective 
strategy for enhancing the therapeutic effects of treadmill walking in PD 
patients. 
The aim of the current study was to explore the effects of a single session 
of anodal tDCS during treadmill walking on gait parameters in PD. In addition, 
we recorded spinal and corticospinalparameters in order to investigate the 
possible neural mechanisms involved in the effects of the combined therapy. 
Our hypothesis was that anodal tDCS will enhance the effect of treadmill 
walking on gait parameters in PD. 
4.3.3 Material and methods 
Participants 
Eighteen individuals diagnosed with idiopathic PD by a neurologist, 
according to the United Kingdom Bank Criteria (Hughes et al., 1992) were 
recruited for the study from a local community. Inclusion criteria for 
participants were: diagnosis of idiopathic PD, the ability to walk for 10 
minutes without stopping or walking assistance, absence of neurologic 
disorders other than PD, not being treated with deep brain stimulation, and 
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absence of orthopaedic, cardiovascular or visual disturbances that could 
affect the gait. No participant showed dementia as assessed by the MMSE. 
The severity of the motor signs associated with PD was measured using the 
UPDRS-III (Fahn et al., 1987) and H&Y scale (Hoehn, 1967). Tests were 
conducted with the patients in the “ON” state (45 minutes – 1.5 hours after 
medication intake) when they were moving freely and easily without dystonia, 
excessive rigidity or tremor. All participants gave their informed consent 
according to the Declaration of Helsinki (1964) before entering the study and 
the protocol were approved by the local ethics committee. Details of 
participants are shown on Table 9. 
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Table 9 Details of participants. 
 Sex Age 
(Yr) 
Wei
ght 
(Kg) 
Heig
ht 
(cm) 
Leg 
len
gth 
(cm
) 
Dise
ase  
Dur
atio
n 
 (yr) 
H&Y UPD
RS 
III 
MM
SE 
Bod
y 
side  
mor
e 
affe
cted 
Medication 
1 M 59 74 165 83.5 5 1.5 24 29 R Levodopa/Carbidopa 600/150, 
Rasagiline 1, Rotigotine 14 
2 M 63 79 166 82 6 1.5 13 29 R Pramipexole 3.15, 
Levodopa/Carbidopa 100/25, 
Rasagiline 1 
3 M 45 84 170 87.5 7 2 30 30 L Levodopa/Carbidopa 750/187.5, 
Entacapone 1000, Pramipexole 2.1, 
Rasagiline 1 
4 M 85 69 180 90.1 16 3 58 27 R Levodopa/Carbidopa 600/150, 
Entacapone 800 
5 M 42 87 175 92 2 1.5 18 28 L Levodopa/Carbidopa 200/50, 
Entacapone 200 
6 F 67 51 151 80.5 4 1.5 21 29 L Levodopa/Benserazide 250/50, 
Rasagiline 1 
7 F 51 62 160 88 10 2 21 29 I Levodopa/Carbidopa 800/400, 
Pramipexole 3.15, Amantadine 300 
8 M 67 81 174 91 8 1.5 9 30 L Levodopa/Carbidopa 450/112.5, 
Entacapone 600, Pramipexole 3.6 
9 F 45 64 171 93 7 1.5 21 30 L Levodopa/Carbidopa 150/25, 
Trihexyphenidyl 2 
10 M 60 85 165 82 5 1.5 23 30 R Levodopa/Benserazide 175/43.75, 
Pramipexole 2.1 
11 M 36 86 1.68 90 4 1 9 29 R Levodopa/Carbidopa 150/37.5 
Entacapone 600, Rotigotine 4, 
Rasagiline 1 
12 M 59 75 170 83.5 2 1.5 32 30 R Rasagiline 1, Pramipexole 1 
13 M 56 75 173 90 3 2.5 26 30 L Levodopa/Carbidopa 350/75 
Rasagiline 1, Rotigotine 8 
14 F 67 67 147 74 3 1.5 18 29 R Rasagiline 1 
15 F 49 73 150 77.5 8 1.5 12 26 R Levodopa/Carbidopa 500/125 
Pramipexole 1 
16 F 62 76 160 85 10 1.5 12 30 L Levodopa/Benserazide 900/225, 
Ropinirole 16, Rasigiline 1 
17 M 59 75 165 91.1 9 2 16 27 R Levodopa/Carbidopa 300/75, 
Rasagiline 1, Ropinirole 6 
18 F 48 56 1.68 91.5 2 1.5 18 27 L Levodopa/Benserazide 100/25, 
Ropirinole 16 
Mean  56.67 73.28 146.96 86.23 6.17 1.65 21.17 28.83   
DS  11.63 10.23 53.60 5.49 3.65 0.42 11.31 1.29   
Yr, years; M, male; F, female; R, right; L, left. 
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Study protocol 
All participants performed four sessions, one familiarization session with 
the treadmill and tDCS, and three experimental sessions corresponding to 
three treadmill walking conditions: treadmill walking alone (treadmill), 
treadmill walking combined with anodal transcranial direct current stimulation 
(AtDCS+treadmill), and treadmill walking combined with sham stimulation 
(StDCS+treadmill). The experimental sessions were arranged in random 
order and separated by a period of one week. 
A description of the experimental procedure is summarized in Figure 10. 
Spinal, walking overground performance and corticospinalmeasurements 
were recorded, in that order, before (pre) and after (post) the treadmill 
walking conditions. Cortical measurements were tested at the end, since it 
has been shown that the maximum increase in cortical excitability occurs 15 
minutes post-AtDCS stimulation (López-Alonso et al., 2015). The individual 
velocity obtained during overground walking at the beginning of each 
experimental session was used for the subsequent treadmill walking 
conditions. Subjects walked on a motorized treadmill (SporsArt 6300, Sports 
Arts Fitness) under the close supervision of a physical therapist. 
The treadmill conditions consisted on four 5 minutes blocks (T1–T4) of 
treadmill walking holding the handrails with a rest period between blocks of 
3 minutes. In all treadmill blocks, during the first minute, the belt speed was 
progressively increased to the overground speed.  
The AtDCS+treadmill condition was the same as the treadmill condition 
but was combined with a 20 minutes session of anodal tDCS stimulation. 
Anodal tDCS was delivered at 2 mA through a pair of saline-soaked sponge 
surface electrodes (3.5 cm2) connected to a DC stimulator (neuroConn, 
Germany). The active electrode (anode) was placed over the motor cortex 
and positioned in the hotspot of the TA muscle contralateral to the most 
affected body side. This area was localized using a TMS procedure. The 
cathode was placed contralateral to the anode, over the supraorbital region. 
The stimulator was turned on at the first rest period. Subjects received a 
continuous 20 minutes anodal tDCS stimulation session (during the 
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corresponding blocks and rest periods). The current was faded in and faded 
out for 8 seconds. 
The StDCS+treadmill condition was identical to the AtDCS+treadmill 
condition except that the current of the anodal tDCS was switched off after 8 
seconds of stimulation. 
Walking performance and H-reflex amplitudes were evaluated during each 
treadmill walking condition (during block T3 at 3 and 4 minutes for walking 
performance and H-reflex, respectively). 
 
Figure 10 Scheme of one experimental session od Study III.  
 
 
PRE, overground pre-treadmill; DURING, tests during treadmill walking; POST, 
overground post-treadmill. Treadmill walking protocol consists of 4 blocks (5 minutes 
per block) of treadmill walking (T1, T2, T3, T4) and 3 periods of 3 minutes of rest 
between blocks (R). Hatched part of the scheme represents 20 minutes of brain 
stimulation (ANODAL tDCS). 
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Outcome measurements 
Walking performance 
Gait performance was recorded overground and on the treadmill using an 
optical detection system (Optogait, Microgait, USA). Overground gait was 
evaluated after a familiarization trial. Participants walked up and down an 8 
meters walkway, for a total time of 2 minutes, at a self-selected comfortable 
speed. The gait parameters were recorded during the straight walking portion 
and not when the subjects were turning. 
The following variables of gait were evaluated: speed (m/s), stride length 
(m), stride frequency (Hz), CV of the stride length (%) and of the stride 
frequency (%). CV is an indicator of variability, where CV = (standard 
deviation/ mean) x100. 
Neurophysiologic measurements  
EMG: A pair of adhesive surface electrodes 2-cm apart (bipolar) were 
placed over the muscle bellies of the SOL and TA muscles (on the 
symptomatic side). The reference electrode was placed over the medial 
malleolus bone surface. EMG signals were amplified and filtered with a 
bandwidth frequency ranging from 10 Hz to 1 kHz. The EMG signals were 
recorded at a sampling rate of 5 kHz per channel (Digitimer D360, Welwyn 
Garden City, UK). 
Spinal and corticospinalmeasurements were obtained at rest position 
before and after each treadmill walking condition. Subjects were comfortably 
seated in a reclining armchair; with the hips and the knees semi-flexed at 
120 degrees and 160 degrees, respectively, and the ankles at 110 degrees 
plantar flexion with the feet resting on a foot support. Subjects remained in 
this position during the recordings, ensuring that there was no voluntary 
activity or excessive tremor. 
Hmax/Mmax ratio: Transcutaneous electrical stimulation of the posterior 
tibial nerve was used to elicit the SOL H-reflex using a Digitimer stimulator 
(model DS7, Welwyn Garden City, UK). The optimum site of nerve stimulation 
was located using a hand-held electrode. The cathode (2 cm diameter brass 
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hemisphere) was placed in the popliteal fossa and the anode (5 cm2) above 
the patella. These adhesive electrodes were fixed with an elastic strap. The 
stimulus used was a rectangular pulse of 1 ms duration. The Hmax and the 
Mmax were recorded. 
Reciprocal Ia-inhibition: To record reciprocal Ia-inhibition from the TA to 
the SOL muscle, the size of the SOL control H-reflexes was adjusted to 
Hmax/2 and to the 20-25% of Mmax, and kept constant throughout the 
experiment (Crone et al., 1990). The conditioning stimulus of the common 
peroneal nerve was elicited through bipolar electrodes at the neck of the 
fibulae. Rectangular pulses of 1 ms at TA motor threshold intensity were used. 
Special care was taken to ensure a pure TA muscle contraction without any 
peroneal muscle contraction (Meunier et al., 1993). The conditioning–test 
interstimulus interval was determined using 0.5 ms steps until the maximum 
reflex response was reached and this value was then kept constant 
throughout the experiment. Ten unconditioned and 10 conditioned reflexes 
were recorded in randomized order. The amount of inhibition was defined as: 
[(mean control H amplitude – mean conditioned H amplitude)/mean control 
H amplitude)] ×100. 
H-reflex amplitude during walking: The SOL H-reflex was evoked by 
stimulation of the posterior tibial nerve. Test stimuli were 1 ms rectangular 
pulses delivered every 5 s. The H-reflexes during walking were elicited in 2 
cycle phases: in the middle of the stance phase and in the middle of the swing 
phase. To determine the electric stimulus in the stance and swing phases, 
the latency between the stride marker and the stimulus was adjusted to each 
stride cycle. The beginning of a stride cycle was defined as the time when a 
stride marker, placed on the heel of the shoe, makes contact with the ground. 
To acquire H-reflexes evoked by the same stimulus intensity at each phase 
of the step cycle, the corresponding M-waves were used as indicators of the 
effective stimulus strength. The peak-to-peak amplitude of M-wave between 
25% of Mmax was used to check the stability of stimulation conditions within 
the given phase of step cycle (Capaday & Stein, 1986). Mmax amplitude was 
measured during rest with the patients in a standing position. H-reflexes were 
elicited after 2 minutes of treadmill walking (T3). The amplitude of 10-H reflex 
was averaged in each step phase.  
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Corticospinal measurements: MEP, SICI and ICF of the TA muscle elicited 
by TMS were recorded. A double cone coil connected to a Magstim 200 
magnetic stimulator (Magstim, Dyfed, United Kingdom) was used. The coil 
was placed over inter hemispheric scissura and moved around until the 
hotspot of the TA muscle, contralateral to the affected side, was localized. 
RMT was determined to the nearest 1% of the maximum stimulator output 
and defined as the minimum stimulus intensity required to produce MEPs of 
>50 µV in at least 5 of 10 consecutive trials (Rossini et al., 1994). In the 
paired-pulse TMS recordings, a subthreshold conditioning stimulus was 
delivered at 80% of the RMT, following a suprathreshold test stimulus 
intensity set at 130% of the RMT. SICI and ICF were elicited at an 
interstimulus intervals of 3 ms and 15 ms, respectively (Vacherot et al., 
2010a). A total of 10 tests, 10 SICIs and 10 ICFs stimuli were randomly 
delivered and recorded in one single block (Kujirai et al., 1993). SICI and ICF 
amplitudes were expressed as a percentage of the mean amplitude of the 
unconditioned MEP.  
Statistical analysis 
To compare the gait pattern between overground pre-treadmill walking 
and the treadmill walking conditions, three-way ANOVAs with “treadmill 
condition” (AtDCS+treadmill, StDCS+treadmill and treadmill) and “time” (pre 
and during) as main factors were performed for the following variables: stride 
length, stride frequency, CV of stride length and CV of stride frequency.  
To explore the changes in overground gait and of the neurophysiological 
parameters before and after each treadmill walking condition, three-way 
ANOVAs, with “treadmill condition” (AtDCS+treadmill, StDCS+treadmill and 
treadmill) and "time" (pre and post) as main factors, were used for the 
following variables: speed, stride length, stride frequency, CV of stride length 
and CV of stride frequency, Hmax/Mmax ratio, reciprocal Ia-inhibition, MEP, 
ICF and SICI. 
To analyse the modulation of the H-reflex amplitudes of the gait phases 
during the treadmill walking conditions, a three-way ANOVA, with “treadmill 
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condition” (AtDCS+treadmill, StDCS+treadmill and treadmill) and “phase” 
(stance and swing) as main factors was conducted. 
Post Hoc t-tests were computed when required. Variables did not violate 
assumption of normality, except for SICI and ICF. Therefore, analyses of 
these variables were conducted on logarithmic transformation values. All 
statistical analyses were performed using PASW Statistics 18. A P value ≤ 0, 
05 was considered statistically significant. 
4.3.4 Results 
Pre-treadmill overground walking vs. Treadmill walking 
Results of gait parameters are shown in Table 10.  
Table 10 Results of gait parameters. 
    
 AtDCS+Treadmill StDCS+treadmill Treadmill 
 PRE DU POST PRE DU POST PRE DU POST 
Gait 
speed 
(m/s) 
1.18±
0.21  
1.24±
0.21 
1.17±
0.25  
1.21±
0.26 
1.16±
0.25  
1.23±
0.23 
Stride 
length 
(m) 
1.24±
0.16 
1.28±
0.18 
1.29±
0.16 
1.24±
0.19 
1.27±
0.21 
1.27±
0.19 
1.23±
0.18 
1.29±
0.21 
1.29±
0.17 
Stride 
frequency 
(Hz) 
0.95±
0.08 
0.90±
0.18 
0.96±
0.09 
0.94±
0.1 
0.90±
0.09 
0.94±
0.1 
0.94±
0.09 
0.88±
0.12 
0.94±
0.08 
CV of 
stride 
length 
(%) 
4.35±
2.21 
2.16±
1.41 
4.17±
2.33 
4.1±1.
76 
2.51±
1.42 
4.60±
2.93 
4.37±
1.91 
3.69±
5.95 
3.90±
1.69 
CV of 
stride 
frequency 
(%) 
2.78±
1.19 
1.96±
2.13 
2.65±
1.09 
2.71±
0.78 
1.74±
1.27 
3.07±
1.42 
2.99±
1.31 
2.85±
5.66 
2.83±
0.97 
PRE, pretests; DU, tests during treadmill walking; POST, postests; CV, coeffiecient 
of variation. 
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The analysis of the stride length showed a significant main effect for time 
(F=16.211, p=0.001), without a significant treadmill condition effect or a 
condition×time interaction. The stride length was longer during the treadmill 
conditions compared with pre-treadmill overground walking (Figure 11). For 
the stride frequency, the analysis showed a significant main effect for time 
(F=9.538, p=0.007). However, there was no significant effect for treadmill 
condition nor any significant interactions. Stride frequency decreased during 
all treadmill walking conditions compared with pre-treadmill overground 
walking (Figure 11). The ANOVA for CV of stride length showed a significant 
main effect for time (F=5.693, p=0.034), without a significant effect for 
treadmill condition, nor any significant interactions. The CV of stride length 
was smaller during all treadmill walking conditions in comparison with pre-
treadmill walking (Figure 11). No significant main effects or interactions were 
found for CV of stride frequency. 
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Figure 11 Results of walking performance before and during treadmill 
walking conditions.  
PRE, overground pre-treadmill; DURING, during treadmill walking; *, significant main 
effect (p<0.005). 
 
Overground gait pre-treadmill vs. post-treadmill 
The analysis of the gait speed showed a significant main effect for time 
(F=11.524, p=0.003), without significant effect for treadmill condition or a 
significant condition×time interaction. Overground gait speed was greater 
post-treadmill compared with pre-treadmill walking (Figure 12). For the stride 
length, the analysis showed a significant main effect for time (F=16.211, 
p=0.001), without a significant treadmill condition effect or a condition×time 
interaction. PD participants walked with a longer stride length post-treadmill 
compared with pre-treadmill walking (Figure 12). The analysis for the 
remaining gait parameters did not show significant main effects or 
interactions (Figure 12). 
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Figure 12 Results of walking performance before and after treadmill walking 
conditions.  
PRE, overground pre-treadmill; POST, overground post-treadmill; *, significant main 
effect (p<0.005). 
 
Neurophysiological measurements 
The analysis of the Hmax/Mmax ratio revealed a significant main effect 
for time (F=25.451, p<0.001), without a significant effect of treadmill 
condition nor a significant interaction. The Hmax/Mmax ratio was lower post-
treadmill compared with pre-treadmill walking (Figure 13A). 
For the reciprocal Ia-inhibition, the ANOVA showed a significant 
condition×time interaction (F=4.429, p=0.02). However, there were no 
significant main effects for treadmill condition and time. Post hoc analysis 
showed that the reciprocal Ia-inhibition significantly decreased after the 
StDCS+treadmill (p=0.019) and treadmill (p=0.048) conditions compared 
with pre-treadmill walking. No significant reciprocal Ia-inhibition changes 
were found pre vs post the AtDCS+treadmill condition (Figure 13B). 
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The analysis of the absolute MEP amplitudes for single TMS pulses did not 
show significant main effects nor a significant interaction. The analysis of the 
ICF showed a significant main effect for time (F=7.506, p=0.016), without a 
significant effect for the treadmill condition or a condition×time interaction. 
ICF values decreased post-treadmill compared with pre-treadmill walking 
(Figure 13C). The analysis of the SICI revealed a significant main effect for 
time (F=6.446, p=0.024), without a significant treadmill condition effect nor 
any significant interactions. The SICI increased post-treadmill compared with 
pre-treadmill walking (Figure 13D). 
The analysis of the H-reflex amplitude during treadmill walking showed a 
significant main effect for phase (F=83.824; p<0.001), without a significant 
effect for treadmill condition or a significant interaction. Greater H-reflex 
amplitudes were observed during the stance phase compared with the swing 
phase across treadmill walking conditions (Figure 13E). 
94 | S T U D Y  3 :  T D C S  c o m b i n e d  w i t h  T r e a d m i l l  
 
 
 
Figure 13 Results of neurophysiological measurements.  
A-D: Spinal and cortical measurements at rest. E: H-reflex during treadmill walking. 
PRE, overground pre-treadmill; POST, overground post-treadmill; SICI, 
intracorticalinhibition; ICF, intracortical facilitation; Stance, stance phase; Swing, 
swing phase; *, significant main effect (p<0.005); #, significanton post hoc test 
(p<0.005). 
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4.3.5 Discussion 
The current study demonstrated that a single session of treadmill walking 
combined with anodal tDCS did not enhance the effects of treadmill walking 
on gait parameters in PD. Concurrently, the application of anodal tDCS to the 
leg motor cortex during treadmill walking modulated the reciprocal Ia-
inhibition reflex in the patients. As far as we are aware, this is the first 
randomised, sham controlled study that evaluated gait and neurophysiologic 
effects of treadmill walking combined with anodal tDCS in PD.  
The current investigation showed that PD participants increased their 
overground gait speed and stride length after 20 minutes of three different 
treadmill walking conditions: treadmill, AtDCS+treadmill and 
StDCS+treadmill. These results reinforce previous findings showing 
immediate improvements in gait speed, stride length and double stance 
support time during overground walking, following a single session of 
treadmill walking, in PD patients (Miyai et al., 2000; Bello et al., 2008; Kurtais 
et al., 2008). Moreover, the PD participants in our study walked with longer 
stride length, reduced stride frequency and reduced gait variability (CV of 
stride length) during the three treadmill walking conditions, compared with 
overground walking at the same speed. Only two studies have investigated 
differences between treadmill and overground walking, showing that people 
with PD walked with a more stable pattern over the treadmill (Frenkel-Toledo 
et al., 2005; Bello et al., 2008). Therefore, our data support the evidence 
that during and after treadmill walking, people with PD improve their gait 
performance. 
Our results showed that the combination of treadmill walking with anodal 
tDCS stimulation did not lead to enhanced improvements in PD gait 
(compared with those observed with treadmill walking alone or with sham 
tDCS stimulation). This finding does not support our initial hypothesis that 
the combination of both techniques could be a more efficient strategy 
compared with the single use of a treadmill device. Given the novelty of this 
approach and thus, the lack of similar studies, we can only speculate as to 
the explanation for this finding. Several studies have reported that motor 
training programs with anodal tDCS lead to significantly greater 
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improvements in motor function compared with motor training alone, in 
healthy, stroke and PD subjects (Filmer et al., 2014; Kaski et al., 2014; 
Márquez et al., 2015). Therefore, it is possible that more sessions would be 
needed in order to obtain an additive effect of the tDCS stimulation on 
treadmill walking. In addition, several factors related with the tDCS technique 
could have influenced the current results, such as the electrode 
configuration/location and the inter-individual variability demonstrated in 
response to tDCS (Van Asseldonk, 2015). 
In addition to the improvements in gait parameters, changes in 
neurophysiological parameters were, with the exception of the reciprocal Ia-
inhibition, comparable across treadmill conditions. 
All treadmill conditions lead to SICI increases and ICF decreases in the TA 
muscle in comparison with values recorded before the treadmill interventions. 
The increase in SICI suggests that the mechanisms involved in intracortical 
inhibition are also involved in the gait improvements associated with treadmill 
walking. Improvements in PD gait together with an increase in intracortical 
inhibition of the first digital interosseous muscle have been reported following 
a high intensity treadmill training program (Fisher, 2008). The authors 
interpreted these changes as a normalization of cortical excitability since SICI 
is abnormally reduced in PD (Valls-Solé & Valldeoriola, 2002). Although, they 
related this increment to the intensity of the exercise, it may also have been 
due to the treadmill walking itself. The decrease in ICF after treadmill walking 
that we observed is difficult to interpret since a previous study found that ICF 
reductions in the TA muscle correlated with stride length and velocity 
impairments in PD (Vacherot et al., 2010a). However, half of the PD subjects 
included in that study manifested freezing of gait episodes, which reflect a 
more severe gait impairment than that observed in the participants of the 
current study. It is possible that the severity of the disease may affect 
intracortical facilitation mechanisms and could thus account for the 
contrasting findings. Further studies are needed to explore the relationship 
between ICF and gait parameters in PD. 
We found that the H-reflex modulations were similar across the three 
treadmill conditions. During all treadmill walking conditions H-reflex 
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amplitudes were larger in the stance phase compared to the swing phase. In 
addition, values of the SOL muscle Hmax/Mmax ratio at rest were lower post-
treadmill compared with pre-treadmill walking. The modulation that we 
observed in PD patients during walking is similar to that reported in healthy 
subjects (Capaday & Stein, 1986). This is in line with previous findings 
showing that the recruitment curve and the Hmax/Mmax ratio at rest in PD 
patients are not significantly different from normal subjects (Dietrichson, 
1971; Krassoievitch and Tissot, 1971). However, our study is the first study 
that has recorded the H-reflex during treadmill walking. Our findings suggest 
that the contribution of this reflex pathway to treadmill walking is not 
impaired in PD.  
The reciprocal Ia-inhibition from the TA muscle to the SOL muscle 
decreased after treadmill walking alone and after treadmill walking combined 
with sham tDCS, compared with pre-treadmill walking. This reduction may 
indicate abnormalities of the spinal interneuron activity in PD that are related 
to a dysfunction in the descending reticulospinal tract, directly influencing Ia 
and Ib spinal interneurons (Delwaide et al., 2000). For instance, Meunier and 
colleagues (2000) found a reduction of the reciprocal Ia-inhibition from the 
TA to the SOL muscle at the onset of a voluntary ankle dorsiflexion, which 
correlated with axial signs in PD patients (Meunier et al., 2000a). 
Interestingly, in our study treadmill walking in combination with anodal tDCS 
did not induce a reduction in this reflex. This specific effect may result from 
an interaction between anodal tDCS and treadmill walking since anodal tDCS 
by itself, applied to the leg motor cortex, decreases reciprocal Ia-inhibition 
from the TA to the SOL muscle (Roche et al., 2011). However, since the 
combination of treadmill and anodal tDCS did not lead to enhanced 
improvements in walking compared with the other conditions, the functional 
meaning of this reflex modulation remains unknown. Rather than being 
controversial, we view such puzzling finding as a motivation to keep exploring 
the combination of treadmill and anodal tDCS in futures studies. 
 
  
 
 
  
CHAPTER 5.  
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There are several limitations in this thesis that must be addressed. 
 The severity of PD symptoms in participants was moderate. Gait 
improvements as a result of treadmill training have been shown to be 
more marked in the advanced stages when compared with subjects 
with moderate PD (Bello et al., 2008). Moreover, it has been reported 
that anodal tDCS combined with physical training gives enhanced gait 
improvements in advanced PD patients (Kaski et al., 2014). There may 
be a ceiling effect of gait improvements and of neural effects in 
moderate PD patients. Thus, it would be important to replicate the 
studies included in this thesis in more advanced PD patients. 
 PD patients were tested only in the “on” state. “On” medication may 
have impacted cognitive and gait performance, since it is known that 
dual-task walking deficits are improved by anti-Parkinson medications 
(Lord et al., 2011). In addition, the effects of combined AtDCS 
stimulation and treadmill walking may not be applicable to patients in 
the “off” state. However, from a rehabilitation point of view, it is more 
informative to explore this in the “on” state, rather than in the “off” 
state.  
 In studies 2 and 3 control subjects were not included, since one of the 
main goals of this study was to compare neurophysiological 
parameters in PD patients across different walking conditions, rather 
than with healthy subjects. However, future studies including control 
subjects are warranted in order to determine whether the spinal and 
cortical modulations that are associated with treadmill, overground 
walking and treadmill combined with tDCS, are specific to PD. 
 Several neurophysiological parameters (i.e. SICI and ICF) were 
obtained at rest rather than during walking. However, it was thought 
that these parameters would be functionally more informative if 
recorded during movement rather than at rest, as it would have been 
a methodological challenge to do so while the patients were walking on 
the treadmill.  
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 Attentional resources do not influence the gait improvements observed 
in individuals with PD during treadmill walking.  
 The improvements of gait in PD patients during treadmill walking are 
independent of attentional demands to the task of walking. 
 The belt displacement and constant speed are the main underlying 
mechanisms of treadmill walking improvements in PD subjects. 
 A single session of treadmill walking, but not of overground walking, 
led to gait improvements in PD patients, suggesting a specific 
therapeutic effect of treadmill walking in PD subjects. 
 The measurements of spinal and cortical modulations included in this 
thesis, such as monosynaptic stretch reflex and reciprocal inhibition 
reflex, as well as SICI and ICF, are not associated with the specific 
therapeutic effect of treadmill walking in PD patients. 
 The modulation of the H-reflex in PD patients during treadmill walking 
is similar to that reported in healthy subjects, thus the contribution of 
this reflex pathway to treadmill walking is not impaired in PD. 
 A single session of treadmill walking combined with anodal tDCS 
stimulation of the primary motor cortex does not enhance the 
improvements of gait parameters associated with treadmill walking in 
PD subjects. 
 The combination of both techniques resulted in a specific modulation 
of the reciprocal Ia-inhibition from the TA to the SOL muscle. Further 
studies are needed to explore the functional significance of this 
interaction. 
 
  
  
 
CHAPTER 7.  
REFERENCES 
  
 
 
C h a p t e r  7  R e f e r e n c e s  | 109 
 
 
 
Alam, M., Schwabe, K., & Krauss, J. K. (2010). The pedunculopontine nucleus 
area: critical evaluation of interspecies differences relevant for its use as 
a target for deep brain stimulation. Brain, 134(1). 
Albin, R. L., Young, A. B., & Penney, J. B. (1989). The functional anatomy of 
basal ganglia disorders. Trends in Neurosciences, 12(10), 366–375. 
article. 
Almeida, Q. J., & Bhatt, H. (2012). A manipulation of visual feedback during 
gait training in Parkinson’s disease. Parkinson’s Disease. 
Amboni, M., Barone, P., Picillo, M., Cozzolino, A., Longo, K., Erro, R., & 
Iavarone, A. (2010). A two-year follow-up study of executive 
dysfunctions in parkinsonian patients with freezing of gait at on-state. 
Movement Disorders : Official Journal of the Movement Disorder Society, 
25(6), 800–2. http://doi.org/10.1002/mds.23033 
Andersen, J. B., Larsen, B., & Sinkjaer, T. (1994). Modulation of the human 
SOL stretch reflex during gait. In Proceedings of the 16th Annual 
International Conference of the IEEE Engineering in Medicine and Biology 
Society. Part 1 (of 2) (Vol. 16, pp. 432–433). inproceedings, Piscataway, 
NJ, United States: IEEE. 
Angel, R. W. (1963). The H Reflex in Normal, Spastic, and Rigid Subjects. 
Archives of Neurology, 8(6), 591. 
http://doi.org/10.1001/archneur.1963.00460060021002 
Baker, K., Rochester, L., & Nieuwboer, A. (2008). The effect of cues on gait 
variability-Reducing the attentional cost of walking in people with 
Parkinson’s disease. Parkinsonism and Related Disorders, 14(4), 314–
320. article. 
Barone, P., Antonini, A., Colosimo, C., Marconi, R., Morgante, L., Avarello, T. 
P., … Dotto, P. Del. (2009). The PRIAMO study: A multicenter assessment 
of nonmotor symptoms and their impact on quality of life in Parkinson’s 
disease. Movement Disorders : Official Journal of the Movement Disorder 
Society, 24(11), 1641–9. http://doi.org/10.1002/mds.22643 
Bateni, H., & Maki, B. E. (2005). Assistive devices for balance and mobility: 
Benefits, demands, and adverse consequences. Archives of Physical 
Medicine and Rehabilitation, 86(1), 134–145. article. 
Bello, O. (2013). The effects of treadmill or overground walking training 
program on gait in Parkinson’s disease. Gait Posture. article. 
Bello, O., & Fernandez-Del-Olmo, M. (2012). How does the treadmill affect 
gait in parkinson’s disease? Current Aging Science, 5(1), 28–34. article. 
Bello, O., Marquez, G., Camblor, M., & Fernandez-Del-Olmo, M. (2010). 
Mechanisms involved in treadmill walking improvements in Parkinson’s 
disease1. Bello O, Marquez G, Camblor M, Fernandez-Del-Olmo M. 
Mechanisms involved in treadmill walking improvements in Parkinson’s 
disease. Gait Posture. 2010;32(1):118-123. Gait and Posture, 32(1), 
110 | R e f e c e n c e s  
 
 
118–123. article. 
Bello, O., Sanchez, J. A., & Fernandez-del-Olmo, M. (2008). Treadmill walking 
in Parkinson’s disease patients: Adaptation and generalization effect. 
Movement Disorders, 23(9), 1243–1249. article. 
Benninger, D. H., & Hallett, M. (2015). Non-invasive brain stimulation for 
Parkinson’s disease: Current concepts and outlook 2015. 
NeuroRehabilitation, 37(1), 11–24. http://doi.org/10.3233/NRE-151237 
Benninger, D. H., Lomarev, M., Lopez, G., Wassermann, E. M., Li, X., 
Considine, E., & Hallett, M. (2010). Transcranial direct current 
stimulation for the treatment of Parkinson’s disease. Journal of 
Neurology, Neurosurgery, and Psychiatry, 81(10), 1105–11. 
http://doi.org/10.1136/jnnp.2009.202556 
Berardelli, A., Rona, S., Inghilleri, M., & Manfredi, M. (1996). Cortical 
inhibition in Parkinson’s disease. Brain, 119(1). 
Berardelli, A., Rothwell, J. C., Thompson, P. D., & Hallett, M. (2001). 
Pathophysiology of bradykinesia in Parkinson’s disease. Brain : A Journal 
of Neurology, 124(Pt 11), 2131–46. 
http://doi.org/10.1093/brain/124.11.2131 
Berardelli, A., Wenning, G. K., Antonini, A., Berg, D., Bloem, B. R., Bonifati, 
V., … Vidailhet, M. (2013). EFNS/MDS-ES/ENS [corrected] 
recommendations for the diagnosis of Parkinson’s disease. European 
Journal of Neurology, 20(1), 16–34. http://doi.org/10.1111/ene.12022 
Bloem, B. R. (2000). “Stops walking when talking” does not predict falls in 
Parkinson’s disease [1]. Annals of Neurology, 48(2), 268. article. 
Bloem, B. R., Grimbergen, Y. a M., van Dijk, J. G., & Munneke, M. (2006). 
The “posture second” strategy: a review of wrong priorities in Parkinson’s 
disease. Journal of the Neurological Sciences, 248(1–2), 196–204. 
http://doi.org/10.1016/j.jns.2006.05.010 
Bloem, B. R., Hausdorff, J. M., Visser, J. E., & Giladi, N. (2004). Falls and 
freezing of gait in Parkinson’s disease: a review of two interconnected, 
episodic phenomena. Movement Disorders : Official Journal of the 
Movement Disorder Society, 19(8), 871–84. 
http://doi.org/10.1002/mds.20115 
Bloem, B. R., Marinus, J., Almeida, Q., Dibble, L., Nieuwboer, A., Post, B., … 
Schrag, A. (2016). Measurement instruments to assess posture, gait, 
and balance in Parkinson’s disease: Critique and recommendations. 
Movement Disorders : Official Journal of the Movement Disorder Society. 
http://doi.org/10.1002/mds.26572 
Boehm, R. L., Almeida, Q. J., & Knobl, P. (2011). Sensory attention focused 
exercise in Parkinson’s disease: A randomized double-crossover trial. 
MOVEMENT DISORDERS, 26, S331–S332. 
C h a p t e r  7  R e f e r e n c e s  | 111 
 
 
 
Bond, J. M. (2000). Goal-directed secondary motor tasks: Their effects on 
gait in subjects with Parkinson disease. Archives of Physical Medicine and 
Rehabilitation, 81(1), 110–116. article. 
Braak, H., Rüb, U., Gai, W. P., & Del Tredici, K. (2003). Idiopathic Parkinson’s 
disease: possible routes by which vulnerable neuronal types may be 
subject to neuroinvasion by an unknown pathogen. Journal of Neural 
Transmission (Vienna, Austria : 1996), 110(5), 517–36. 
http://doi.org/10.1007/s00702-002-0808-2 
Brauer, S. G., & Morris, M. E. (2010). Can people with Parkinson’s disease 
improve dual tasking when walking? Gait and Posture, 31(2), 229–233. 
article. 
Bronstein, J. M., Tagliati, M., Alterman, R. L., Lozano, A. M., Volkmann, J., 
Stefani, A., … L, A. (2011). Deep Brain Stimulation for Parkinson Disease. 
Archives of Neurology, 68(2), 1436–1438. 
http://doi.org/10.1001/archneurol.2010.260 
Brotchie, P., Iansek, R., & Horne, M. K. (1991). Motor function of the monkey 
globus pallidus. Brain, 114(4). 
Canning, C. G. (2005). The effect of directing attention during walking under 
dual-task conditions in Parkinson’s disease. Parkinsonism and Related 
Disorders, 11(2), 95–99. article. 
Cantello, R., Gianelli, M., Bettucci, D., Civardi, C., De Angelis, M. S., & Mutani, 
R. (1991). Parkinson’s disease rigidity: Magnetic motor evoked potentials 
in a small hand muscle. Neurology, 41(9), 1449–1449. 
http://doi.org/10.1212/WNL.41.9.1449 
Cantello, R., Tarletti, R., & Civardi, C. (2002). Transcranial magnetic 
stimulation and Parkinson’s disease. Brain Research Reviews, 38(3), 
309–327. http://doi.org/10.1016/S0165-0173(01)00158-8 
Capaday, C. (2002). The special nature of human walking and its neural 
control. Trends in Neurosciences, 25(7), 370–376. 
http://doi.org/10.1016/S0166-2236(02)02173-2 
Capaday, C., & Stein, R. B. (1986). Amplitude modulation of the SOL H-reflex 
in the human during walking and standing. The Journal of Neuroscience : 
The Official Journal of the Society for Neuroscience, 6(5), 1308–13. 
Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/3711981 
Chaudhuri, K. R., Healy, D. G., & Schapira,  a H. (2006). Non-motor 
symptoms of Parkinson’s disease: diagnosis and management. Lancet 
Neurol, 5(3), 235–245. http://doi.org/10.1016/s1474-4422(06)70373-8 
Chawla, H., Walia, S., Behari, M., & Noohu, M. M. (2015). Effect of type of 
secondary task on cued gait on people with idiopathic Parkinson ’ s 
disease, 5(1), 18–23. http://doi.org/10.4103/0976-3147.127865 
Chin-Chan, M., Navarro-Yepes, J., & Quintanilla-Vega, B. (2015). 
112 | R e f e c e n c e s  
 
 
Environmental pollutants as risk factors for neurodegenerative disorders: 
Alzheimer and Parkinson diseases. Frontiers in Cellular Neuroscience, 9, 
124. http://doi.org/10.3389/fncel.2015.00124 
Connine, C. M. (1996). Phoneme monitoring. Language and Cognitive 
Processes, 11(6), 635–645. article. 
Crommert, H. W. A. A. Van De, Mulder, T., & Duysens, J. (1998). Neural 
control of locomotion: Sensory control of the central pattern generator 
and its relation to treadmill training. Gait and Posture, 7(3), 251–263. 
article. 
Crone. (1990). Sensitivity of monosynaptic test reflexes to facilitation and 
inhibition as a function of the test r. Experimental Brain Research, 81(1), 
35. article. 
Cunnington, R., Iansek, R., Bradshaw, J. L., & Phillips, J. G. (1995). 
Movement-related potentials in Parkinson’s disease - Presence and 
predictability of temporal and spatial cues. Brain, 118(4), 935–950. 
article. 
De Munter, J. P. J. M., Melamed, E., & Wolters, E. C. (2014). Stem cell grafting 
in parkinsonism – Why, how and when. Parkinsonism & Related 
Disorders, 20, S150–S153. http://doi.org/10.1016/S1353-
8020(13)70036-1 
DeLong, M. R. (1990). Primate models of movement disorders of basal 
ganglia origin. Trends in Neurosciences, 13(7), 281–285. 
http://doi.org/10.1016/0166-2236(90)90110-V 
Delwaide, P. J., Pepin, J.-L., De Pasqua, V., & de Noordhout,  a. M. (2000). 
Projections from basal ganglia to tegmentum: a subcortical route for 
explaining the pathophysiology of Parkinson’s disease signs? Journal of 
Neurology, 247(S2), II75-II81. http://doi.org/10.1007/PL00007765 
Delwaide PJ, Pepin JL, M. de N. A. (1993). Contribution of reticular nuclei to 
the pathophysiology of parkinsonian rigidity. Adv Neuro, 60(381–5). 
Dietrichson, P. (1971). PHASIC ANKLE REFLEX IN SPASTICITY AND 
PARKINSONIAN RIGIDITY. Acta Neurologica Scandinavica, 47(1), 22–51. 
http://doi.org/10.1111/j.1600-0404.1971.tb07462.x 
Dietz, V. (2003). Spinal cord pattern generators for locomotion. Clinical 
Neurophysiology, 114(8), 1379–1389. article. 
http://doi.org/10.1016/S1388-2457(03)00120-2 
Dirnberger, G., & Jahanshahi, M. (2013). Executive dysfunction in Parkinson’s 
disease: A review. Journal of Neuropsychology, 7(2), 193–224. 
http://doi.org/10.1111/jnp.12028 
Dixon, L., Duncan, D. C., Johnson, P., Kirkby, L., O’Connell, H., Taylor, H. J., 
& Deane, K. (2007). Occupational therapy for patients with Parkinson’s 
disease. In K. Deane (Ed.), Cochrane Database of Systematic Reviews. 
C h a p t e r  7  R e f e r e n c e s  | 113 
 
 
 
Chichester, UK: John Wiley & Sons, Ltd. 
http://doi.org/10.1002/14651858.CD002813.pub2 
Ebersbach, G., Moreau, C., Gandor, F., Defebvre, L., & Devos, D. (2013). 
Clinical syndromes: Parkinsonian gait. Movement Disorders, 28(11), 
1552–1559. http://doi.org/10.1002/mds.25675 
Edgerton, V. R., Roy, R. R., Hodgson, J. A., Prober, R. J., de Guzman, C. P., 
& de Leon, R. (1992). Potential of adult mammalian lumbosacral spinal 
cord to execute and acquire improved locomotion in the absence of 
supraspinal input. Journal of Neurotrauma, 9 Suppl 1, S119-28. 
Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1588602 
Edwin H.F. van Asseldonk, T. A. B. (2015). Transcranial Direct Current 
Stimulation of the Leg Motor Cortex. Brain Stimulation, 
http://dx.doi.org/doi:10.1016/j.brs.2015.10.001. 
http://doi.org/10.1016/j.brs.2015.10.001 
Elahi, B., Elahi, B., & Chen, R. (2009). Effect of transcranial magnetic 
stimulation on Parkinson motor function-Systematic review of controlled 
clinical trials. Movement Disorders, 24(3), 357–363. 
http://doi.org/10.1002/mds.22364 
Fahn S, Elton R. In: Fahn S, Marsden CD, Caine DB, Goldstein M, editors. 
Members of the UPDRS development committee. Recent developments 
in Parkinson’s disease, vol. 2. Florham Park, NJ: MacMillan Health Care 
Information; 1987. (n.d.). 
Ferraye, M. U., Debû, B., Fraix, V., Goetz, L., Ardouin, C., Yelnik, J., … Price, 
D. (2010). Effects of pedunculopontine nucleus area stimulation on gait 
disorders in Parkinson’s disease. Brain : A Journal of Neurology, 133(Pt 
1), 205–14. http://doi.org/10.1093/brain/awp229 
Filmer, H. L., Dux, P. E., & Mattingley, J. B. (2014). Applications of 
transcranial direct current stimulation for understanding brain function. 
Trends in Neurosciences, 37(12), 742–753. 
http://doi.org/10.1016/j.tins.2014.08.003 
Findley, L. J. (2007). The economic impact of Parkinson’s disease. 
Parkinsonism and Related Disorders, 13(SUPPL. SEPT.), 8–12. 
http://doi.org/10.1016/j.parkreldis.2007.06.003 
Fisher, B. E., Wu, A. D., Salem, G. J., Song, J., Lin, C.-H. J. (Janice)-H. (J )., 
Yip, J., … Petzinger, G. (2008b). The Effect of Exercise Training in 
Improving Motor Performance and Corticomotor Excitability in People 
With Early Parkinson’s Disease. Archives of Physical Medicine and 
Rehabilitation, 89(7), 1221–1229. article. 
http://doi.org/10.1016/j.apmr.2008.01.013 
Fox, S. H., Katzenschlager, R., Lim, S.-Y., Ravina, B., Seppi, K., Coelho, M., 
… Sampaio, C. (2011). The Movement Disorder Society Evidence-Based 
Medicine Review Update: Treatments for the motor symptoms of 
Parkinson’s disease. Movement Disorders : Official Journal of the 
114 | R e f e c e n c e s  
 
 
Movement Disorder Society, 26 Suppl 3, S2-41. 
http://doi.org/10.1002/mds.23829 
Fregni, F., Boggio, P. S., Santos, M. C., Lima, M., Vieira, A. L., Rigonatti, S. 
P., … Pascual-Leone, A. (2006). Noninvasive cortical stimulation with 
transcranial direct current stimulation in Parkinson’s disease. Movement 
Disorders : Official Journal of the Movement Disorder Society, 21(10), 
1693–702. http://doi.org/10.1002/mds.21012 
Fregni, F., Simon, D. K., Wu, A., & Pascual-Leone, A. (2005b). Non-invasive 
brain stimulation for Parkinson’s disease: a systematic review and meta-
analysis of the literature. Journal of Neurology, Neurosurgery & 
Psychiatry, 76(12), 1614–1623. 
http://doi.org/10.1136/jnnp.2005.069849 
Frenkel-Toledo, S., Giladi, N., Peretz, C., Herman, T., Gruendlinger, L., & 
Hausdorff, J. M. (2005). Treadmill walking as an external pacemaker to 
improve gait rhythm and stability in Parkinson’s disease. Movement 
Disorders, 20(9), 1109–1114. article. 
Freyler, K., Weltin, E., Gollhofer, A., & Ritzmann, R. (2014). Improved 
postural control in response to a 4-week balance training with partially 
unloaded bodyweight. Gait & Posture, 40(2), 291–296. 
http://doi.org/10.1016/j.gaitpost.2014.04.186 
Fujioka, S., & K.Wszolek, Z. (2014). Genetic Parkinsonism. In C. Wolters, 
Erik; Baumann (Ed.), Parkinson Disease and Other Movement Disorders 
(pp. 321–362). Amsterdam: VU University Press. 
Gage, H., & Storey, L. (2004). Rehabilitation for Parkinson’s disease: a 
systematic review of available evidence. Clinical Rehabilitation, 18(5), 
463–82. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/15293481 
Galletly, R., & Brauer, S. G. (2005). Does the type of concurrent task affect 
preferred and cued gait in people with Parkinson’s disease? Australian 
Journal of Physiotherapy, 51(3), 175–180. article. 
Gerfen, C. R., & Surmeier, D. J. (2011). Modulation of striatal projection 
systems by dopamine. Annual Review of Neuroscience, 34, 441–66. 
http://doi.org/10.1146/annurev-neuro-061010-113641 
Gisbert, R. (2015). Physical Therapist Interventions for Parkinson Disease, 
(March), 299–306. 
Grabli, D., Karachi, C., Welter, M., Lau, B., Hirsch, E. C., Vidailhet, M., … 
Pierre, U. (2013). NIH Public Access, 83(10). 
http://doi.org/10.1136/jnnp-2012-302263.Normal 
Grabli, D., Karachi, C., Welter, M.-L., Lau, B., Hirsch, E. C., Vidailhet, M., & 
François, C. (2012). Normal and pathological gait: What we learn from 
Parkinson’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 
83(10), 979–985. article. 
C h a p t e r  7  R e f e r e n c e s  | 115 
 
 
 
Hallett, M. (2014). Tremor: Pathophysiology. Parkinsonism & Related 
Disorders, 20, S118–S122. http://doi.org/10.1016/S1353-
8020(13)70029-4 
Halliday, G., Lees, A., & Stern, M. (2011). Milestones in Parkinson’s disease-
-clinical and pathologic features. Movement Disorders : Official Journal of 
the Movement Disorder Society, 26(6), 1015–21. 
http://doi.org/10.1002/mds.23669 
Hanakawa, T., Fukuyama, H., Katsumi, Y., Honda, M., & Shibasaki, H. (1999). 
Enhanced lateral premotor activity during paradoxical gait in Parkinson’s 
disease. Annals of Neurology, 45(3), 329–336. 
http://doi.org/10.1002/1531-8249(199903)45:3<329::AID-
ANA8>3.0.CO;2-S 
Hanakawa, T., Katsumi, Y., Fukuyama, H., Honda, M., Hayashi, T., Kimura, 
J., & Shibasaki, H. (1999b). Mechanisms underlying gait disturbance in 
Parkinson’s disease: a single photon emission computed tomography 
study. Brain : A Journal of Neurology, (7), 1271–82. 
http://doi.org/10.1093/brain/122.7.1271 
Hariz, M., Blomstedt, P., & Zrinzo, L. (2013). Future of brain stimulation: new 
targets, new indications, new technology. Movement Disorders : Official 
Journal of the Movement Disorder Society, 28(13), 1784–92. 
http://doi.org/10.1002/mds.25665 
Hausdorff, J. M. (2003). Effects of Cognitive Challenge on Gait Variability in 
Patients with Parkinson’s Disease. Journal of Geriatric Psychiatry and 
Neurology, 16(1), 53–58. article. 
Hausdorff, J. M., Lowenthal, J., Herman, T., Gruendlinger, L., Peretz, C., & 
Giladi, N. (2007). Rhythmic auditory stimulation modulates gait 
variability in Parkinson’s disease. European Journal of Neuroscience, 
26(8), 2369–2375. http://doi.org/10.1111/j.1460-9568.2007.05810.x 
Herman, T., Giladi, N., Gruendlinger, L., & Hausdorff, J. M. (2007). Six Weeks 
of Intensive Treadmill Training Improves Gait and Quality of Life in 
Patients With Parkinson’s Disease: A Pilot Study. Archives of Physical 
Medicine and Rehabilitation, 88(9), 1154–1158. article. 
http://doi.org/10.1016/j.apmr.2007.05.015 
Herman, T., Giladi, N., & Hausdorff, J. M. (2013). Neuroimaging as a window 
into gait disturbances and freezing of gait in patients with Parkinson’s 
disease. Current Neurology and Neuroscience Reports, 13(12). 
http://doi.org/10.1007/s11910-013-0411-y 
Hermens, H. J., Freriks, B., Disselhorst-Klug, C., & Rau, G. (2000). 
Development of recommendations for SEMG sensors and sensor 
placement procedures. Journal of Electromyography and Kinesiology, 
10(5), 361–374. http://doi.org/10.1016/S1050-6411(00)00027-4 
Hiraoka, K., Matsuo, Y., & Abe, K. (2005). SOL H-reflex inhibition during gait 
initiation in Parkinson’s disease. Movement Disorders : Official Journal of 
116 | R e f e c e n c e s  
 
 
the Movement Disorder Society, 20(7), 858–64. 
http://doi.org/10.1002/mds.20448 
Hiraoka, K., Matuo, Y., Iwata, A., Onishi, T., & Abe, K. (2006). The effects of 
external cues on ankle control during gait initiation in Parkinson’s 
disease. Parkinsonism & Related Disorders, 12(2), 97–102. article. 
http://doi.org/10.1016/j.parkreldis.2005.07.006 
Hoehn MM, H. M. (1967). Parkinsonism: onset, progression and mortality. 
Neurology, 17, 427–42. 
Huang, X., Mahoney, J. M., Lewis, M. M., Guangwei Du, Piazza, S. J., & 
Cusumano, J. P. (2012). Both coordination and symmetry of arm swing 
are reduced in Parkinson’s disease. Gait & Posture, 35(3), 373–7. 
http://doi.org/10.1016/j.gaitpost.2011.10.180 
Hughes AJ, Daniel SE, Kilford L, L. A. (1992). Accuracy of clinical diagnosis of 
idiopathic Parkinson’s disease: a clinico- pathological study of 100 cases. 
J Neurol Neurosurg Psychiatry, 55, 121–184. 
Hummel, F., Celnik, P., Giraux, P., Floel, A., Wu, W.-H., Gerloff, C., & Cohen, 
L. G. (2005). Effects of non-invasive cortical stimulation on skilled motor 
function in chronic stroke. Brain : A Journal of Neurology, 128(Pt 3), 490–
9. http://doi.org/10.1093/brain/awh369 
Huys, A.-C. M. L., Bally, J. F., & Pollak, P. (2014). Deep Brain Stimulation in 
Pakinson´s Disease. In E. C. Wolters & C. Baumann (Eds.), Parkinson 
Disease and Other Movement Disorders (pp. 271–285). Amsterdam: VU 
University Press. 
Iansek, R., Bradshaw, J. L., Phillips, J. G., Cunnington, R., & Morris, M. E. 
(1995). Chapter 3 Interaction of the basal ganglia and supplementary 
motor area in the elaboration of movement. Advances in Psychology, 
111, 37–59. http://doi.org/10.1016/S0166-4115(06)80006-3 
Ivanoff, J. (2005). Capacity limits of information processing in the brain, 9(6). 
http://doi.org/10.1016/j.tics.2005.04.010 
Jankovic, J. (2008). Parkinson’s disease: clinical features and diagnosis. 
Journal of Neurology, Neurosurgery, and Psychiatry, 79(4), 368–76. 
http://doi.org/10.1136/jnnp.2007.131045 
Jellinger, K. a. (2012). Neuropathology of sporadic Parkinson’s disease: 
Evaluation and changes of concepts. Movement Disorders, 27(1), 8–30. 
article. http://doi.org/10.1002/mds.23795 
Johnson, K. E. (2015). Approach to the patient with Parkinson disease. 
Primary Care, 42(2), 205–15. http://doi.org/10.1016/j.pop.2015.01.005 
Kakkar, A. K., & Dahiya, N. (2015). Management of Parkinson׳s disease: 
Current and future pharmacotherapy. European Journal of 
Pharmacology, 750, 74–81. 
http://doi.org/10.1016/j.ejphar.2015.01.030 
C h a p t e r  7  R e f e r e n c e s  | 117 
 
 
 
Kalinderi, K., Bostantjopoulou, S., & Fidani, L. (2016). The genetic 
background of Parkinson’s disease: current progress and future 
prospects. Acta Neurologica Scandinavica. 
http://doi.org/10.1111/ane.12563 
Karachi, C., Grabli, D., Bernard, F. A., Tandé, D., Wattiez, N., Belaid, H., … 
François, C. (2010). Cholinergic mesencephalic neurons are involved in 
gait and postural disorders in Parkinson disease. Journal of Clinical 
Investigation, 120(8), 2745–2754. http://doi.org/10.1172/JCI42642 
Kaski, D., Dominguez, R., Allum, J., Islam, A., & Bronstein, A. (2014). 
Combining physical training with transcranial direct current stimulation 
to improve gait in Parkinson’s disease: a pilot randomized controlled 
study. Clinical Rehabilitation. 
http://doi.org/10.1177/0269215514534277 
Katzenschlager, R., & Lees, A. J. (2002). Treatment of Parkinson’s disease: 
levodopa as the first choice. Journal of Neurology, 249 Suppl, II19-24. 
http://doi.org/10.1007/s00415-002-1204-4 
Kelly, V. E., Eusterbrock, A. J., & Shumway-Cook, A. (2012). A review of 
dual-task walking deficits in people with Parkinson’s disease: Motor and 
cognitive contributions, mechanisms, and clinical implications. 
Parkinson’s Disease. article. 
Keus, S. H. J., Munneke, M., Nijkrake, M. J., Kwakkel, G., & Bloem, B. R. 
(2009). Physical therapy in Parkinson’s disease: Evolution and future 
challenges. Movement Disorders, 24(1), 1–14. article. 
Kieburtz, K., & Wunderle, K. B. (2013). Parkinson’s disease: evidence for 
environmental risk factors. Movement Disorders : Official Journal of the 
Movement Disorder Society, 28(1), 8–13. 
http://doi.org/10.1002/mds.25150 
Kim, S. D., Allen, N. E., Canning, C. G., & Fung, V. S. C. (2013). Postural 
instability in patients with Parkinson’s disease: Epidemiology, 
pathophysiology and management. CNS Drugs, 27(2), 97–112. 
http://doi.org/10.1007/s40263-012-0012-3 
Krassoievitch, M., and Tissot, R. (1971). No Title Etude des reflexes H et T 
dans la maladie de Parkinson. Modi- fications de ces reflexes par la L-
dopa. Encephale, 60, 36–57. 
Kujirai, T., Caramia, M. D., Rothwell, J. C., Day, B. L., Thompson, P. D., 
Ferbert, A., … Marsden, C. D. (1993). Corticocortical inhibition in human 
motor cortex. The Journal of Physiology, 471(1), 501–519. 
http://doi.org/10.1113/jphysiol.1993.sp019912 
Kurtais, Y., Kutlay, S., Tur, B. S., Gok, H., & Akbostanci, C. (2008). Does 
treadmill training improve lower-extremity tasks in Parkinson disease? A 
randomized controlled trial. Clinical Journal of Sport Medicine, 18(3), 
289–291. article. 
118 | R e f e c e n c e s  
 
 
Lang, N., Siebner, H. R., Ward, N. S., Lee, L., Nitsche, M. A., Paulus, W., … 
Frackowiak, R. S. (2005). How does transcranial DC stimulation of the 
primary motor cortex alter regional neuronal activity in the human brain? 
European Journal of Neuroscience, 22(2), 495–504. 
http://doi.org/10.1111/j.1460-9568.2005.04233.x 
Langston, J. W., Langston, E. B., & Irwin, I. (1984). MPTP-induced 
parkinsonism in human and non-human primates--clinical and 
experimental aspects. Acta Neurologica Scandinavica. Supplementum, 
100, 49–54. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/6333134 
Lavoie, B. A., Devanne, H., Capaday, C., Gj, Q., Brigitte, A., & Dif-, C. C. 
(2013). Differential Control of Reciprocal Inhibition During Walking 
Versus Postural and Voluntary Motor Tasks in Humans Differential Control 
of Reciprocal Inhibition During Walking Versus Postural and Voluntary 
Motor Tasks in Humans, 429–438. 
López-Alonso, V., Fernández-del-Olmo, M., Costantini, A., Gonzalez-
Henriquez, J. J., & Cheeran, B. (2015). Intra-individual variability in the 
response to anodal transcranial direct current stimulation. Clinical 
Neurophysiology. http://doi.org/10.1016/j.clinph.2015.03.022 
Lord, S., Baker, K., Nieuwboer, A., Burn, D., & Rochester, L. (2011). Gait 
variability in Parkinson’s disease: An indicator of non-dopaminergic 
contributors to gait dysfunction? Journal of Neurology, 258(4), 566–572. 
http://doi.org/10.1007/s00415-010-5789-8 
Marois, R., Ivanoff, J., Rousselet, G. A., al.,  et, Neumann, J. Von, Chun, M. 
M., … al.,  et. (2005). Capacity limits of information processing in the 
brain. Trends in Cognitive Sciences, 9(6), 296–305. 
http://doi.org/10.1016/j.tics.2005.04.010 
Marquez, J., van Vliet, P., McElduff, P., Lagopoulos, J., & Parsons, M. (2015). 
Transcranial direct current stimulation (tDCS): does it have merit in 
stroke rehabilitation? A systematic review. International Journal of 
Stroke : Official Journal of the International Stroke Society, 10(3), 306–
16. http://doi.org/10.1111/ijs.12169 
Marras, C., & Chaudhuri, K. R. (2016). Nonmotor features of Parkinson’s 
disease subtypes. Movement Disorders : Official Journal of the Movement 
Disorder Society. http://doi.org/10.1002/mds.26510 
Marsden, C. D., & Obeso, J. A. (1994). The functions of the basal ganglia and 
the paradox of stereotaxic surgery in Parkinson’s disease. Brain, 117(4), 
877–897. http://doi.org/10.1093/brain/117.4.877 
Matsui, H., Udaka, F., Miyoshi, T., Hara, N., Tamaura, A., Oda, M., … 
Kameyama, M. (2005). Three-dimensional stereotactic surface projection 
study of freezing of gait and brain perfusion image in Parkinson’s disease. 
Movement Disorders : Official Journal of the Movement Disorder Society, 
20(10), 1272–7. http://doi.org/10.1002/mds.20520 
C h a p t e r  7  R e f e r e n c e s  | 119 
 
 
 
Mehrholz, J., Friis, R., Kugler, J., Twork, S., Storch, A., & Pohl, M. (2010). 
Treadmill training for patients with Parkinson’s disease. Cochrane 
Database of Systematic Reviews (Online), (1). article. 
Mena-Segovia, J., Bolam, J. P., & Magill, P. J. (2004). Pedunculopontine 
nucleus and basal ganglia: distant relatives or part of the same family? 
Trends in Neurosciences, 27(10), 585–8. 
http://doi.org/10.1016/j.tins.2004.07.009 
Meunier, S., Kwon, J., Russmann, H., Ravindran, S., Mazzocchio, R., & Cohen, 
L. (2007). Spinal use-dependent plasticity of synaptic transmission in 
humans after a single cycling session. The Journal of Physiology, 579(2), 
375–388. http://doi.org/10.1113/jphysiol.2006.122911 
Meunier, S., Pol, S., Houeto, J. L., & Vidailhet, M. (2000a). Abnormal 
reciprocal inhibition between antagonist muscles in Parkinson’s disease. 
Brain, 123(5), 1017–1026. article. 
Mito, Y., Yoshida, K., Yabe, I., Makino, K., Tashiro, K., Kikuchi, S., & Sasaki, 
H. (2006). Brain SPECT analysis by 3D-SSP and clinical features of 
Parkinson’s disease. [Hokkaido Igaku Zasshi] The Hokkaido Journal of 
Medical Science, 81(1), 15–23. Retrieved from 
http://europepmc.org/abstract/med/16528976 
Miyai, I., Fujimoto, Y., Ueda, Y., Yamamoto, H., Nozaki, S., Saito, T., & Kang, 
J. (2000). Treadmill training with body weight support: Its effect on 
Parkinson’s disease. Archives of Physical Medicine and Rehabilitation, 
81(7), 849–852. article. 
Miyai, I., Fujimoto, Y., Yamamoto, H., Ueda, Y., Saito, T., Nozaki, S., & Kang, 
J. (2002). Long-term effect of body weight-supported treadmill training 
in Parkinson’s disease: A randomized controlled trial. Archives of Physical 
Medicine and Rehabilitation, 83(10), 1370–1373. article. 
Moreau, M. S., Meunier, S., Vidailhet, M., Pol, S., Galitzky, M., Rascol, O., … 
De, L. (2002). Transmission of group II heteronymous pathways is 
enhanced in rigid lower limb of de novo patients with Parkinson ’ s 
disease. 
Morris, M. E. (2000). Movement Disorders in People With Parkinson Disease: 
A Model for Physical Therapy. Physical Therapy, 80(6). 
Morris, M. E., Iansek, R., Matyas, T. A., & Summers, J. J. (1994). The 
pathogenesis of gait hypokinesia in Parkinson’s disease. Brain, 117(5), 
1169–1181. article. 
Morris, M. E., Iansek, R., Matyas, T. A., & Summers, J. J. (1996). Stride 
length regulation in Parkinson’s disease: Normalization strategies and 
underlying mechanisms. Brain, 119(2), 551–568. article. 
Nadeau A, Pourcher E, C. P. (2014). Effects of 24 wk of treadmill training on 
gait performance in Parkinson’s disease. Med Sci Sports Exerc, 46(4), 
645–55. 
120 | R e f e c e n c e s  
 
 
Neptune, R. R., Kautz, S. A., & Zajac, F. E. (2001). Contributions of the 
individual ankle plantar flexors to support, forward progression and swing 
initiation during walking. Journal of Biomechanics, 34(11), 1387–1398. 
http://doi.org/10.1016/S0021-9290(01)00105-1 
Nielsen, J. B., & Sinkjaer, T. (2002). Afferent feedback in the control of 
human gait. Journal of Electromyography and Kinesiology, 12(3), 213–
217. article. 
Nielsen, J. B., & Sinkjær, T. (2002). Reflex excitation of muscles during 
human walking (Vol. 508). book. 
Nieuwboer, A., Weerdt, W. de, Dom, R., & Lesaffre, E. (2009). A frequency 
and correlation analysis of motor deficits in Parkinson patients. Disability 
and Rehabilitation, 20(4), 142–150. 
http://doi.org/10.3109/09638289809166074 
Nitsche, M. a., & Paulus, W. (2000). Excitability changes induced in the 
human motor cortex by weak transcranial direct current stimulation. The 
Journal of Physiology, 527(3), 633–639. http://doi.org/10.1111/j.1469-
7793.2000.t01-1-00633.x 
Nitsche, M. A., Schauenburg, A., Lang, N., Liebetanz, D., Exner, C., Paulus, 
W., & Tergau, F. (2003). Facilitation of implicit motor learning by weak 
transcranial direct current stimulation of the primary motor cortex in the 
human. Journal of Cognitive Neuroscience, 15(4), 619–26. 
http://doi.org/10.1162/089892903321662994 
Nitsche, M. a, Cohen, L. G., Wassermann, E. M., Priori, A., Lang, N., Antal, 
A., … Pascual-Leone, A. (2008). Transcranial direct current stimulation: 
State of the art 2008. Brain Stimulation, 1(3), 206–23. 
http://doi.org/10.1016/j.brs.2008.06.004 
Nitsche, M. a, Seeber, A., Frommann, K., Klein, C. C., Rochford, C., Nitsche, 
M. S., … Tergau, F. (2005). Modulating parameters of excitability during 
and after transcranial direct current stimulation of the human motor 
cortex. The Journal of Physiology, 568(Pt 1), 291–303. 
http://doi.org/10.1113/jphysiol.2005.092429 
Noyes, K., Liu, H., Li, Y., Holloway, R., & Dick, A. W. (2006). Economic burden 
associated with Parkinson’s disease on elderly Medicare beneficiaries. 
Movement Disorders, 21(3), 362–372. 
http://doi.org/10.1002/mds.20727 
Nutt, J. G. (2001). Motor fluctuations and dyskinesia in Parkinson’s disease. 
Parkinsonism & Related Disorders, 8(2), 101–108. 
http://doi.org/10.1016/S1353-8020(01)00024-4 
Nutt, J. G., Bloem, B. R., Giladi, N., Hallett, M., Horak, F. B., & Nieuwboer, 
A. (2011). Freezing of gait: moving forward on a mysterious clinical 
phenomenon. The Lancet. Neurology, 10(8), 734–44. 
http://doi.org/10.1016/S1474-4422(11)70143-0 
C h a p t e r  7  R e f e r e n c e s  | 121 
 
 
 
O’Shea, S., Morris, M. E., & Iansek, R. (2002). Dual task interference during 
gait in people with Parkinson disease: Effects of motor versus cognitive 
secondary tasks. Physical Therapy, 82(9), 888–897. article. 
Obeso, J. A., Marin, C., Rodriguez-Oroz, C., Blesa, J., Benitez-Temiño, B., 
Mena-Segovia, J., … Olanow, C. W. (2008). The basal ganglia in 
Parkinson’s disease: Current concepts and unexplained observations. 
Annals of Neurology, 64(SUPPL. 2), S30–S46. article. 
Obeso, J. A., Rodríguez-Oroz, M. C., Benitez-Temino, B., Blesa, F. J., Guridi, 
J., Marin, C., & Rodriguez, M. (2008). Functional organization of the basal 
ganglia: Therapeutic implications for Parkinson’s disease. Movement 
Disorders, 23(SUPPL. 3), S548–S559. article. 
Obeso, J. A., Rodriguez-Oroz, M. C., Rodriguez, M., Lanciego, J. L., Artieda, 
J., Gonzalo, N., & Olanow, C. W. (2000). Pathophysiology of the basal 
ganglia in Parkinson’s disease. Trends in Neurosciences, 23(10 SUPPL.), 
S8–S19. article. 
Okuma, Y. (2014). Freezing of gait and falls in Parkinson’s disease. Journal 
of Parkinson’s Disease, 4(2), 255–60. http://doi.org/10.3233/JPD-
130282 
Orlovskiĭ, G. N., Deliagina, T. G., & Grillner, S. . (1999). Neuronal control of 
locomotion: from mollusc to man. Oxford University Press. 
Pahapill, P. A., & Lozano, A. M. (2000). The pedunculopontine nucleus and 
Parkinson’s disease. Brain, 123, 1767–1783. 
Parkinson, J. (2002). An essay on the shaking palsy. 1817. The Journal of 
Neuropsychiatry and Clinical Neurosciences, 14(2), 223–36; discussion 
222. http://doi.org/10.1176/jnp.14.2.223 
Perez, M. a, Lundbye-Jensen, J., & Nielsen, J. B. (2007). Task-specific 
depression of the SOL H-reflex after cocontraction training of antagonistic 
ankle muscles. Journal of Neurophysiology, 98(6), 3677–3687. article. 
http://doi.org/10.1152/jn.00988.2007 
Perez, M. a, Lungholt, B. K. S., Nyborg, K., & Nielsen, J. B. (2004). Motor skill 
training induces changes in the excitability of the leg cortical area in 
healthy humans. Experimental Brain Research, 159(2), 197–205. article. 
http://doi.org/10.1007/s00221-004-1947-5 
Pierantozzi, M., Giuseppina, Æ. M., Salvatore, P. Æ., Paolo, G. Æ., Moschella, 
V., Grazia, Æ. M., … Alessandro, M. Æ. (2008). Pedunculopontine nucleus 
deep brain stimulation changes spinal cord excitability in Parkinson ’ s 
disease patients, 731–735. http://doi.org/10.1007/s00702-007-0001-8 
Plotnik, M., Giladi, N., Dagan, Y., & Hausdorff, J. M. (2011). Postural 
instability and fall risk in Parkinson’s disease: Impaired dual tasking, 
pacing, and bilateral coordination of gait during the “oN” medication 
state. Experimental Brain Research, 210(3–4), 529–538. article. 
122 | R e f e c e n c e s  
 
 
Pohl, M., Rockstroh, G., Rückriem, S., Mrass, G., & Mehrholz, J. (2003). 
Immediate Effects of Speed-Dependent Treadmill Training on Gait 
Parameters in Early Parkinson’s Disease. Archives of Physical Medicine 
and Rehabilitation, 84(12), 1760–1766. article. 
Post, B., van der Eijk, M., Munneke, M., & Bloem, B. R. (2011). 
Multidisciplinary care for Parkinson’s disease: not if, but how! Practical 
Neurology, 11(2), 58–61. http://doi.org/10.1136/jnnp.2011.241604 
Pötter-Nerger, M., & Volkmann, J. (2013). Deep brain stimulation for gait and 
postural symptoms in Parkinson’s disease. Movement Disorders : Official 
Journal of the Movement Disorder Society, 28(11), 1609–15. 
http://doi.org/10.1002/mds.25677 
Protas, E. J., Mitchell, K., Williams, A., Qureshy, H., Caroline, K., & Lai, E. C. 
(2005). Gait and step training to reduce falls in Parkinson’s disease. 
NeuroRehabilitation, 20(3), 183–190. article. 
Ramig, L. O., Sapir, S., Countryman, S., Pawlas, A. A., O’Brien, C., Hoehn, 
M., & Thompson, L. L. (2001). Intensive voice treatment (LSVT(R)) for 
patients with Parkinson’s disease: a 2 year follow up. Journal of 
Neurology, Neurosurgery & Psychiatry, 71(4), 493–498. 
http://doi.org/10.1136/jnnp.71.4.493 
Richardson, J. R., Shalat, S. L., Buckley, B., Winnik, B., O’Suilleabhain, P., 
Diaz-Arrastia, R., … YF, L. (2009). Elevated Serum Pesticide Levels and 
Risk of Parkinson Disease. Archives of Neurology, 66(7), 341–346. 
http://doi.org/10.1001/archneurol.2009.89 
Roche, N., Lackmy,  a, Achache, V., Bussel, B., & Katz, R. (2011). Effects of 
anodal transcranial direct current stimulation over the leg motor area on 
lumbar spinal network excitability in healthy subjects. The Journal of 
Physiology, 589(Pt 11), 2813–26. 
http://doi.org/10.1113/jphysiol.2011.205161 
Roche, N., Lackmy,  a, Achache, V., Bussel, B., & Katz, R. (2012). Effects of 
anodal tDCS on lumbar propriospinal system in healthy subjects. Clinical 
Neurophysiology : Official Journal of the International Federation of 
Clinical Neurophysiology, 123(5), 1027–34. 
http://doi.org/10.1016/j.clinph.2011.09.011 
Rochester, L., Galna, B., Lord, S., & Burn, D. (2014). The nature of dual-task 
interference during gait in incident Parkinson’s disease. Neuroscience, 
265, 83–94. http://doi.org/10.1016/j.neuroscience.2014.01.041 
Rochester, L., Hetherington, V., Jones, D., Nieuwboer, A., Willems, A.-M., 
Kwakkel, G., & Wegen, E. Van. (2004). Attending to the task: 
Interference effects of functional tasks on walking in Parkinson’s disease 
and the roles of cognition, depression, fatigue, and balance. Archives of 
Physical Medicine and Rehabilitation, 85(10), 1578–1585. article. 
Rodriguez-Oroz, M. C., Jahanshahi, M., Krack, P., Litvan, I., Macias, R., 
Bezard, E., & Obeso, J. A. (2009). Initial clinical manifestations of 
C h a p t e r  7  R e f e r e n c e s  | 123 
 
 
 
Parkinson’s disease: features and pathophysiological mechanisms. The 
Lancet Neurology, 8(12), 1128–1139. http://doi.org/10.1016/S1474-
4422(09)70293-5 
Rossini, P. M., Barker, A. T., Berardelli, A., Caramia, M. D., Caruso, G., 
Cracco, R. Q., … Tomberg, C. (1994). Non-invasive electrical and 
magnetic stimulation of the brain, spinal cord and roots: basic principles 
and procedures for routine clinical application. Report of an IFCN 
committee. Electroencephalography and Clinical Neurophysiology, 91(2), 
79–92. http://doi.org/10.1016/0013-4694(94)90029-9 
Meunier, E. Pierrot-Deseilligny, M. S. (1993). Pattern of monosynaptic 
heteronymous Ia connections in the human lower limb. Experimental 
Brain Research, 96(3), 534–544. 
Sage, M. D., & Almeida, Q. J. (2009). Symptom and gait changes after 
sensory attention focused exercise vs aerobic training in Parkinson’s 
disease. Movement Disorders, 24(8), 1132–1138. article. 
Schaafsma, J. D. (2003). Gait dynamics in Parkinson’s disease: Relationship 
to Parkinsonian features, falls and response to levodopa. Journal of the 
Neurological Sciences, 212(1–2), 47–53. article. 
Schapira, A. H., & Jenner, P. (2011). Etiology and pathogenesis of Parkinson’s 
disease. Movement Disorders : Official Journal of the Movement Disorder 
Society, 26(6), 1049–55. http://doi.org/10.1002/mds.23732 
Schrag, A., Jahanshahi, M., & Quinn, N. (2000). How does Parkinson’s disease 
affect quality of life? A comparison with quality of life in the general 
population. Movement Disorders, 15(6), 1112–1118. article. 
Shahed, J., & Jankovic, J. (2007). Motor symptoms in Parkinson ’ s disease, 
83. 
Shepherd, R. (1999). Treadmill walking in neurorehabilitation. 
Neurorehabilitation and Neural Repair, 13(3), 171–173. article. 
Shibasaki Hiroshi Fukuyama, H. H. T. M. S. S. D. G. W. M., Shibasaki, H., 
Fukuyama, H., & Hanakawa, T. (2004). Neural control mechanisms for 
normal versus Parkinsonian gait. Progress in Brain Research, 143(3), 
199–205. misc. http://doi.org/10.1016/S0079-6123(03)43020-3 
Sinkjaer, T., Andersen, J. B., Ladouceur, M., Christensen, L. O. D., & Nielsen, 
J. B. (2000). Major role for sensory feedback in SOL EMG activity in the 
stance phase of walking in man. The Journal of Physiology, 523(3), 817–
827. http://doi.org/10.1111/j.1469-7793.2000.00817.x 
Soh, S.-E., Morris, M. E., & McGinley, J. L. (2011). Determinants of health-
related quality of life in Parkinson’s disease: a systematic review. 
Parkinsonism & Related Disorders, 17(1), 1–9. 
http://doi.org/10.1016/j.parkreldis.2010.08.012 
Springer, S., Giladi, N., Peretz, C., Yogev, G., Simon, E. S., & Hausdorff, J. 
124 | R e f e c e n c e s  
 
 
M. (2006). Dual-tasking effects on gait variability: The role of aging, falls, 
and executive function. Movement Disorders, 21(7), 950–957. article. 
Stacy, M. (2009). Medical Treatment of Parkinson Disease. Neurologic Clinics, 
27(3), 605–631. http://doi.org/10.1016/j.ncl.2009.04.009 
Tolosa, E., & Pont-Sunyer, C. (2011). Progress in defining the premotor phase 
of Parkinson’s disease. Journal of the Neurological Sciences, 310(1–2), 
4–8. http://doi.org/10.1016/j.jns.2011.05.027 
Tombu, M., & Jolicœur, P. (2003). A central capacity sharing model of dual-
task performance. Journal of Experimental Psychology: Human 
Perception and Performance, 29(1), 3–18. http://doi.org/10.1037/0096-
1523.29.1.3 
Tomlinson, C. L. (2012). Physiotherapy versus placebo or no intervention in 
Parkinson’s disease. Cochrane Database of Systematic Reviews, 7. 
article. 
Tomlinson, C. L., Patel, S., Meek, C., Herd, C. P., Clarke, C. E., Stowe, R., … 
Ives, N. (2012). Physiotherapy intervention in Parkinson’s disease: 
systematic review and meta-analysis. Bmj, 345(aug06 1), e5004–e5004. 
http://doi.org/10.1136/bmj.e5004 
Toole, T., Maitland, C. G., Warren, E., Hubmann, M. F., & Panton, L. (2005). 
The effects of loading and unloading treadmill walking on balance, gait, 
fall risk, and daily function in Parkinsonism. NeuroRehabilitation, 20(4), 
307–322. article. 
Tseng, IJ and Yuan, Rey-Yue and Jeng, C. (n.d.). Treadmill Training Improves 
Forward and Backward Gait in Early Parkinson Disease. American Journal 
of Physical Medicine \& rehabilitation/Association of Academic 
Physiatrists. http://doi.org/10.1097/PHM.0000000000000273 
Twelves, D., Perkins, K. S. M., & Counsell, C. (2003). Systematic review of 
incidence studies of Parkinson’s disease. Movement Disorders, 18(1), 
19–31. http://doi.org/10.1002/mds.10305 
Vacherot, F., Attarian, S., Vaugoyeau, M., & Azulay, J. (2010a). A motor 
cortex excitability and gait analysis on Parkinsonian patients. Movement 
Disorders, 25(16), 2747–2755. article. 
Valentino, F., Cosentino, G., Brighina, F., Pozzi, N. G., Sandrini, G., Fierro, 
B., … Pacchetti, C. (2014). Transcranial direct current stimulation for 
treatment of freezing of gait: A cross-over study. Movement Disorders : 
Official Journal of the Movement Disorder Society, 0(0), 1–5. 
http://doi.org/10.1002/mds.25897 
Valls-Solé, J., Pascual-Leone, A., Brasil-Neto, J. P., Cammarota, A., McShane, 
L., & Hallett, M. (1994). Abnormal facilitation of the response to 
transcranial magnetic stimulation in patients with Parkinson’s disease. 
Neurology, 44(4), 735–41. http://doi.org/10.1212/WNL.44.4.735 
C h a p t e r  7  R e f e r e n c e s  | 125 
 
 
 
Valls-Solé, J., & Valldeoriola, F. (2002). Neurophysiological correlate of 
clinical signs in Parkinson’s disease. Clinical Neurophysiology, 113(6), 
792–805. http://doi.org/10.1016/S1388-2457(02)00080-9 
Van Den Eeden, S. K. (2003). Incidence of Parkinson’s Disease: Variation by 
Age, Gender, and Race/Ethnicity. American Journal of Epidemiology, 
157(>11), 1015–1022. http://doi.org/10.1093/aje/kwg068 
Van der Marck, M. A., & Bloem, B. R. (2014). How to organize multispecialty 
care for patients with Parkinson’s disease. Parkinsonism & Related 
Disorders, 20 Suppl 1, S167-73. http://doi.org/10.1016/S1353-
8020(13)70040-3 
Verheyden, G., Purdey, J., Burnett, M., Cole, J., & Ashburn, A. (2013). 
Immediate effect of transcranial direct current stimulation on postural 
stability and functional mobility in Parkinson’s disease. Movement 
Disorders : Official Journal of the Movement Disorder Society, 28(14), 
2040–1. http://doi.org/10.1002/mds.25640 
Warner, T. T., & Schapira, A. H. V. (2003). Genetic and environmental factors 
in the cause of Parkinson’s disease. Annals of Neurology, 53 Suppl 3, 
S16-23–5. http://doi.org/10.1002/ana.10487 
Werhahn, K. J., Kunesch, E., Noachtar, S., Benecke, R., & Classen, J. (1999). 
Differential effects on motorcortical inhibition induced by blockade of 
GABA uptake in humans. The Journal of Physiology, 517(2), 591–597. 
http://doi.org/10.1111/j.1469-7793.1999.0591t.x 
Wernig, A., & Müller, S. (1992). Laufband locomotion with body weight 
support improved walking in persons with severe spinal cord injuries. 
Paraplegia, 30(4), 229–38. http://doi.org/10.1038/sc.1992.61 
Wichmann, T., Delong, M. R., Guridi, J., & Obeso, J. A. (2011). Milestones in 
research on the pathophysiology of Parkinson’s disease. Movement 
Disorders, 26(6), 1032–1041. http://doi.org/10.1002/mds.23695 
Wild, L., de Lima, D., Balardin, J., Rizzi, L., Giacobbo, B., Oliveira, H., … 
Bromberg, E. (2013). Characterization of cognitive and motor 
performance during dual-tasking in healthy older adults and patients with 
Parkinson’s disease. Journal of Neurology, 260(2), 580–589. article. 
Wirdefeldt, K., Adami, H.-O., Cole, P., Trichopoulos, D., & Mandel, J. (2011). 
Epidemiology and etiology of Parkinson’s disease: A review of the 
evidence. European Journal of Epidemiology, 26(SUPPL. 1), S1–S58. 
article. 
Wolters Ch., E., de Munter, H., & Steinbusch, H. (2014). Parkinson´s Disease. 
In E. C. Wolters & C. R. Bauman (Eds.), Parkinson Disease and Other 
Movement Disorders (pp. 149–162). Amsterdam: VU University Press. 
Wood, B. H., Bilclough, J. A., Bowron, A., & Walker, R. W. (2002). Incidence 
and prediction of falls in Parkinson’s disease: a prospective 
multidisciplinary study. Journal of Neurology, Neurosurgery, and 
126 | R e f e c e n c e s  
 
 
Psychiatry, 72(6), 721–5. Retrieved from 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1737913&t
ool=pmcentrez&rendertype=abstract 
Yogev, G., Giladi, N., Peretz, C., Springer, S., Simon, E. S., & Hausdorff, J. 
M. (2005). Dual tasking, gait rhythmicity, and Parkinson’s disease: Which 
aspects of gait are attention demanding? European Journal of 
Neuroscience, 22(5), 1248–1256. article. 
Yogev-Seligmann, G., Hausdorff, J. M., & Giladi, N. (2008). The role of 
executive function and attention in gait. Movement Disorders, 23(3), 
329–342. article. 
Yogev-Seligmann, G., Hausdorff, J. M., & Giladi, N. (2012). Do we always 
prioritize balance when walking? Towards an integrated model of task 
prioritization. Movement Disorders : Official Journal of the Movement 
Disorder Society, 27(6), 765–70. http://doi.org/10.1002/mds.24963 
Yogev-Seligmann, G., Rotem-Galili, Y., Dickstein, R., Giladi, N., & Hausdorff, 
J. M. (2012). Effects of explicit prioritization on dual task walking in 
patients with Parkinson’s disease. Gait and Posture, 35(4), 641–646. 
article. 
Yu, P. N. G., Bruce, R. A., Lovejoy, F. W., & Mcdowell, M. E. (1951). Variations 
in Electrocardiographic Responses during Exercise. Circulation, 3(3). 
Zhang, R., Wang, Z., Howson, P. A., Xia, Z., Zhou, S., Wu, E., … Hu, Y. 
(2012). Smilagenin attenuates beta amyloid (25–35)-induced 
degeneration of neuronal cells via stimulating the gene expression of 
brain-derived neurotrophic factor. Neuroscience, 210, 275–285. 
http://doi.org/10.1016/j.neuroscience.2012.03.017 
Zhu, H., Lu, Z., Jin, Y., Duan, X., Teng, J., Duan, D., … Herwig, U. (2015). 
Low-frequency repetitive transcranial magnetic stimulation on Parkinson 
motor function: a meta-analysis of randomised controlled trials. Acta 
Neuropsychiatrica, 27(2), 82–89. http://doi.org/10.1017/neu.2014.43 
Ziemann, U., L�nnecker, S., Steinhoff, B., & Paulus, W. (1996). The effect 
of lorazepam on the motor cortical excitability in man. Experimental Brain 
Research, 109(1). http://doi.org/10.1007/BF00228633 
Zweig, R. M., Jankel, W. R., Hedreen, J. C., Mayeux, R., & Price, D. L. (1989). 
The pedunculopontine nucleus in Parkinson’s disease. Annals of 
Neurology, 26(1), 41–6. http://doi.org/10.1002/ana.410260106 
  
 
 
 
 
CHAPTER 8.     
APPENDIX 
  
C h a p t e r  8  A p p e n d i x  | 129 
 
 
 
8.1 Resumen 
La enfermedad de Parkinson (EP) es una enfermedad neurodegenerativa, 
caracterizada por un conjunto de síntomas motores y no motores. Los 
trastornos de la marcha se consideran entre los síntomas motores más 
incapacitantes que afectan severamente a la calidad de vida de los pacientes 
con EP. 
En las últimas décadas, el tapiz rodante ha sido explorado como una 
herramienta que mejora la marcha de los pacientes con EP. Varias semanas 
de entrenamiento en tapiz rodante condujeron a mejoras en varios 
parámetros cinemáticos, tales como un aumento de la longitud de zancada y 
la velocidad de la marcha, como también una menor variabilidad temporal de 
la marcha (Bello, 2013, Nadeau Et al., 2014, Tseng et al., 2015). Un estudio 
reciente mostró que las  mejoras de la marcha perduraron incluso 6 meses 
después del entrenamiento en tapiz rodante (Nadeau et al., 2014). Además 
de estos efectos a largo plazo, también se han reportado mejoras inmediatas 
después de una sola sesión de tapiz rodante en la EP (Bello et al., 2008). 
Conocer los mecanismos subyacentes a estas mejoras, ayudará a aumentar 
la eficacia y la prescripción de la fisioterapia en la EP. Sin embargo, a pesar 
de la creciente evidencia que vincula la marcha a la función cognitiva, todavía 
no sabemos el papel de la atención como mecanismo subyacente a las 
mejoras de la marcha asociadas al tapiz rodante en la EP. De la misma 
manera, no se han explorado los posibles mecanismos neurofisiológicos 
asociados. 
Por otro lado, se ha explorado recientemente la estimulación transcraneal 
de corriente continua directa (tDCS), una modalidad de estimulación cerebral 
no invasiva, para mejorar la marcha en la EP, ofreciendo una herramienta 
prometedora para potenciar la eficacia de las estrategias de rehabilitación, 
además de mejorar nuestra comprensión de la fisiopatología en la EP. Sin 
embargo, todavía no ha investigado la combinación de tDCS con el tapiz 
rodante en la EP. 
130 | A p p e n d i x  
 
 
Por lo tanto, pese a la literatura existente en torno al uso del tapiz rodante 
en la rehabilitación de la marcha en la EP, algunas cuestiones de interés 
siguen sin resolverse: 
1) ¿Las demandas atencionales son un mecanismo subyacente a las 
mejoras de la marcha asociadas al uso del tapiz rondante en la EP? 
2) ¿Cuál es el coste cognitivo de la marcha en el tapiz rodante y en el suelo 
bajo la condición de doble tarea en la EP? 
3) ¿Podría una sesión de tapiz rodante conducir a mejoras en la marcha en 
pacientes con EP en comparación con una sesión de marcha sobre el suelo? 
4) ¿Cuáles son los mecanismos neurales que subyacen a las mejoras de la 
marcha relacionadas con el tapiz rondate en individuos con EP? 
5) ¿Cuáles son los efectos de la combinación de la tDCS y el tapiz rodante 
sobre la marcha de personas con EP? 
6) ¿Cuáles son los efectos neurofisiológicos de la combinación de la tDCS 
y el tapiz rodante en personas con de EP? 
Para responder a estas preguntas se han llevado a cabo tres estudios. Las 
preguntas 1 y 2 se abordarán en el primer estudio. Las preguntas 3 y 4 se 
abordarán en el segundo estudio. Las preguntas 5 y 6 se abordarán en el 
tercer estudio. 
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8.2 Estudio 1: Patrón de la marcha y rendimiento cognitivo 
durante la marcha en tapiz rodante en la EP 
El objetivo del primer estudio fue explorar si las demandas atencionales 
están involucradas en las mejoras de la marcha en pacientes con EP cuando 
caminan en un tapiz rodante.  
Para ello se contó con una muestra de 19 individuos con EP idiopático y 
19 controles sanos. Los participantes caminaron sobre un tapiz rodante y 
sobre el suelo bajo las condiciones de tarea simple (caminar solamente) y 
doble tarea (DT) (caminar realizando una tarea cognitiva simultánea). El 
paradigma de la DT se utilizó para evaluar a la influencia de la atención sobre 
la marcha. La tarea cognitiva utilizada fue el "paradigma del monitoreo de 
fonemas". Éste consistió en contar las veces que se repetían dos palabras, 
especificadas previamente, en un texto que se escuchaba a través de unos 
auriculares.  
Se midieron la velocidad, la longitud de zancada, la frecuencia de zancada, 
el CV de la longitud de zancada y el CV de la frecuencia de zancada. También 
se evaluó el rendimiento cognitivo, medido en función del porcentaje de 
errores cometidos en la tarea cognitiva. Nuestra hipótesis inicial fue que el 
desempeño de una tarea cognitiva durante la marcha en tapiz rodante 
conduciría a un deterioro en una o ambas de las tareas en los individuos con 
EP. En cuanto al análisis estadístico se utilizó una ANOVA de medidas 
repetidas de tres factores y comparaciones post hoc, para las variables de la 
marcha. Se utilizó la prueba de rango de Wilcoxon y la prueba de Mann-
Whitney para la variable de no paramétrica del rendimiento cognitivo. 
Los resultados revelaron que el grupo con EP caminó con una menor 
variabilidad temporal y espacial de la marcha sobre el tapiz rodante en 
comparación con el suelo. Sin embargo, esta reducción de la variabilidad no 
se deterioró durante la DT. Por otra parte, no hubo diferencias en el 
rendimiento cognitivo entre el tapiz y el suelo (TablaA1). 
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Tabla A1. Media, desviación típica y resultados de la ANOVA de las variables 
de la marcha. 
A. Variables de la marcha en los grupos EP y control.  
 EP CONTROL 
 Suelo Tapizl Suelo Tapiz 
 ST DT ST DT ST DT ST DT 
Velocidad 
(m/s) 
1.07 ± 
0.23 
1.01 ± 
0.24 
1.07 ± 
0.23 
1.07 ± 
0.23 
1.33 ± 
0.20 
1.25 ± 
0.22 
1.33 ± 
0.20 
1.33 ± 
0.20 
Longitud de 
zancada 
(m) 
1.18 ± 
0.20 
1.13 ± 
0.20 
1.20 ± 
0.23 
1.19 ± 
0.24 
1.35 ± 
0.17 
1.31 ± 
0.17 
1.34 ± 
0.18 
1.36 ± 
0.16 
Frecuencia 
de zancada 
(Hz) 
0.90 ± 
0.07 
0.93 ± 
0.15 
0.90 ± 
0.07 
0.93 ± 
0.09 
0.98 ± 
0.07 
0.95 ± 
0.09 
1.00 ± 
0.09 
0.98 ± 
0.08 
CV de la 
longitud de 
zancada 
(%) 
4.27 ± 
2.52 
4.63 ± 
2.44 
1.73 ± 
0.93 
1.54 ± 
0.76 
2.65 ± 
1.00 
3.35 ± 
1.41 
1.56 ± 
0.84 
1.56 ± 
0.83 
CV de la 
frecuencia 
de zancada 
(%) 
2.60 ± 
0.80 
2.96 ± 
0.94 
1.90 ± 
1.12 
1.88 ± 
1.07 
1.84 ± 
0.53 
2.37 ± 
0.91 
2.91 ± 
1.97 
2.80 ± 
2.01 
Los valores son media ± SD.  EP, Enfermedad de Parkinson; ST, Tarea simple; DT, doble 
tarea; CV, Coeficiente de Variación. 
B. Resultados de la ANOVA de las variables de la marcha. 
 Superficie Tarea Grupo 
Superficie
× 
Tarea 
Surperfici
e× 
Grupo 
Tarea× 
Grupo 
Superficie
× 
Tarea× 
Grupo 
Velocidad 
(m/s) __ 
F=46.76 
P<0.001 
F=12.03 
P=0.001 __ __ NS NS 
Logitud de 
zancada (m) 
F=8.00 
P=0.008 
F=21.32 
P<0.001 
F=6.73 
P=0.01 
F= 29.77 
P<0.001 NS NS NS 
Frecuencia 
de zancada 
(Hz) 
NS NS F=7.37 P=0.01 NS NS NS NS 
CV de la 
longitud de 
zancada (%) 
F=73.35 
P<0.001 NS 
F=4.11 
P=0.05 
F=5.72 
P=0.02 
F=7.67 
P=0.009 NS NS 
CV de la 
frecuencia de 
zancada (%) 
NS NS NS F=4.65 P=0.04 
F=11.71 
P=0.002 NS NS 
CV, Coeficiente de Variación; NS, No significativo. 
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Por lo tanto, los resultados de este estudio mostraron que durante la 
marcha en el tapiz rodante, los individuos con EP redujeron su variabilidad 
de la marcha. Redujeron tanto la variabilidad temporal, de acuerdo con 
estudios previos, como espacial, siendo este el primer estudio que lo indica. 
Por lo tanto, el presente trabajo extiende los beneficios del tapiz rodante en 
la EP. 
Además, las mejoras de la marcha observadas no se deterioraron con el 
desempeño de una tarea cognitiva concurrente. Y, por otra parte, el 
rendimiento cognitivo no mostró diferencias estadísticas entre la el tapiz y 
suelo. Lo que sugiere que las mejoras la marcha observadas en este estudio 
en personas con EP no se deben únicamente a los mecanismos atencionales. 
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8.3 Estudio 2: Efectos cinemáticos y neurofisiológicos 
inmediatos de la marcha sobre el tapiz rodante y en 
suelo en la EP 
El uso del tapiz rodante como una herramienta de rehabilitación de la 
marcha ha proporcionado nuevas opciones para el tratamiento de los 
desórdenes de la marcha en la EP. Sin embargo, los mecanismos neuronales 
subyacentes a estos efectos terapéuticos en la EP siguen siendo 
desconocidos.  
El objetivo del segundo estudio fue examinar los efectos inmediatos a 
corto plazo de una sola sesión de marcha en tapiz y de una sesión de marcha 
en suelo sobre los parámetros espinales y corticales en la EP.  
Quince participantes con EP idiopático se evaluaron bajo estas dos 
condiciones de marcha, en sesiones separadas: marcha en tapiz rodante y 
marcha en suelo. Se realizaron las siguientes mediciones antes y después de 
cada condición: se evaluó la cinemática de la marcha en el suelo, el reflejo H 
de músculo sóleo, el reflejo de inhibición recíproca-Ia del músculo tibial al 
músculo sóleo, la facilitación intracortical (ICF) y la inhibición intracortical 
(SICI) del músculo tibial (Figura A1). En cuanto al Análisis estadístico se 
utilizó una ANOVA de medidas repetidas y comparaciones post hoc. 
 
 
Figura 1A. Esquema de una sesión experimental del estudio II.. 
El protocolo de la marcha consistió en 4 bloques (5 minutos por bloque) de narcha 
en tapiz y marcha en suelo, con tres minutos de descanso entre bloques. 
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Se observó que la velocidad de la marcha aumentó significativamente 
después de la sesión tapiz y no después de la sesión suelo. Lo mismo ocurrió 
con la longitud de zancada, que fue significativamente mayor después de que 
los participantes caminaran en el tapiz, pero no después de que caminasen 
en suelo. El resto de las variables de la marcha no mostraron diferencias 
significativas. Por otra parte, en cuanto a las variables neurofisiológicas, el 
reflejo H del sóleo, expresado como el ratio entre la onda H máxima de la 
respuesta motora refleja y la máxima onda M, de la respuesta de las 
motoneuronas alfa estimuladas directamente, disminuyó significativamente 
después de ambas sesiones. Lo mismo ha ocurrido con la ICF, cuyos valores 
fueron menores después de la sesión tapiz y de la sesión suelo. Mientras que 
la SICI y el reflejo de inhibición recíproca-Ia, no mostraron diferencias 
significativas. 
Según nuestro conocimiento, el estudio actual es el primero en demostrar 
que 20 minutos de marcha en suelo no produce mejoras en la marcha en los 
sujetos con EP, sugiriendo un efecto terapéutico inmediato específico del tapiz 
rodante en la EP. Sin embargo, ambas condiciones de marcha modulaban los 
parámetros espinales y corticales de una manera similar. Al no haber 
diferencias entre las superficies, estos hallazgos sugieren que los cambios 
observados tanto el reflejo H como la facilitación intracortical, se deben al 
simple hecho de caminar y no están relacionados con las mejoras de la 
marcha asociadas a una sesión de tapiz rodante en la EP. 
Por lo tanto, este estudio proporciona evidencia de un efecto terapéutico 
específico de una sola sesión de marcha en tapiz rodante en la EP, siendo 
necesarios más estudios para explorar otros posibles mecanismos 
neuronales. 
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8.4 Estudio 3: La marcha en tapiz rodante en combinación 
con la tDCS en la EP: Un estudio piloto de los efectos 
cinemáticos y neurofisiológicos 
El uso del tapiz rodante como una herramienta de rehabilitación de la 
marcha y los avances en la estimulación cerebral no invasiva han 
proporcionado opciones nuevas y de bajo riesgo para el tratamiento de los 
desórdenes de la marcha en la EP. 
En el presente estudio se ha investigado si la tDCS en combinación con el 
tapiz rodante potencia las mejoras en la marcha asociadas a caminar sobre 
este dispositivo en la EP. Se exploraron los efectos de la terapia combinada 
en los parámetros cinemáticos de la marcha y en los neurofisiológicos, tanto 
espinales como corticales.  
Se evaluaron 18 participantes con EP idiopático en sesiones separadas, 
bajo tres condiciones de marcha en tapiz: marcha en tapiz rodante solamente 
(tapiz), marcha en tapiz rodante combinada con tDCS anódica (AtDCS + 
tapiz) y marcha en tapiz rodante con tDCS simulada (stDCS + tapiz rodante). 
Se midió la cinemática de la marcha en suelo, el reflejo H del SOL, el reflejo 
de inhibición recíproca-Ia del músculo TA al SOL, la ICF y SICI del músculo 
TA. También se evaluó el reflejo H del SOL y la cinemática de la marcha sobre 
el tapiz rodante. En cuanto al análisis estadístico se utilizó una ANOVA de 
medidas repetidas y comparaciones post hoc. 
En cuanto a los resultados de la cinemática de la marcha, se observó que 
la longitud de zancada aumentó significativamente durante la marcha en 
tapiz, en comparación con la marcha previa en suelo, sin distinción entre las 
sesiones. Mientras que el CV de la longitud de zancada disminuyó durante la 
marcha en tapiz en comparación con la marcha en suelo medida previamente, 
para todas las sesiones.  
Por otra parte, se observó que la longitud de zancada y la velocidad de la 
marcha aumentaron significativamente después de las sesiones para todas 
las condiciones.   
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Por lo tanto, estos datos apoyan la evidencia de que durante y después 
de una sesión sobre el tapiz rodante, las personas con EP mejoran el 
rendimiento de su marcha. Sin embargo, la combinación de marcha en tapiz 
rodante y tDCS anodal no condujo a unas mejoras mayores. 
En cuanto a los parámetros neurofisiológicos, observamos que la ICF 
disminuyó significativamente después de todas las sesiones en comparación 
con antes, mientras que el SICI aumentó significativamente después de todas 
las sesiones en comparación con antes. El reflejo H, expresado como el ratio 
entre la onda H máxima y la onda M máxima, disminuyó significativamente 
después en comparación con antes, de nuevo sin distinción entre las 
sesiones. De nuevo, la excitabilidad del reflejo H durante la marcha en tapiz 
mostró un comportamiento similar entre las tres sesiones. Por lo tanto, todas 
las condiciones de marcha en tapiz mejoraron la cinemática de la marcha y 
modularon los parámetros espinales y corticales de manera similar 
Sin embrago, la inhibición recíproca del músculo TA al SOL disminuyó 
significativamente después de la sesión tDCS simulada y de la sesión tapiz 
solamente. Pero, curiosamente, la sesión combinada con tDCS anodal, no 
indujo una reducción en este reflejo. Este efecto específico puede ser el 
resultado de una interacción entre el tDCS anodal y la marcha en tapiz 
rodante.  
Por lo tanto, a pesar de que una sola sesión combinada de marcha en tapiz 
y tDCS anodal no potenció las mejoras de los parámetros de la marcha 
asociados con la marcha en tapiz en la EP, la modulación específica del refejo 
de Inhibición Recíproc-Ia apunta a una interacción de los efectos de estas 
herramientas. Se necesitan más estudios para explorar el significado 
funcional de esta interacción. 
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8.5 Conclusiones 
• Los recursos atencionales no influyen en las mejoras de la marcha 
observadas en los individuos con EP cuando caminan sobre un tapiz 
rodante. 
• Las mejoras de la marcha en pacientes con EP durante la caminata 
en tapiz rodante son independientes de la focalización de la 
atención sobre la tarea de caminar.  
• El desplazamiento de la banda rodante y la velocidad constante son 
los principales mecanismos subyacentes a las mejoras de la marcha 
asociadas al tapiz rodante en personas con EP. 
• Una sola sesión de marcha en tapiz rodante, pero no de marcha 
sobre el suelo, condujo a unas mejoras de la marcha en sujetos con 
EP, lo que sugiere un efecto terapéutico específico del tapiz en la 
EP. 
• Las medidas de las modulaciones espinales y corticales incluidas en 
esta tesis, como el reflejo de estiramiento monosináptico y reflejo 
de inhibición recíproca, así como SICI e ICF, no están asociadas con 
el efecto terapéutico específico de la marcha en tapiz rodante en 
pacientes con EP. 
• La modulación del reflejo H en los pacientes con EP durante la 
marcha en tapiz rodante es similar a la reportada en sujetos sanos, 
por lo que la contribución de esta vía refleja durante la marcha en 
el tapiz rodante no se ve afectada en la EP. 
• Una sola sesión de marcha en tapiz rodante combinada con la tDCS 
anodal aplicada sobre la corteza motora primaria no potencia las 
mejoras de los parámetros de la marcha asociados con la marcha 
en tapiz rodante en sujetos con EP. 
• La combinación de ambas técnicas resultó en una modulación 
específica del reflejo de inhibición recíproca Ia del músculo TA al 
músculo SOL. Se necesitan más estudios para explorar el 
significado funcional de esta interacción. 
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8.6 Limitaciones 
Hay varias limitaciones en esta tesis que deben ser abordadas. 
• La gravedad de los síntomas de la EP en los participantes fue 
moderada. Se ha demostrado que las mejoras en la marcha como 
resultado del entrenamiento en tapiz rodante son más marcadas en 
las etapas avanzadas en comparación con sujetos con EP moderada 
(Bello et al., 2008). Además, se ha informado de que la tDCS anodal 
combinado con el entrenamiento físico proporciona mejoras en la 
marcha en pacientes con EP avanzado (Kaski et al., 2014). Puede 
haber un efecto techo sobre las mejoras en la marcha y de los 
efectos neurales en pacientes con EP moderado. Por lo tanto, sería 
importante replicar los estudios incluidos en esta tesis en pacientes 
con EP avanzado. 
• Los pacientes de EP se sometieron a las pruebas sólo en estado 
"ON". La medicación puede haber influido en el rendimiento 
cognitivo y de la marcha, ya que se sabe que los desórdenes de la 
marcha durante la doble tarea se mejoran con los medicamentos 
antiparkinsonianos (Lord et al., 2011). Además, los efectos de la 
marcha en tapiz combinada con la tDCS de tipo anodal no pueden 
ser aplicables a pacientes en estado "OFF". Sin embargo, desde el 
punto de vista de la rehabilitación, es más informativo explorar esto 
en el estado "ON". 
• En los estudios 2 y 3 no se incluyeron los sujetos control, ya que 
uno de los principales objetivos fue comparar parámetros 
neurofisiológicos en pacientes con EP en diferentes condiciones de 
la marcha, en lugar de en sujetos sanos. Sin embargo, estudios 
futuros incluyendo sujetos controles sanos, están justificados para 
determinar si las modulaciones espinales y corticales son 
específicas para la EP. 
• Varios de los parámetros neurofisiológicos medidos 
(concretamente, SICI e ICF) se obtuvieron en reposo. A pesar de 
que se contempló que estos parámetros serían funcionalmente más 
informativos si se registraran durante el movimiento, supuso un 
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reto metodológico hacerlo mientras los pacientes estuvieran 
caminando sobre el tapiz rodante. 
